He-P
4062.01 Purpose. The purpose of this rule is to set forth the
requirements that the waste generator must comply with to show that the
material in question is properly classified, described, packaged, marked,
labeled and is in proper condition for transport.
Source. #7958, eff 9-20-03; ss by #9981, eff 9-20-11; ss by #12873, INTERIM, eff 9-25-19, EXPIRED: 3-23-20
New. #13062, eff 6-25-20
He-P 4062.02 Scope.
This rule shall apply to any person involved in the transfer for
disposal and disposal of waste, including the waste generator, waste collector,
waste processor, and disposal facility operator.
Source. #7958, eff 9-20-03; ss by #9981, eff 9-20-11; ss by #12873, INTERIM, eff 9-25-19, EXPIRED: 3-23-20
New. #13062, eff 6-25-20
He-P 4062.03 Transfer for Disposal and Manifests.
(a)
Any licensee shipping radioactive waste intended for ultimate disposal
at a licensed land disposal facility must document the information required on NRC's
Uniform Low-Level Radioactive Waste Manifest and transfer this recorded
manifest information to the intended consignee in accordance with appendix G to
10 CFR part 20.
(b)
Each shipment manifest must include a certification by the waste
generator as specified in section II of appendix G to 10 CFR part 20.
(c)
Each person involved in the transfer for disposal and disposal of waste,
including the waste generator, waste collector, waste processor, and disposal
facility operator, shall comply with the requirements specified in section III
of appendix G to 10 CFR part 20.
Source. #7958, eff 9-20-03; ss by #9981, eff 9-20-11; ss by #12873, INTERIM, eff 9-25-19, EXPIRED: 3-23-20
New. #13062, eff 6-25-20
PART He-P 4063 -
4069 Reserved
PART He-P
4070 FEES FOR CERTIFICATES OF
REGISTRATION, RADIOACTIVE MATERIAL LICENSES, AND OTHER REGULATORY SERVICES
He-P 4070.01 Purpose. The rules in this part establish fees for
radioactive material licensing, general licensed device registration, radiation or MRI machine registration, and provide for their
payment.
Source. #5903, eff 2-1-95, EXPIRED: 2-1-01
New. #7919, eff 7-18-03; ss by #9947, eff 6-22-11; ss by #10865, eff 6-25-15
He-P 4070.02 Scope. Except as otherwise specifically provided,
the rules in this part shall apply to any person who is an applicant for, or a
holder of:
(a) A radioactive
material license or a general licensed device registration issued pursuant to
He-P 4030, He‑P 4031, He-P 4032, He-P 4033, He-P 4034, He-P 4035, He-P
4036, He-P 4037, or He-P 4039; or
(b) A certificate
of registration for radiation or MRI machines issued pursuant to He-P 4040.
Source. #5903, eff 2-1-95, EXPIRED: 2-1-01
New. #7919, eff 7-18-03; ss by #9947, eff 6-22-11; ss by #10865, eff 6-25-15
He-P 4070.03 Payment of Fees.
(a) Each application for a radioactive material license
or a general licensed device registration shall be accompanied by a fee equal
to the annual fee described in He-P 4070.05.
(b) An application for a license covering more
than one fee category shall be accompanied by the prescribed fee for the
highest fee category.
(c) An application for a certificate of
registration shall be accompanied by the annual fee described in He-P 4070.06.
(d) The total annual fee paid for a certificate
of registration for radiation and MRI machines located at any one physical
address shall not exceed $25,000.
(e) No application for a certificate of
registration shall be accepted for filing or processed prior to payment of the
full amount required.
(f) An application for an amendment to a license
that results in a change to a category with a higher fee shall result in a fee
being charged equal to the prorated difference between the fee for the current
category and the one to which the amended license will escalate.
(g) The prorated costs in (f) above shall be
based on monthly intervals and shall be charged from the first day of the month
the amendment is effective until the expiration date of the license.
(h) The department of health and human services
(DHHS) shall bill the licensee for the prorated amounts required by (f) and (g)
above accordingly.
Source. #5903, eff 2-1-95, EXPIRED: 2-1-01
New. #7919, eff 7-18-03; ss by #9947, eff 6-22-11; ss by #10865, eff 6-25-15
He-P 4070.04 Method of Payment.
(a) Fee payment shall be:
(1) In cash; or
(2) By check or money order made payable to
“Treasurer - State of
(b) The payments may be made by personal delivery
or by mail.
Source. #5903, eff 2-1-95, EXPIRED: 2-1-01
New. #7919, eff 7-18-03; ss by #9947, eff 6-22-11; ss by #10865, eff 6-25-15
He-P 4070.05 Schedule of Annual Fees for Radioactive Material
Licenses and General Licensed Device Registrations.
(a) The rules in this section establish annual
fees that shall apply in accordance with He-P 4070.02(a).
(b) The categories of licensure and the annual
fee by category shall be set out in Table 4070.1, “Annual Fees for Radioactive
Material Licenses and Services.”
(c) The category of general licensed devices and
the annual fee per location of use of all devices possessed and registered,
shall be set out in Table 4070.1-B, “Annual Fees for Registered General
Licensed Devices.”
(d) The criteria for registration of general
licensed devices shall be set out in Table 4070.1-C, “Criteria for Registration
of General Licensed Devices,” and in He-P 4031.04(e).
(e) The annual fee for general
licensed devices shall not be per device, but shall be assessed per location of
use regardless of the number of devices possessed and registered by the
registrant. A location of use may
consist of different buildings in the same general location which may have
different street addresses.
Table
4070.1-A Annual Fees for Radioactive
Material Licenses
and Services
License or
Service Category |
Annual Fee |
|
|
Accelerator (Licenses authorizing
production and possession of radioactive material produced by an accelerator) |
$6500 |
|
Agency-Accepted
Training Course (Licenses authorizing
possession and use of radioactive material for the purposes of providing
training in the use of radioactive material or devices containing radioactive
material) |
$1500 |
|
Bone Mineral
Analyzer (Licenses
authorizing possession and use of radioactive material in bone mineral
analyzers for human or veterinary diagnostic purposes) |
$850 |
|
Broad Scope
License (Licenses of
broad scope authorizing possession and use of radioactive material issued
under parts He-P 4030 and 4033 of this chapter for research and development
purposes, and/or for processing or manufacturing of items containing
radioactive material for commercial distribution, and/or for diagnostic
and/or therapeutic veterinary or human use of radioactive material) |
$5500 |
|
Calibration
Service (survey instruments)
(Licenses authorizing possession and use of radioactive material in survey
instrument calibration services) |
$850 |
|
Calibration
Service (using reference sources) (Licenses authorizing
possession and use of radioactive material as reference sources for
calibration services) |
$750 |
|
Civil Defense (Licenses
authorizing possession and use of radioactive material for civil defense
activities) |
$850 |
|
Decontamination/Decommissioning
Services (Licenses
authorizing possession and receipt of radioactive materials or items
contaminated with radioactive material for the purposes of decontaminating
such items) |
$6500 |
|
Demonstration/Sales (Licenses
authorizing possession and use of devices containing radioactive material for
demonstration, exhibition or sales purposes) |
$1300 |
|
Distribution
Only (Licenses authorizing
receipt, storage and distribution of radioactive material or items containing
radioactive material, not involving processing or manufacturing of
radioactive material or items containing radioactive material) |
$4300 |
|
Environmental
Laboratory (Licenses
authorizing possession and use of radioactive material for environmental
laboratory use purposes) |
$650 |
|
Eye Applicator (Licenses
authorizing possession and use of eye applicator devices containing
radioactive material for therapeutic human or veterinary purposes) |
$850 |
|
Fixed Multi-Beam
Teletherapy (Licenses
authorizing possession and use of fixed multi-beam teletherapy devices
containing radioactive material for therapeutic human purposes) |
$3800 |
|
Fluorescence
X-Ray Analyzer (in-plant use only) (Licenses
authorizing possession and use of radioactive material as sealed sources for
use in portable x-ray fluorescence analyzers) |
$650 |
|
Fluorescence
X-Ray Analyzer (temporary job sites) (Licenses authorizing
possession, use and transport of radioactive material as sealed sources for
use in portable x-ray fluorescence analyzers) |
$850 |
|
Hand-held Light
Intensifying Imaging Device (Licenses
authorizing possession and use of radioactive material as sealed sources for
use in hand-held light intensifying imaging devices) |
$750 |
|
Gas
Chromatograph (Licenses
authorizing possession and use of radioactive material in sealed sources for
use in gas chromatography devices) |
$550 |
|
Gauges (fixed) (Licenses
authorizing possession and use of radioactive material as sealed sources for
use in fixed gauging devices) |
$700 |
|
Gauges (portable
or mobile) (Licenses
authorizing possession, use and transport of radioactive material in sealed
sources in portable or mobile gauging devices) |
$950 |
|
Industrial
Radiography (fixed facility) (Licenses
authorizing possession and use of radioactive material issued under Parts
He-P 4030 and He-P 4034 of this chapter for industrial radiography at fixed
facility/permanent sites) |
$4000 |
|
Industrial
Radiography (temporary field site) (Licenses
authorizing possession, use and transport of radioactive material issued
under Parts He-P 4030 and He-P 4034 for industrial radiography at temporary
jobsites) |
$4500 |
|
Installation,
Repair, or Maintenance (Licenses
authorizing possession of radioactive material incident to installation,
repair, or maintenance of devices containing radioactive sources, or for possession
only of naturally occurring radioactive material incident to technological
enhancement) |
$1100 |
|
In-vitro Use of
Radioactive Materials (Licenses
authorizing possession and use of radioactive material for in-vitro testing
and use purposes) |
$650 |
|
In-vitro Test
Kit Manufacturer (Licenses
authorizing manufacturer of in-vitro test kits) |
$3250 |
|
Irradiator
(self-shielded) (Licenses
authorizing possession and use of radioactive material in sealed sources for
irradiation of materials in which the source is not removed from its shield) |
$1350 |
|
Irradiator
(containing less than 10,000 curies) (Licenses
authorizing possession and use of less than 10,000 curies of radioactive material
in sealed sources for irradiation of materials in which the source is exposed
for irradiation purposes. This category also includes underwater irradiators
for irradiation of materials where the source is not exposed for irradiation
purposes) |
$2750 |
|
Irradiator
(containing 10,000 curies or more) (Licenses
authorizing possession and use of 10,000 curies or more of radioactive material
in sealed sources for irradiation of materials in which the source is exposed
for irradiation purposes. This category also includes underwater irradiators
for irradiation of materials where the source is not exposed for irradiation
purposes) |
$5500 |
|
Leak Test
Service (Licenses
authorizing possession and use of radioactive material for testing of sealed
sources for leakage or contamination) |
$650 |
|
Manufacturing
and Commercial Distribution (Licenses
authorizing possession and use of radioactive material for processing or
manufacturing radioactive material or items containing radioactive material
for commercial distribution, and/or for distribution of radioactive material
or items containing radioactive material) |
$4500 |
|
Medical Therapy
(unsealed) (Licenses
authorizing possession and human use of radioactive material in the form of
unsealed radioactive material, issued under Parts He-P 4030 and 4035 of this
chapter for therapeutic purposes) |
$2200 |
|
Medical Therapy
(sealed) (Licenses
authorizing possession and human use of radioactive material in the form of
sealed radioactive material, issued under Parts He-P 4030 and 4035 of this
chapter for therapeutic purposes, except licenses for radioactive material in
sealed sources contained in teletherapy or remote controlled brachytherapy
devices) |
$2750 |
|
Mobile Nuclear
Medicine Services (Licenses
authorizing receipt, possession, transport, and use of radioactive material
for diagnostic human or veterinary use at client sites) |
$2750 |
|
Mobile Scanning
Service (sealed sources only) (Licenses
authorizing possession of radioactive material and transport of radioactive
material and/or devices containing radioactive material to a medical client’s
facility) |
$1750 |
|
Nuclear Medicine
(diagnostic only) (Licenses
restricted to only the diagnostic human use of radioactive material for
uptake, dilution, excretion, imaging or localization studies, sealed sources
for diagnosis; and in-vitro studies) |
$1650 |
|
Nuclear Laundry (Licenses
authorizing the commercial collection and laundering of items contaminated
with radioactive material) |
$4500 |
|
Nuclear Pharmacy (Licenses
authorizing possession, use, distribution and
redistribution of radioactive material in the form radiopharmaceuticals,
generators, reagent kits, and/or other sources or devices, issued under Parts
He-P 4030, 4032 and 4035 of this chapter, and not involving processing of
radioactive material) |
$4000 |
|
Possession
Incident to Exempt Distribution (Licenses
authorizing possession, receipt, storage and repackaging of radioactive
material or items containing radioactive material for eventual distribution
to persons exempt under a specific license issued by the United States
Nuclear Regulatory Commission) |
$800 |
|
Radiopharmaceutical
Manufacturing (Licenses
authorizing possession, use, processing and manufacturing radioactive
material in the form radiopharmaceuticals, generators, and/or reagent kits, issued
under Parts He-P 4030 and 4032 of this chapter) |
$5500 |
|
Remote
Controlled Brachytherapy Device (including low dose-rate and high dose-rate
remote afterloaders and intravenous brachytherapy) (Licenses
authorizing possession and use of radioactive material in Remote Controlled
Brachytherapy Devices for therapeutic human or veterinary uses) |
$2750 |
|
Research and/or
Development (Licenses
authorizing possession and use of radioactive material for research and
development that does not authorize commercial distribution of radioactive
material or devices containing radioactive material) |
$3800 |
|
Sealed Source or
Device Safety Evaluation (commercial distribution) (Departmental
safety evaluation of sealed sources containing radioactive material, or
devices or products containing radioactive material for commercial
distribution) |
$2750 |
|
Sealed Source or
Device Safety Evaluation (unique specification) (Departmental safety
evaluation of sealed sources containing radioactive material, or devices or
products containing radioactive material, manufactured in accordance with the
unique specifications of, and for use by, a single applicant) |
$2750 |
|
Sealed Source or
Device Safety Annual Maintenance Fee (A fee per
active evaluation sheet maintained by DHHS, except unique specification
sealed source and device evaluation sheets) |
$700 |
|
Source Material
(shielding) (Licenses
authorizing possession, use, and/or installation of source material for
shielding) |
$375 |
|
Source Material
(other) (Licenses which
authorize the possession and use of source material for commercial,
educational, and/or research purposes, excluding manufacturing and
distribution purposes) |
$2200 |
|
Special Nuclear
Material (other) (Licenses
authorizing possession and use of special nuclear material in quantities not
sufficient to form a critical mass, as defined in He-P 4003 of this chapter,
in unsealed form for other authorized purposes) |
$2200 |
|
Special Nuclear
Material (sealed sources) (Licenses
authorizing possession and use of special nuclear material in quantities not
sufficient to form a critical mass, as defined in He-P 4003, in the form of
sealed sources for calibration and other authorized purposes) |
$550 |
|
Storage Only (Licenses
authorizing storage only of radioactive material, but does not include
facilities described as centralized low-level radioactive waste storage
facilities) |
$5500 |
|
Teletherapy (Licenses issued
under Parts He-P 4030 and 4035 of this chapter authorizing human and
non-human use of radioactive material in sealed sources contained in
teletherapy devices) |
$3800 |
|
Tracer Studies
(non-oil well) (Licenses for possession
and use of radioactive material for field flooding tracer studies) |
$3250 |
|
Veterinary
(diagnostic) (Licenses
authorizing possession and use of radioactive material for diagnostic
purposes in veterinary medicine) |
$1600 |
|
Veterinary
(therapy) (Licenses
authorizing possession and use of radioactive material for therapeutic
purposes in veterinary medicine) |
$1800 |
|
Waste Processing
(packaging or repackaging for transfer) (Licenses
authorizing the possession and receipt of low-level radioactive waste
material for preparation for shipment, packaging, or repackaging for transfer
to a person authorized to receive or dispose of the radioactive waste
material) |
$4500 |
|
Waste Processing
(prepackaged transfer only) (Licenses authorizing
the possession and receipt of low-level radioactive waste material from other
persons, incident to transfer to a person authorized to receive or dispose of
the material) |
$2750 |
|
Well Logging
Other Than Field Flooding Tracer Studies (Licenses
authorizing possession and use of radioactive material for wireline services
and well surveys) |
$3250 |
|
Additional
Authorized Use Sites Where Radioactive Material Is Used or......... 20% of Stored under the
Same License applicable
(Licenses authorizing possession and use of radioactive material at fee additional
authorized use sites where radioactive material is used |
|
|
Reciprocity
Annual fee for Nuclear
Regulatory Commission, |
|
|
Radiological Incident
Response and Radiation Safety Assessments................. Full
cost (Departmental
response or reaction to an radiological incident or
event in recovery order to protect
the public health and safety and protection of property and |
|
|
Non-Routine
and/or Reactive Inspections...................................................... (Inspection
conducted in response or reaction to a complaint, allegation, follow-up to
inspection deficiencies or inspections to determine implementation of safety
issues) |
$1000 |
Table 4070.1-B Annual
Fee for Registration of General Licensed Devices
Registration
Category |
Annual Fee per
Location of Use of Device(s) |
Registration of general
licensed devices as specified in He-P 4031.04(e) and Table 4070.1-C below. |
$150.00 |
Table 4070.1-C
Criteria for Registration of General Licensed Devices
Radionuclide |
Activity Greater
Than or Equal to: |
Strontium-90,
Radium-226 |
3.7
megabecquerel (0.1 millicurie) |
Cobalt-60,
Curium-244, Americium-241, Californium-252 |
37 megabecquerel
(1 millicurie) |
Cesium-137 |
370
megabecquerel (10 millicurie) |
Source. #5903, eff 2-1-95, EXPIRED: 2-1-01
New. #7919, eff 7-18-03; ss by #9947, eff 6-22-11; ss by #10865, eff 6-25-15; amd by #10910, eff 8-21-15
He-P 4070.06 Schedule of Annual Fees for Certificates of Registration for Radiation or MRI
Machines.
(a) Annual fees for certificates of registration for
radiation or MRI machines shall be those set out in Table 4070.2, “Annual Fees
for Radiation or MRI Machine Registration.”
(b) Annual fee for each machine shall be based on
the number of machine-made sources of ionizing radiation the machine controls.
Table 4070.2 Annual Fees for
Radiation or MRI Machine Registration
Type of Radiation or MRI Machine |
Annual fee Number of Sources Controlled by Machine 1 2 3 or more |
||||
A. X-ray machines for diagnostic or
visualization purposes in the healing arts or veterinary medicine |
|||||
1. |
Radiographic x-ray machines for dental purposes, including, but not limited
to, dental intraoral, dental cephalometric, and dental panoramic x-ray
machines, and machines combining those functions |
$145 |
$254 |
$362 |
|
2. |
Radiographic x-ray machines for podiatric purposes |
$145 |
|
|
|
3. |
Radiographic x-ray machines for healing arts or veterinary medicine
purposes designed to be portable as defined in He-P 4041.02(dj) |
$145 |
|
|
|
4. |
Radiation machines for the generation of information in the healing arts
or veterinary medicine, including bone mineral densitometers and medical
x-ray cabinets |
$145 |
|
|
|
5. |
Non-portable diagnostic x-ray machines for healing arts or veterinary
medicine purposes, including general purpose radiographic machines, mobile
x-ray machines, mini c-arm units, micro-computed tomography units, dedicated
chest units, conventional tomography machines, cone-beam computed tomography
machines, veterinary, chiropractic, and standard mammography machines |
$275 |
$482 |
|
|
6. |
X-ray machines with fluoroscopic capability without regard to whether
they also have radiographic capabilities, including radiographic-fluoroscopic
combination machines, C-arm units, angiographic machines, and therapy
simulators |
$400 |
$600 |
$800 |
|
7. |
Computed tomography (CT),
stereotactic mammography machines and 3D mammographic machines |
$400 |
$600 |
$800 |
|
B. Machines for therapeutic use
in the healing arts or veterinary medicine |
|||||
1. |
X-ray machines capable of being used at potentials of 500,000 volts or
less |
$500 |
|
|
|
2. |
X-ray machines capable of being used at potentials greater than 500,000
volts |
$2000 |
|
|
|
3. |
Particle accelerators capable of being used at energies of 500,000
electron volts or less |
$1000 |
|
|
|
4. |
Particle accelerators capable of being used at energies greater than
500,000 electron volts |
$2000 |
|
|
|
5. |
Electronic Brachytherapy |
$1000 |
|
|
|
C. Machines not used for
diagnostic or therapeutic purposes on humans or animals |
|||||
1. |
Particle accelerators |
|
|
|
|
|
a. Ion implanters |
$850 |
|
|
|
|
b. Irradiators |
$850 |
|
|
|
|
c. For the
production of radioactive material |
$2500 |
|
|
|
|
d. Other accelerators,
including research accelerators |
$2000 |
|
|
|
2. |
Industrial Machines |
|
|
|
|
|
a. Cabinet x-ray system as
defined in He-P 4034.03 |
$320 |
$560 |
|
|
|
b. Industrial radiographic units |
$800 |
|
|
|
3. |
Analytical x‑ray machines as defined in He-P 4043.03 |
|
|
|
|
|
a. X-ray fluorescence
machines |
$350 |
|
|
|
|
b. X-ray diffraction
machines |
$350 |
|
|
|
4. |
X-ray gauges (thickness/level) |
$400 |
|
|
|
5. |
Items of electronic equipment that produce radiation incidental to
their operation for other purposes (SEM or TEM) and which are not exempt from
registration under the provisions of He-P 4040.06(a) |
$125 |
|
|
|
D. Non-ionizing radiation
equipment |
|||||
|
Magnetic resonance imaging machines |
$500 |
|
|
|
E. Other circumstances |
|||||
1. |
Radiation or MRI machines not otherwise specified above used for the
following purpose: a. Diagnostic b. Therapeutic c. Industrial d. Non-medical Security Screening System |
$400 $600 $400 $275 |
|
|
|
F. Exempt from Fee Proration |
|||||
1. |
Radiation or MRI machines registered as in storage under the provisions
of He-P 4040.12 |
$100 |
|
|
|
2. |
Radiation or MRI machines used solely for educational demonstration
(non-human use) purposes |
$100 |
|
|
|
3. |
Service Provider Registration |
$125 |
|
|
|
|
|
|
|
|
|
4. |
Reciprocal recognition of out-of-state radiation or MRI machine
registration |
Half annual fee
of applicable machine type |
|||
|
|
|
|
|
|
Source. #6827, eff 8-6-98; ss by #7919, eff 7-18-03; ss by #9947, eff 6-22-11; ss by #10865, eff 6-25-15; Table 4070.2 category E.1.d. amd by #12024, INTERIM, eff 10-28-16, EXPIRED: 4-26-17; Table 4070.2 category E.1.d. amd by #12215, eff 6-20-17
He-P 4070.07 Proration of Annual Fees for Registration
of Radiation or MRI Machines. For
each machine a registrant acquires after July 31 of a year, the fee due shall
be calculated by multiplying the annual fee for the machine set out in Table
4070.2 A-E by the proration factor in Table 4070.3, “Proration Factors
Applicable to Fees for Certificates of Registration for Radiation or MRI
Machines”.
Table 4070.3
Proration Factors Applicable to Fees for
Certificates of
Registration for Radiation or MRI Machines
Month of
acquisition of the radiation
machine |
Proration factor |
August |
1.00 |
September |
0.92 |
October |
0.83 |
November |
0.75 |
December |
0.67 |
January |
0.58 |
February |
0.50 |
March |
0.42 |
April |
0.33 |
May |
0.25 |
June |
0.17 |
July |
0.00 |
Source. #6827, eff 8-6-98; ss by #7919, eff 7-18-03; ss by #9947, eff 6-22-11; ss by #10865, eff 6-25-15
He-P 4070.08 Administrative Fines.
(a) The DHHS shall impose an administrative fine
against any person who is required under these rules to submit
an application for certificate of radiation for a radiation or MRI
machine and the applicable fee, or for an annual fee for a radioactive material
license or general licensed device registration, and who fails to do so in a
timely manner.
(b) Such administrative fines shall be imposed as
follows:
(1) If a person responsible for submitting to the
DHHS an application for a certificate of registration for a radiation or MRI
machine and the applicable fee, or for an annual fee for a radioactive material
license or general licensed device registration, fails to do so within 30 days
of the date that the application and fee are due, the person shall be assessed
a fine of $100.00;
(2) At the time that the fine is imposed DHHS
shall provide the individual written notice that states:
a. The reason(s) for the imposition of the fine;
and
b. The right of the person to an adjudicative
proceeding allowed in He-C 200;
(3) Failure of the person to request a hearing
within 30 days of the receipt of the notice shall result in the imposition of
the fine becoming final;
(4) If the person fails to pay the fee due and
the imposed fine within 30 days of the date that the fine was imposed or, in
the case where an adjudicative hearing is requested, within 30 days of the date
that the fine is upheld following the hearing, the amount of the fine shall be
doubled; and
(5) If the person fails to pay the fee due and
the imposed fine within 30 days of the date that the fine is doubled in
accordance with (4) above, the matter shall be referred to the department of
justice in order that it may institute civil action to collect the fine in
accordance with RSA 125‑F:22, IV.
Source. #6827, eff 8-6-98; ss by #7919, eff 7-18-03; ss by #9947, eff 6-22-11; ss by #10865, eff 6-25-15
He-P 4070.09 Insufficient
Funds. Should a check or other
instrument from an applicant, licensee, or registrant be uncollectible from the
paying institution, the DHHS shall:
(a) Add any bank, state treasurer,
or other charges resulting to the amount owed;
(b) Notify the applicant,
licensee, or registrant in writing to the last address known to the DHHS; and
(c) Allow the person 15 days to
correct the matter without penalty per He-P 4070.08(b)(1).
Source. #5903, eff 2-1-95, EXPIRED: 2-1-01
New. #7919, eff 7-18-03; ss by #9947, eff 6-22-11; ss by #10865, eff 6-25-15
PART He-P
4071 LOW-LEVEL RADIOACTIVE WASTE
MANAGEMENT FUND
He-P 4071.01 Purpose. These rules provide the amount of generator
fee(s), and the mechanism for fee payment.
Source. #5903, eff 2-1-95, EXPIRED: 2-1-01
New. #10141, eff 5-26-12, EXPIRED 5-26-22
New #13452, eff 9-28-22
He-P 4071.02 Scope.
The rules of this part shall apply to generators of low-level
radioactive waste in the state of
Source. #5903, eff 2-1-95, EXPIRED: 2-1-01
New. #10141, eff 5-26-12, EXPIRED 5-26-22
New. #13452, eff 9-28-22
He-P 4071.03 Quarterly Reports and Fees.
(a)
Any person who generates low-level radioactive waste requiring transfer
to an authorized low-level radioactive waste disposal site as provided in He-P
4030.16 in a 3-month period shall file certified quarterly activity reports on
Form DHHS/RHS-20 “Low-Level Radioactive Waste (LLRW) Management Fund Quarterly
Report Form,” (9/2022) with the department of health and human services
radiological health section (DHHS/RHS).
(b)
The following shall be submitted with each quarterly report in (a)
above:
(1) A copy of the waste shipment manifest
containing information as required in He-P 4023.06; and
(2) The fee payment due the state.
(c)
Form DHHS/RHS-20 shall be obtained from the DHHS/RHS.
(d)
The quarterly reports shall be filed with the DHHS/RHS in accordance
with the time schedule set forth in He-P 4071.03(g).
(e)
Fees to be paid by the generators of low-level radioactive waste shall
be computed as follows:
(1) A fee of $15.00 shall be paid by a waste
generator for each cubic foot of radioactive waste exported from the state
during the reporting quarter in accordance with the provisions of RSA
125-F:8-a, III; and
(2) The fee of $15 per cubic feet of radioactive
waste shall be calculated from the information written on the generator’s
manifests. If a generator records the
quantities of wastes in other than units of cubic feet, the record shall also
reflect the mechanism for conversion to units of cubic feet for the quarterly
report.
(f)
Payment of fees shall be:
(1) By check made out to the Treasurer, State of
New Hampshire;
(2) Accompanied by the quarterly report as set
forth in He-P 4071.03(a); and
(3) Filed with the DHHS/RHS within 60 days
following the close of the quarterly reporting period as set forth in He-P
4071.03(g) to the address listed in He-P 4001.08
(g)
Quarterly reporting and fee payment periods shall be as set forth in
Table 4071.1 below:
Table 4071.1 Quarterly Reporting and Fee Payment
Periods
Quarter |
Period
Covered |
Report
Due On or Before |
1st |
January
1 to March 31 |
May
30 |
2nd |
April
1 to June 30 |
August
29 |
3rd |
July
1 to September 30 |
December
30 |
4th |
October
1 to December 31 |
March
1 |
Source. #5903, eff 2-1-95, EXPIRED: 2-1-01
New. #10141, eff 5-26-12, EXPIRED 5-26-22
New. #13452, eff 9-28-22
He-P 4071.04 Record-Keeping. A generator shall keep a copy of each
quarterly report for a period of 7 years from the due date of the report.
Source. #5903, eff 2-1-95, EXPIRED: 2-1-01
New. #10141, eff 5-26-12, EXPIRED 5-26-22
New. #13452, eff 9-28-22
He-P 4071.05 Exemptions. The following wastes shall not be subject to
the generator fees collected under He-P 4071.03(a):
(a)
Radioactive material transferred to an authorized recipient as provided
in He-P 4030.16, other than a licensed low-level radioactive waste disposal
site; and
(b)
Radioactive waste disposed of in accordance with He-P 4023.
Source. #5903, eff 2-1-95, EXPIRED: 2-1-01
New. #10141, eff 5-26-12, EXPIRED 5-26-22
New. #13452, eff 9-28-22
PART He-P 4072 -
4089 Reserved
PaRT He-P 4090
Annual Limits On Intake (ALI) And Derived Air Concentrations (DAC) Of
Radionuclides For Occupational Exposure; Effluent Concentrations;
Concentrations For Release To Sanitary Sewerage
He-P 4090.01 Annual Limits on Intake (ALI) and Derived
Air Concentrations (DAC) of Radionuclides For Occupational Exposure; Effluent
Concentrations; Concentrations for Release To Sanitary Sewerage. The annual limits on intake (ALI) and the
derived air concentrations (DAC) of radionuclides for occupational exposure,
effluent concentration, and concentrations for release to sanitary sewerage
shall be in compliance with Table 4090.1 below:
Table
I Table
II Table III
Occupational
Values Effluent Releases to
Concentrations Sewers
Oral Monthly
Ingestion Inhalation Average
Atomic Radionuclide Class ALI ALI DAC Air Water Concentration
No. (μCi) (μCi) (μCi/ml) (μCi/ml) (μCi/ml) (μCi/ml)
1 Hydrogen-3 Water, DAC includes skin
absorption 8E+4 8E+4 2E-5 1E-7 1E-3 1E-2
Gas
(HT or T2) Submersion1: Use above values as HT and T2
oxidize in air and in the body to HTO.
4 Beryllium-7 W, all compounds except 4E+4 2E+4 9E-6 3E-8 6E-4 6E-3
those given for Y
Y,
oxides, halides, and
nitrates - 2E+4 8E-6 3E-8 - -
4 Beryllium-10 W, see 7Be 1E+3 2E+2 6E-8 2E-10 - -
LLI
wall
(1E+3) - - - 2E-5 2E-4
Y,
see 7Be - 1E+1 6E-9 2E-11 - -
6 Carbon-112 Monoxide - 1E+6 5E-4 2E-6 - -
Dioxide - 6E+5 3E-4 9E-7 - -
Compounds 4E+5 4E+5 2E-4 6E-7 6E-3 6E-2
6 Carbon-14 Monoxide - 2E+6 7E-4 2E-6 - -
Dioxide - 2E+5 9E-5 3E-7 - -
Compounds 2E+3 2E+3 1E-6 3E-9 3E-5 3E-4
9 Fluorine-182 D, fluorides of H, Li,
Na,
K, Rb, Cs, and Fr 5E+4 7E+4 3E-5 1E-7 - -
St
wall
(5E+4) - - - 7E-4 7E-3
W,
fluorides of Be, Mg,
Ca, Sr, Ba, Ra,
In, Tl, As, Sb, Bi, Fe,
Ru, Os, Co, Ni, Pd,
Pt,
Cu, Ag, Au, Zn, Cd, Hg,
Sc, Y, Ti, Zr, V, Nb,
Ta, Mn, Tc, and Re - 9E+4 4E-5 1E-7 - -
Y,
lanthanum fluoride - 8E+4 3E-5 1E-7 - -
11 Sodium-22 D, all compounds 4E+2 6E+2 3E-7 9E-10 6E-6 6E-5
11 Sodium-24 D, all compounds 4E+3 5E+3 2E-6 7E-9 5E-5 5E-4
Table
I Table
II Table III
Occupational
Values Effluent Releases to
Concentrations Sewers
Oral Monthly
Ingestion Inhalation Average
Atomic Radionuclide Class ALI ALI DAC Air Water Concentration
No. (μCi) (μCi) (μCi/ml) (μCi/ml) (μCi/ml) (μCi/ml)
12 Magnesium-28 D, all compounds except
those given for W 7E+2 2E+3 7E-7 2E-9 9E-6 9E-5
W,
oxides, hydroxides,
carbides, halides, and
nitrates - 1E+3 5E-7 2E-9 - -
13 Aluminum-26 D, all compounds except
those given for W 4E+2 6E+1 3E-8 9E-11 6E-6 6E-5
W,
oxides, hydroxides,
carbides, halides, and
nitrates - 9E+1 4E-8 1E-10 - -
14 Silicon-31 D, all compounds except
those given for W and Y 9E+3 3E+4 1E-5 4E-8 1E-4 1E-3
W,
oxides, hydroxides,
carbides, and nitrates - 3E+4 1E-5 5E-8 - -
Y,
aluminosilicate glass - 3E+4 1E-5 4E-8 - -
14 Silicon-32 D, see 31Si 2E+3 2E+2 1E-7 3E-10 - -
LLI
wall
(3E+3) - - - 4E-5 4E-4
W,
see 31Si - 1E+2 5E-8 2E-10 - -
Y,
see 31Si - 5E+0 2E-9 7E-12 - -
15 Phosphorus-32 D, all compounds except
phosphates given for W 6E+2 9E+2 4E-7 1E-9 9E-6 9E-5
W,
phosphates of Zn2+,
S3+, Mg2+, Fe3+, Bi3+,
and lanthanides - 4E+2 2E-7 5E-10 - -
15 Phosphorus-33 D, see 32P 6E+3 8E+3 4E-6 1E-8 8E-5 8E-4
W,
see 32P - 3E+3 1E-6 4E-9 - -
16 Sulfur-35 Vapor - 1E+4 6E-6 2E-8 - -
D,
sulfides and sulfates
except those given for W 1E+4 2E+4 7E-6 2E-8 - -
LLI
wall
(8E+3) - - - 1E-4 1E-3
W,
elemental sulfur, 6E+3
sulfides of Sr, Ba, Ge,
Sn, Pb, As, Sb, Bi, Cu,
Ag, Au, Zn, Cd, Hg, W, and
Ba, Ra, As, Sb, and Bi - 2E+3 9E-7 3E-9 - -
17 Chlorine-36 D, chlorides of H, Li,
Na, K, Rb, Cs, and Fr 2E+3 2E+3 1E-6 3E-9 2E-5 2E-4
W,
chlorides of lantha-
nides, Be, Mg, Ca, Sr,
Ba, Ra,
Ge, Sn, Pb, As, Sb, Bi,
Fe, Ru, Os, Co, Rh,
Ir,
Ni, Pd, Pt, Cu, Ag, Au,
Zn, Cd, Hg, Sc, Y, Ti,
Zr, Hf, V, Nb, Ta, Cr,
Mo, W, Mn, Tc, and Re - 2E+2 1E-7 3E-10 - -
Table
I Table
II Table III
Occupational
Values Effluent Releases to
Concentrations Sewers
Oral Monthly
Ingestion Inhalation Average
Atomic Radionuclide Class ALI ALI DAC Air Water Concentration
No. (μCi) (μCi) (μCi/ml) (μCi/ml) (μCi/ml) (μCi/ml)
17 Chlorine-382 D, see 36Cl 2E+4 4E+4 2E-5 6E-8 - -
St
wall
(3E+4) - - - 3E-4 3E-3
W,
see 36Cl - 5E+4 2E-5 6E-8 - -
17 Chlorine-392 D, see 36Cl 2E+4 5E+4 2E-5 7E-8 - -
St
wall
(4E+4) - - - 5E-4 5E-3
W,
see 36Cl - 6E+4 2E-5 8E-8 - -
18 Argon-37 Submersion1 - - 1E+0 6E-3 - -
18 Argon-39 Submersion1 - - 2E-4 8E-7 - -
18 Argon-41 Submersion1 - - 3E-6 1E-8 - -
19 Potassium-40 D, all compounds 3E+2 4E+2 2E-7 6E-10 4E-6 4E-5
19 Potassium-42 D, all compounds 5E+3 5E+3 2E-6 7E-9 6E-5 6E-4
19 Potassium-43 D, all compounds 6E+3 9E+3 4E-6 1E-8 9E-5 9E-4
19 Potassium-442 D, all compounds 2E+4 7E+4 3E-5 9E-8 - -
St
wall
(4E+4) - - - 5E-4 5E-3
19 Potassium-452 D, all compounds 3E+4 1E+5 5E-5 2E-7 - -
St
wall
(5E+4) - - - 7E-4 7E-3
20 Calcium-41 W, all compounds 3E+3 4E+3 2E-6 - - -
Bone
surf Bone surf
(4E+3) (4E+3) - 5E-9 6E-5 6E-4
20 Calcium-45 W, all compounds 2E+3 8E+2 4E-7 1E-9 2E-5 2E-4
20 Calcium-47 W, all compounds 8E+2 9E+2 4E-7 1E-9 1E-5 1E-4
21 Scandium-43 Y, all compounds 7E+3 2E+4 9E-6 3E-8 1E-4 1E-3
21 Scandium-44m Y, all compounds 5E+2 7E+2 3E-7 1E-9 7E-6 7E-5
21 Scandium-44 Y, all compounds 4E+3 1E+4 5E-6 2E-8 5E-5 5E-4
21 Scandium-46 Y, all compounds 9E+2 2E+2 1E-7 3E-10 1E-5 1E-4
21 Scandium-47 Y, all compounds 2E+3 3E+3 1E-6 4E-9 - -
LLI
wall
(3E+3) - - - 4E-5 4E-4
21 Scandium-48 Y, all compounds 8E+2 1E+3 6E-7 2E-9 1E-5 1E-4
21 Scandium-492 Y, all compounds 2E+4 5E+4 2E-5 8E-8 3E-4 3E-3
22 Titanium-44 D, all compounds except
those given for W and Y 3E+2 1E+1 5E-9 2E-11 4E-6 4E-5
W,
oxides, hydroxides,
carbides, halides, and
nitrates - 3E+1 1E-8 4E-11 - -
Y,
SrTiO3 - 6E+0 2E-9 8E-12 - -
Table
I Table
II Table III
Occupational
Values Effluent Releases to
Concentrations Sewers
Oral Monthly
Ingestion Inhalation Average
Atomic Radionuclide Class ALI ALI DAC Air Water Concentration
No. (μCi) (μCi) (μCi/ml) (μCi/ml) (μCi/ml) (μCi/ml)
22 Titanium-45 D, see 44Ti 9E+3 3E+4 1E-5 3E-8 1E-4 1E-3
W,
see 44Ti - 4E+4 1E-5 5E-8 - -
Y,
see 44Ti - 3E+4 1E-5 4E-8 - -
23 Vanadium-472 D, all compounds except
those given for W 3E+4 8E+4 3E-5 1E-7 - -
St
wall
(3E+4) - - - 4E-4 4E-3
W,
oxides, hydroxides,
carbides, and halides - 1E+5 4E-5 1E-7 - -
23 Vanadium-48 D, see 47V 6E+2 1E+3 5E-7 2E-9 9E-6 9E-5
W,
see 47V - 6E+2 3E-7 9E-10 - -
23 Vanadium-49 D, see 47V 7E+4 3E+4 1E-5 - - -
LLI
wall Bone surf
(9E+4) (3E+4) - 5E-8 1E-3 1E-2
W,
see 47V - 2E+4 8E-6 2E-8 - -
24 Chromium-48 D, all compounds except
those given for W and Y 6E+3 1E+4 5E-6 2E-8 8E-5 8E-4
W,
halides and nitrates - 7E+3 3E-6 1E-8 - -
Y,
oxides and hydroxides - 7E+3 3E-6 1E-8 - -
24 Chromium-492 D, see 48Cr 3E+4 8E+4 4E-5 1E-7 4E-4 4E-3
W,
see 48Cr - 1E+5 4E-5 1E-7 - -
Y,
see 48Cr - 9E+4 4E-5 1E-7 - -
24 Chromium-51 D, see 48Cr 4E+4 5E+4 2E-5 6E-8 5E-4 5E-3
W,
see 48Cr - 2E+4 1E-5 3E-8 - -
Y,
see 48Cr - 2E+4 8E-6 3E-8 - -
25 Manganese-512 D, all compounds except
those given for W 2E+4 5E+4 2E-5 7E-8 3E-4 3E-3
W,
oxides, hydroxides,
halides, and nitrates - 6E+4 3E-5 8E-8 - -
25 Manganese-52m2 D, see 51Mn 3E+4 9E+4 4E-5 1E-7 - -
St
wall
(4E+4) - - - 5E-4 5E-3
W,
see 51Mn - 1E+5 4E-5 1E-7 - -
25 Manganese-52 D, see 51Mn 7E+2 1E+3 5E-7 2E-9 1E-5 1E-4
W,
see 51Mn - 9E+2 4E-7 1E-9 - -
25 Manganese-53 D, see 51Mn 5E+4 1E+4 5E-6 - 7E-4 7E-3
Bone
surf
- (2E+4) - 3E-8 - -
W,
see 51Mn - 1E+4 5E-6 2E-8 - -
25 Manganese-54 D, see 51Mn 2E+3 9E+2 4E-7 1E-9 3E-5 3E-4
W,
see 51Mn - 8E+2 3E-7 1E-9 - -
25 Manganese-56 D, see 51Mn 5E+3 2E+4 6E-6 2E-8 7E-5 7E-4
W,
see 51Mn - 2E+4 9E-6 3E-8 - -
26 Iron-52 D, all compounds except
those given for W 9E+2 3E+3 1E-6 4E-9 1E-5 1E-4
W,
oxides, hydroxides,
and halides - 2E+3 1E-6 3E-9 - -
Table
I Table
II Table III
Occupational
Values Effluent Releases to
Concentrations Sewers
Oral Monthly
Ingestion Inhalation Average
Atomic Radionuclide Class ALI ALI DAC Air Water Concentration
No. (μCi) (μCi) (μCi/ml) (μCi/ml) (μCi/ml) (μCi/ml)
26 Iron-55 D, see 52Fe 9E+3 2E+3 8E-7 3E-9 1E-4 1E-3
W,
see 52Fe - 4E+3 2E-6 6E-9 - -
26 Iron-59 D, see 52Fe 8E+2 3E+2 1E-7 5E-10 1E-5 1E-4
W,
see 52Fe - 5E+2 2E-7 7E-10 - -
26 Iron-60 D, see 52Fe 3E+1 6E+0 3E-9 9E-12 4E-7 4E-6
W,
see 52Fe - 2E+1 8E-9 3E-11 - -
27 Cobalt-55 W, all compounds except
those given for Y 1E+3 3E+3 1E-6 4E-9 2E-5 2E-4
Y,
oxides, hydroxides,
halides, and nitrates - 3E+3 1E-6 4E-9 - -
27 Cobalt-56 W, see 55Co 5E+2 3E+2 1E-7 4E-10 6E-6 6E-5
Y,
see 55Co 4E+2 2E+2 8E-8 3E-10 - -
27 Cobalt-57 W, see 55Co 8E+3 3E+3 1E-6 4E-9 6E-5 6E-4
Y,
see 55Co 4E+3 7E+2 3E-7 9E-10 - -
27 Cobalt-58m W, see 55Co 6E+4 9E+4 4E-5 1E-7 8E-4 8E-3
Y,
see 55Co - 6E+4 3E-5 9E-8 - -
27 Cobalt-58 W, see 55Co 2E+3 1E+3 5E-7 2E-9 2E-5 2E-4
Y,
see 55Co 1E+3 7E+2 3E-7 1E-9 - -
27 Cobalt-60m2 W, see 55Co 1E+6 4E+6 2E-3 6E-6 - -
St
wall
(1E+6) - - - 2E-2 2E-1
Y,
see 55Co - 3E+6 1E-3 4E-6 - -
27 Cobalt-60 W, see 55Co 5E+2 2E+2 7E-8 2E-10 3E-6 3E-5
Y,
see 55Co 2E+2 3E+1 1E-8 5E-11 - -
27 Cobalt-612 W, see 55Co 2E+4 6E+4 3E-5 9E-8 3E-4 3E-3
Y,
see 55Co 2E+4 6E+4 2E-5 8E-8 - -
27 Cobalt-62m2 W, see 55Co 4E+4 2E+5 7E-5 2E-7 - -
St
wall
(5E+4) - - - 7E-4 7E-3
Y,
see 55Co - 2E+5 6E-5 2E-7 - -
28 Nickel-56 D, all compounds except
those given for W 1E+3 2E+3 8E-7 3E-9 2E-5 2E-4
W,
oxides, hydroxides,
and carbides - 1E+3 5E-7 2E-9 - -
Vapor - 1E+3 5E-7 2E-9 - -
28 Nickel-57 D, see 56Ni 2E+3 5E+3 2E-6 7E-9 2E-5 2E-4
W,
see 56Ni - 3E+3 1E-6 4E-9 - -
Vapor - 6E+3 3E-6 9E-9 - -
28 Nickel-59 D, see 56Ni 2E+4 4E+3 2E-6 5E-9 3E-4 3E-3
W,
see 56Ni - 7E+3 3E-6 1E-8 - -
Vapor - 2E+3 8E-7 3E-9 - -
28 Nickel-63 D, see 56Ni 9E+3 2E+3 7E-7 2E-9 1E-4 1E-3
W,
see 56Ni - 3E+3 1E-6 4E-9 - -
Vapor - 8E+2 3E-7 1E-9 - -
Table
I Table
II Table III
Occupational
Values Effluent Releases to
Concentrations Sewers
Oral Monthly
Ingestion Inhalation Average
Atomic Radionuclide Class ALI ALI DAC Air Water Concentration
No. (μCi) (μCi) (μCi/ml) (μCi/ml) (μCi/ml) (μCi/ml)
28 Nickel-65 D, see 56Ni 8E+3 2E+4 1E-5 3E-8 1E-4 1E-3
W,
see 56Ni - 3E+4 1E-5 4E-8 - -
Vapor - 2E+4 7E-6 2E-8 - -
28 Nickel-66 D, see 56Ni 4E+2 2E+3 7E-7 2E-9 - -
LLI
wall
(5E+2) - - - 6E-6 6E-5
W,
see 56Ni - 6E+2 3E-7 9E-10 - -
Vapor - 3E+3 1E-6 4E-9 - -
29 Copper-602 D, all compounds except
those given for W and Y 3E+4 9E+4 4E-5 1E-7 - -
St
wall
(3E+4) - - - 4E-4 4E-3
W,
sulfides, halides,
and nitrates - 1E+5 5E-5 2E-7 - -
Y,
oxides and hydroxides - 1E+5 4E-5 1E-7 - -
29 Copper-61 D, see 60Cu 1E+4 3E+4 1E-5 4E-8 2E-4 2E-3
W,
see 60Cu - 4E+4 2E-5 6E-8 - -
Y,
see 60Cu - 4E+4 1E-5 5E-8 - -
29 Copper-64 D, see 60Cu 1E+4 3E+4 1E-5 4E-8 2E-4 2E-3
W,
see 60Cu - 2E+4 1E-5 3E-8 - -
Y,
see 60Cu - 2E+4 9E-6 3E-8 - -
29 Copper-67 D, see 60Cu 5E+3 8E+3 3E-6 1E-8 6E-5 6E-4
W,
see 60Cu - 5E+3 2E-6 7E-9 - -
Y,
see 60Cu - 5E+3 2E-6 6E-9 - -
30 Zinc-62 Y, all compounds 1E+3 3E+3 1E-6 4E-9 2E-5 2E-4
30 Zinc-632 Y, all compounds 2E+4 7E+4 3E-5 9E-8 - -
St
wall
(3E+4) - - - 3E-4 3E-3
30 Zinc-65 Y, all compounds 4E+2 3E+2 1E-7 4E-10 5E-6 5E-5
30 Zinc-69m Y, all compounds 4E+3 7E+3 3E-6 1E-8 6E-5 6E-4
30 Zinc-692 Y, all compounds 6E+4 1E+5 6E-5 2E-7 8E-4 8E-3
30 Zinc-71m Y, all compounds 6E+3 2E+4 7E-6 2E-8 8E-5 8E-4
30 Zinc-72 Y, all compounds 1E+3 1E+3 5E-7 2E-9 1E-5 1E-4
31 Gallium-652 D, all compounds except
those given for W 5E+4 2E+5 7E-5 2E-7 - -
St
wall
(6E+4) - - - 9E-4 9E-3
W,
oxides, hydroxides,
carbides, halides, and
nitrates - 2E+5 8E-5 3E-7 - -
31 Gallium-66 D, see 65Ga 1E+3 4E+3 1E-6 5E-9 1E-5 1E-4
W,
see 65Ga - 3E+3 1E-6 4E-9 - -
31 Gallium-67 D, see 65Ga 7E+3 1E+4 6E-6 2E-8 1E-4 1E-3
W,
see 65Ga - 1E+4 4E-6 1E-8 - -
Table
I Table
II Table III
Occupational
Values Effluent Releases to
Concentrations Sewers
Oral Monthly
Ingestion Inhalation Average
Atomic Radionuclide Class ALI ALI DAC Air Water Concentration
No. (μCi) (μCi) (μCi/ml) (μCi/ml) (μCi/ml) (μCi/ml)
31 Gallium-682 D, see 65Ga 2E+4 4E+4 2E-5 6E-8 2E-4 2E-3
W,
see 65Ga - 5E+4 2E-5 7E-8 - -
31 Gallium-702 D, see 65Ga 5E+4 2E+5 7E-5 2E-7 - -
St
wall
(7E+4) - - - 1E-3 1E-2
W,
see 65Ga - 2E+5 8E-5 3E-7 - -
31 Gallium-72 D, see 65Ga 1E+3 4E+3 1E-6 5E-9 2E-5 2E-4
W,
see 65Ga - 3E+3 1E-6 4E-9 - -
31 Gallium-73 D, see 65Ga 5E+3 2E+4 6E-6 2E-8 7E-5 7E-4
W,
see 65Ga - 2E+4 6E-6 2E-8 - -
32 Germanium-66 D, all compounds except
those given for W 2E+4 3E+4 1E-5 4E-8 3E-4 3E-3
W,
oxides, sulfides,
and halides - 2E+4 8E-6 3E-8 - -
32 Germanium-672 D, see 66Ge 3E+4 9E+4 4E-5 1E-7 - -
St
wall
(4E+4) - - - 6E-4 6E-3
W,
see 66Ge - 1E+5 4E-5 1E-7 - -
32 Germanium-68 D, see 66Ge 5E+3 4E+3 2E-6 5E-9 6E-5 6E-4
W,
see 66Ge - 1E+2 4E-8 1E-10 - -
32 Germanium-69 D, see 66Ge 1E+4 2E+4 6E-6 2E-8 2E-4 2E-3
W,
see 66Ge - 8E+3 3E-6 1E-8 - -
32 Germanium-71 D, see 66Ge 5E+5 4E+5 2E-4 6E-7 7E-3 7E-2
W,
see 66Ge - 4E+4 2E-5 6E-8 - -
32 Germanium-752 D, see 66Ge 4E+4 8E+4 3E-5 1E-7 - -
St
wall
(7E+4) - - - 9E-4 9E-3
W,
see 66Ge - 8E+4 4E-5 1E-7 - -
32 Germanium-77 D, see 66Ge 9E+3 1E+4 4E-6 1E-8 1E-4 1E-3
W,
see 66Ge - 6E+3 2E-6 8E-9 - -
32 Germanium-782 D, see 66Ge 2E+4 2E+4 9E-6 3E-8 - -
St
wall
(2E+4) - - - 3E-4 3E-3
W,
see 66Ge - 2E+4 9E-6 3E-8 - -
33 Arsenic-692 W, all compounds 3E+4 1E+5 5E-5 2E-7 - -
St
wall
(4E+4) - - - 6E-4 6E-3
33 Arsenic-702 W, all compounds 1E+4 5E+4 2E-5 7E-8 2E-4 2E-3
33 Arsenic-71 W, all compounds 4E+3 5E+3 2E-6 6E-9 5E-5 5E-4
33 Arsenic-72 W, all compounds 9E+2 1E+3 6E-7 2E-9 1E-5 1E-4
33 Arsenic-73 W, all compounds 8E+3 2E+3 7E-7 2E-9 1E-4 1E-3
Table
I Table
II
Table III
Occupational
Values Effluent Releases to
Concentrations Sewers
Oral Monthly
Ingestion Inhalation Average
Atomic Radionuclide Class ALI ALI DAC Air Water Concentration
No. (μCi) (μCi) (μCi/ml) (μCi/ml) (μCi/ml) (μCi/ml)
33 Arsenic-74 W, all compounds 1E+3 8E+2 3E-7 1E-9 2E-5 2E-4
33 Arsenic-76 W, all compounds 1E+3 1E+3 6E-7 2E-9 1E-5 1E-4
33 Arsenic-77 W, all compounds 4E+3 5E+3 2E-6 7E-9 - -
LLI
wall
(5E+3) - - - 6E-5 6E-4
33 Arsenic-782 W, all compounds 8E+3 2E+4 9E-6 3E-8 1E-4 1E-3
34 Selenium-702 D, all compounds except
those given for W 2E+4 4E+4 2E-5 5E-8 1E-4 1E-3
W,
oxides, hydroxides,
carbides, and
elemental Se 1E+4 4E+4 2E-5 6E-8 - -
34 Selenium-73m2 D, see 70Se 6E+4 2E+5 6E-5 2E-7 4E-4 4E-3
W,
see 70Se 3E+4 1E+5 6E-5 2E-7 - -
34 Selenium-73 D, see 70Se 3E+3 1E+4 5E-6 2E-8 4E-5 4E-4
W,
see 70Se - 2E+4 7E-6 2E-8 - -
34 Selenium-75 D, see 70Se 5E+2 7E+2 3E-7 1E-9 7E-6 7E-5
W,
see 70Se - 6E+2 3E-7 8E-10 - -
34 Selenium-79 D, see 70Se 6E+2 8E+2 3E-7 1E-9 8E-6 8E-5
W,
see 70Se - 6E+2 2E-7 8E-10 - -
34 Selenium-81m2 D, see 70Se 4E+4 7E+4 3E-5 9E-8 3E-4 3E-3
W,
see 70Se 2E+4 7E+4 3E-5 1E-7 - -
34 Selenium-812 D, see 70Se 6E+4 2E+5 9E-5 3E-7 - -
St
wall
(8E+4) - - - 1E-3 1E-2
W,
see 70Se - 2E+5 1E-4 3E-7 - -
34 Selenium-832 D, see 70Se 4E+4 1E+5 5E-5 2E-7 4E-4 4E-3
W,
see 70Se 3E+4 1E+5 5E-5 2E-7 - -
35 Bromine-74m2 D, bromides of H, Li,
Na, K, Rb, Cs, and Fr 1E+4 4E+4 2E-5 5E-8 - -
St
wall
(2E+4) - - - 3E-4 3E-3
W,
bromides of lantha-
nides, Be, Mg, Ca, Sr,
Ba, Ra,
Ge, Sn, Pb, As, Sb, Bi,
Fe, Ru, Os, Co, Rh,
Ir,
Ni, Pd, Pt, Cu, Ag, Au,
Zn, Cd, Hg, Sc, Y, Ti,
Zr, Hf, V, Nb, Ta, Mn,
Tc, and Re - 4E+4 2E-5 6E-8 - -
35 Bromine-742 D, see 74mBr 2E+4 7E+4 3E-5 1E-7 - -
St
wall
(4E+4) - - - 5E-4 5E-3
W,
see 74mBr - 8E+4 4E-5 1E-7 - -
Table
I Table
II
Table III
Occupational
Values Effluent Releases to
Concentrations Sewers
Oral Monthly
Ingestion Inhalation Average
Atomic Radionuclide Class ALI ALI DAC Air Water Concentration
No. (μCi) (μCi) (μCi/ml) (μCi/ml) (μCi/ml) (μCi/ml)
35 Bromine-752 D, see 74mBr 3E+4 5E+4 2E-5 7E-8 - -
St
wall
(4E+4) - - - 5E-4 5E-3
W,
see 74mBr - 5E+4 2E-5 7E-8 - -
35 Bromine-76 D, see 74mBr 4E+3 5E+3 2E-6 7E-9 5E-5 5E-4
W,
see 74mBr - 4E+3 2E-6 6E-9 - -
35 Bromine-77 D, see 74mBr 2E+4 2E+4 1E-5 3E-8 2E-4 2E-3
W,
see 74mBr - 2E+4 8E-6 3E-8 - -
35 Bromine-80m D, see 74mBr 2E+4 2E+4 7E-6 2E-8 3E-4 3E-3
W,
see 74mBr - 1E+4 6E-6 2E-8 - -
35 Bromine-802 D, see 74mBr 5E+4 2E+5 8E-5 3E-7 - -
St
wall
(9E+4) - - - 1E-3 1E-2
W,
see 74mBr - 2E+5 9E-5 3E-7 - -
35 Bromine-82 D, see 74mBr 3E+3 4E+3 2E-6 6E-9 4E-5 4E-4
W,
see 74mBr - 4E+3 2E-6 5E-9 - -
35 Bromine-83 D, see 74mBr 5E+4 6E+4 3E-5 9E-8 - -
St
wall
(7E+4) - - - 9E-4 9E-3
W,
see 74mBr - 6E+4 3E-5 9E-8 - -
35 Bromine-842 D, see 74mBr 2E+4 6E+4 2E-5 8E-8 - -
St
wall
(3E+4) - - - 4E-4 4E-3
W,
see 74mBr - 6E+4 3E-5 9E-8 - -
36 Krypton-742 Submersion1 - - 3E-6 1E-8 - -
36 Krypton-76 Submersion1 - - 9E-6 4E-8 - -
36 Krypton-772 Submersion1 - - 4E-6 2E-8 - -
36 Krypton-79 Submersion1 - - 2E-5 7E-8 - -
36 Krypton-81 Submersion1 - - 7E-4 3E-6 - -
36 Krypton-83m2 Submersion1 - - 1E-2 5E-5 - -
36 Krypton-85m Submersion1 - - 2E-5 1E-7 - -
36 Krypton-85 Submersion1 - - 1E-4 7E-7 - -
36 Krypton-872 Submersion1 - - 5E-6 2E-8 - -
36 Krypton-88 Submersion1 - - 2E-6 9E-9 - -
37 Rubidium-792 D, all compounds 4E+4 1E+5 5E-5 2E-7 - -
St
wall
(6E+4) - - - 8E-4 8E-3
37 Rubidium-81m2 D, all compounds 2E+5 3E+5 1E-4 5E-7 - -
St
wall
(3E+5) - - - 4E-3 4E-2
Table
I Table
II Table III
Occupational
Values Effluent Releases to
Concentrations Sewers
Oral Monthly
Ingestion Inhalation Average
Atomic Radionuclide Class ALI ALI DAC Air Water Concentration
No. (μCi) (μCi) (μCi/ml) (μCi/ml) (μCi/ml) (μCi/ml)
37 Rubidium-81 D, all compounds 4E+4 5E+4 2E-5 7E-8 5E-4 5E-3
37 Rubidium-82m D, all compounds 1E+4 2E+4 7E-6 2E-8 2E-4 2E-3
37 Rubidium-83 D, all compounds 6E+2 1E+3 4E-7 1E-9 9E-6 9E-5
37 Rubidium-84 D, all compounds 5E+2 8E+2 3E-7 1E-9 7E-6 7E-5
37 Rubidium-86 D, all compounds 5E+2 8E+2 3E-7 1E-9 7E-6 7E-5
37 Rubidium-87 D, all compounds 1E+3 2E+3 6E-7 2E-9 1E-5 1E-4
37 Rubidium-882 D, all compounds 2E+4 6E+4 3E-5 9E-8 - -
St
wall
(3E+4) - - - 4E-4 4E-3
37 Rubidium-892 D, all compounds 4E+4 1E+5 6E-5 2E-7 - -
St
wall
(6E+4) - - - 9E-4 9E-3
38 Strontium-802 D, all soluble compounds
except SrTiO3 4E+3 1E+4 5E-6 2E-8 6E-5 6E-4
Y,
all insoluble com-
pounds and SrTiO3 - 1E+4 5E-6 2E-8 - -
38 Strontium-812 D, see 80Sr 3E+4 8E+4 3E-5 1E-7 3E-4 3E-3
Y,
see 80Sr 2E+4 8E+4 3E-5 1E-7 - -
38 Strontium-82 D, see 80Sr 3E+2 4E+2 2E-7 6E-10 - -
LLI
wall
(2E+2) - - - 3E-6 3E-5
Y,
see 80Sr 2E+2 9E+1 4E-8 1E-10 - -
38 Strontium-83 D, see 80Sr 3E+3 7E+3 3E-6 1E-8 3E-5 3E-4
Y,
see 80Sr 2E+3 4E+3 1E-6 5E-9 - -
38 Strontium-85m2 D, see 80Sr 2E+5 6E+5 3E-4 9E-7 3E-3 3E-2
Y,
see 80Sr - 8E+5 4E-4 1E-6 - -
38 Strontium-85 D, see 80Sr 3E+3 3E+3 1E-6 4E-9 4E-5 4E-4
Y,
see 80Sr - 2E+3 6E-7 2E-9 - -
38 Strontium-87m D, see 80Sr 5E+4 1E+5 5E-5 2E-7 6E-4 6E-3
Y,
see 80Sr 4E+4 2E+5 6E-5 2E-7 - -
38 Strontium-89 D, see 80Sr 6E+2 8E+2 4E-7 1E-9 - -
LLI
wall
(6E+2) - - - 8E-6 8E-5
Y,
see 80Sr 5E+2 1E+2 6E-8 2E-10 - -
38 Strontium-90 D, see 80Sr 3E+1 2E+1 8E-9 - - -
Bone
surf Bone surf
(4E+1) (2E+1) - 3E-11 5E-7 5E-6
Y,
see 80Sr - 4E+0 2E-9 6E-12 - -
38 Strontium-91 D, see 80Sr 2E+3 6E+3 2E-6 8E-9 2E-5 2E-4
Y,
see 80Sr - 4E+3 1E-6 5E-9 - -
Table
I Table
II Table III
Occupational
Values Effluent Releases to
Concentrations Sewers
Oral Monthly
Ingestion Inhalation Average
Atomic Radionuclide Class ALI ALI DAC Air Water Concentration
No. (μCi) (μCi) (μCi/ml) (μCi/ml) (μCi/ml) (μCi/ml)
38 Strontium-92 D, see 80Sr 3E+3 9E+3 4E-6 1E-8 4E-5 4E-4
Y,
see 80Sr - 7E+3 3E-6 9E-9 - -
39 Yttrium-86m2 W, all compounds except
those given for Y 2E+4 6E+4 2E-5 8E-8 3E-4 3E-3
Y,
oxides and hydroxides - 5E+4 2E-5 8E-8 - -
39 Yttrium-86 W, see 86mY 1E+3 3E+3 1E-6 5E-9 2E-5 2E-4
Y,
see 86mY - 3E+3 1E-6 5E-9 - -
39 Yttrium-87 W, see 86mY 2E+3 3E+3 1E-6 5E-9 3E-5 3E-4
Y,
see 86mY - 3E+3 1E-6 5E-9 - -
39 Yttrium-88 W, see 86mY 1E+3 3E+2 1E-7 3E-10 1E-5 1E-4
Y,
see 86mY - 2E+2 1E-7 3E-10 - -
39 Yttrium-90m W, see 86mY 8E+3 1E+4 5E-6 2E-8 1E-4 1E-3
Y,
see 86mY - 1E+4 5E-6 2E-8 - -
39 Yttrium-90 W, see 86mY 4E+2 7E+2 3E-7 9E-10 - -
LLI
wall
(5E+2) - - - 7E-6 7E-5
Y,
see 86mY - 6E+2 3E-7 9E-10 - -
39 Yttrium-91m2 W, see 86mY 1E+5 2E+5 1E-4 3E-7 2E-3 2E-2
Y,
see 86mY - 2E+5 7E-5 2E-7 - -
39 Yttrium-91 W, see 86mY 5E+2 2E+2 7E-8 2E-10 - -
LLI
wall
(6E+2) - - - 8E-6 8E-5
Y,
see 86mY - 1E+2 5E-8 2E-10 - -
39 Yttrium-92 W, see 86mY 3E+3 9E+3 4E-6 1E-8 4E-5 4E-4
Y,
see 86mY - 8E+3 3E-6 1E-8 - -
39 Yttrium-93 W, see 86mY 1E+3 3E+3 1E-6 4E-9 2E-5 2E-4
Y,
see 86mY - 2E+3 1E-6 3E-9 - -
39 Yttrium-942 W, see 86mY 2E+4 8E+4 3E-5 1E-7 - -
St
wall
(3E+4) - - - 4E-4 4E-3
Y,
see 86mY - 8E+4 3E-5 1E-7 - -
39 Yttrium-952 W, see 86mY 4E+4 2E+5 6E-5 2E-7 - -
St
wall
(5E+4) - - - 7E-4 7E-3
Y,
see 86mY - 1E+5 6E-5 2E-7 - -
40 Zirconium-86 D, all compounds except
those given for W and Y 1E+3 4E+3 2E-6 6E-9 2E-5 2E-4
W,
oxides, hydroxides,
halides, and nitrates - 3E+3 1E-6 4E-9 - -
Y,
carbide - 2E+3 1E-6 3E-9 - -
40 Zirconium-88 D, see 86Zr 4E+3 2E+2 9E-8 3E-10 5E-5 5E-4
W,
see 86Zr - 5E+2 2E-7 7E-10 - -
Y,
see 86Zr - 3E+2 1E-7 4E-10 - -
Table
I Table
II Table III
Occupational
Values Effluent Releases to
Concentrations Sewers
Oral Monthly
Ingestion Inhalation Average
Atomic Radionuclide Class ALI ALI DAC Air Water Concentration
No. (μCi) (μCi) (μCi/ml) (μCi/ml) (μCi/ml) (μCi/ml)
40 Zirconium-89 D, see 86Zr 2E+3 4E+3 1E-6 5E-9 2E-5 2E-4
W,
see 86Zr - 2E+3 1E-6 3E-9 - -
Y,
see 86Zr - 2E+3 1E-6 3E-9 - -
40 Zirconium-93 D, see 86Zr 1E+3 6E+0 3E-9 - - -
Bone
surf Bone surf
(3E+3) (2E+1) - 2E-11 4E-5 4E-4
W,
see 86Zr - 2E+1 1E-8 - - -
Bone
surf
- (6E+1) - 9E-11 - -
Y,
see 86Zr - 6E+1 2E-8 - - -
Bone
surf
- (7E+1) - 9E-11 - -
40 Zirconium-95 D, see 86Zr 1E+3 1E+2 5E-8 - 2E-5 2E-4
Bone
surf
- (3E+2) - 4E-10 - -
W,
see 86Zr - 4E+2 2E-7 5E-10 - -
Y,
see 86Zr - 3E+2 1E-7 4E-10 - -
40 Zirconium-97 D, see 86Zr 6E+2 2E+3 8E-7 3E-9 9E-6 9E-5
W,
see 86Zr - 1E+3 6E-7 2E-9 - -
Y,
see 86Zr - 1E+3 5E-7 2E-9 - -
41 Niobium-882 W, all compounds except
those given for Y 5E+4 2E+5 9E-5 3E-7 - -
St
wall
(7E+4) - - - 1E-3 1E-2
Y,
oxides and hydroxides - 2E+5 9E-5 3E-7 - -
41 Niobium-892 W, see 88Nb 1E+4 4E+4 2E-5 6E-8 1E-4 1E-3
(66 min)
Y,
see 88Nb - 4E+4 2E-5 5E-8 - -
41 Niobium-89 W, see 88Nb 5E+3 2E+4 8E-6 3E-8 7E-5 7E-4
(122 min)
Y,
see 88Nb - 2E+4 6E-6 2E-8 - -
41 Niobium-90 W, see 88Nb 1E+3 3E+3 1E-6 4E-9 1E-5 1E-4
Y,
see 88Nb - 2E+3 1E-6 3E-9 - -
41 Niobium-93m W, see 88Nb 9E+3 2E+3 8E-7 3E-9 - -
LLI
wall
(1E+4) - - - 2E-4 2E-3
Y,
see 88Nb - 2E+2 7E-8 2E-10 - -
41 Niobium-94 W, see 88Nb 9E+2 2E+2 8E-8 3E-10 1E-5 1E-4
Y,
see 88Nb - 2E+1 6E-9 2E-11 - -
41 Niobium-95m W, see 88Nb 2E+3 3E+3 1E-6 4E-9 - -
LLI
wall
(2E+3) - - - 3E-5 3E-4
Y,
see 88Nb - 2E+3 9E-7 3E-9 - -
41 Niobium-95 W, see 88Nb 2E+3 1E+3 5E-7 2E-9 3E-5 3E-4
Y,
see 88Nb - 1E+3 5E-7 2E-9 - -
41 Niobium-96 W, see 88Nb 1E+3 3E+3 1E-6 4E-9 2E-5 2E-4
Y,
see 88Nb - 2E+3 1E-6 3E-9 - -
Table
I Table
II Table III
Occupational
Values Effluent Releases to
Concentrations Sewers
Oral Monthly
Ingestion Inhalation Average
Atomic Radionuclide Class ALI ALI DAC Air Water Concentration
No. (μCi) (μCi) (μCi/ml) (μCi/ml) (μCi/ml) (μCi/ml)
41 Niobium-972 W, see 88Nb 2E+4 8E+4 3E-5 1E-7 3E-4 3E-3
Y,
see 88Nb - 7E+4 3E-5 1E-7 - -
41 Niobium-982 W, see 88Nb 1E+4 5E+4 2E-5 8E-8 2E-4 2E-3
Y,
see 88Nb - 5E+4 2E-5 7E-8 - -
42 Molybdenum-90 D, all compounds except
those given for Y 4E+3 7E+3 3E-6 1E-8 3E-5 3E-4
Y,
oxides, hydroxides,
and MoS 2E+3 5E+3 2E-6 6E-9 - -
42 Molybdenum-93m D, see 90Mo 9E+3 2E+4 7E-6 2E-8 6E-5 6E-4
Y,
see 90Mo 4E+3 1E+4 6E-6 2E-8 - -
42 Molybdenum-93 D, see 90Mo 4E+3 5E+3 2E-6 8E-9 5E-5 5E-4
Y,
see 90Mo 2E+4 2E+2 8E-8 2E-10 - -
42 Molybdenum-99 D, see 90Mo 2E+3 3E+3 1E-6 4E-9 - -
LLI
wall
(1E+3) - - - 2E-5 2E-4
Y,
see 90Mo 1E+3 1E+3 6E-7 2E-9 - -
42 Molybdenum-1012 D, see 90Mo 4E+4 1E+5 6E-5 2E-7 - -
St
wall
(5E+4) - - - 7E-4 7E-3
Y,
see 90Mo - 1E+5 6E-5 2E-7 - -
43 Technetium-93m2 D, all compounds except
those given for W 7E+4 2E+5 6E-5 2E-7 1E-3 1E-2
W,
oxides, hydroxides,
halides, and nitrates - 3E+5 1E-4 4E-7 - -
43 Technetium-93 D, see 93mTc 3E+4 7E+4 3E-5 1E-7 4E-4 4E-3
W,
see 93mTc - 1E+5 4E-5 1E-7 - -
43 Technetium-94m2 D, see 93mTc 2E+4 4E+4 2E-5 6E-8 3E-4 3E-3
W,
see 93mTc - 6E+4 2E-5 8E-8 - -
43 Technetium-94 D, see 93mTc 9E+3 2E+4 8E-6 3E-8 1E-4 1E-3
W,
see 93mTc - 2E+4 1E-5 3E-8 - -
43 Technetium-95m D, see 93mTc 4E+3 5E+3 2E-6 8E-9 5E-5 5E-4
W,
see 93mTc - 2E+3 8E-7 3E-9 - -
43 Technetium-95 D, see 93mTc 1E+4 2E+4 9E-6 3E-8 1E-4 1E-3
W,
see 93mTc - 2E+4 8E-6 3E-8 - -
43 Technetium-96m2 D, see 93mTc 2E+5 3E+5 1E-4 4E-7 2E-3 2E-2
W,
see 93mTc - 2E+5 1E-4 3E-7 - -
43 Technetium-96 D, see 93mTc 2E+3 3E+3 1E-6 5E-9 3E-5 3E-4
W,
see 93mTc - 2E+3 9E-7 3E-9 - -
43 Technetium-97m D, see 93mTc 5E+3 7E+3 3E-6 - 6E-5 6E-4
St
wall
- (7E+3) - 1E-8 - -
W,
see 93mTc - 1E+3 5E-7 2E-9 - -
Table
I Table
II Table III
Occupational
Values Effluent Releases to
Concentrations Sewers
Oral Monthly
Ingestion Inhalation Average
Atomic Radionuclide Class ALI ALI DAC Air Water Concentration
No. (μCi) (μCi) (μCi/ml) (μCi/ml) (μCi/ml) (μCi/ml)
43 Technetium-97 D, see 93mTc 4E+4 5E+4 2E-5 7E-8 5E-4 5E-3
W,
see 93mTc - 6E+3 2E-6 8E-9 - -
43 Technetium-98 D, see 93mTc 1E+3 2E+3 7E-7 2E-9 1E-5 1E-4
W,
see 93mTc - 3E+2 1E-7 4E-10 - -
43 Technetium-99m D, see 93mTc 8E+4 2E+5 6E-5 2E-7 1E-3 1E-2
W,
see 93mTc - 2E+5 1E-4 3E-7 - -
43 Technetium-99 D, see 93mTc 4E+3 5E+3 2E-6 - 6E-5 6E-4
St
wall
- (6E+3) - 8E-9 - -
W,
see 93mTc - 7E+2 3E-7 9E-10 - -
43 Technetium-1012 D, see 93mTc 9E+4 3E+5 1E-4 5E-7 - -
St
wall
(1E+5) - - - 2E-3 2E-2
W,
see 93mTc - 4E+5 2E-4 5E-7 - -
43 Technetium-1042 D, see 93mTc 2E+4 7E+4 3E-5 1E-7 - -
St
wall
(3E+4) - - - 4E-4 4E-3
W,
see 93mTc - 9E+4 4E-5 1E-7 - -
44 Ruthenium-942 D, all compounds except
those given for W and Y 2E+4 4E+4 2E-5 6E-8 2E-4 2E-3
W,
halides - 6E+4 3E-5 9E-8 - -
Y,
oxides and hydroxides - 6E+4 2E-5 8E-8 - -
44 Ruthenium-97 D, see 94Ru 8E+3 2E+4 8E-6 3E-8 1E-4 1E-3
W,
see 94Ru - 1E+4 5E-6 2E-8 - -
Y,
see 94Ru - 1E+4 5E-6 2E-8 - -
44 Ruthenium-103 D, see 94Ru 2E+3 2E+3 7E-7 2E-9 3E-5 3E-4
W,
see 94Ru - 1E+3 4E-7 1E-9 - -
Y,
see 94Ru - 6E+2 3E-7 9E-10 - -
44 Ruthenium-105 D, see 94Ru 5E+3 1E+4 6E-6 2E-8 7E-5 7E-4
W,
see 94Ru - 1E+4 6E-6 2E-8 - -
Y,
see 94Ru - 1E+4 5E-6 2E-8 - -
44 Ruthenium-106 D, see 94Ru 2E+2 9E+1 4E-8 1E-10 - -
LLI
wall
(2E+2) - - - 3E-6 3E-5
W,
see 94Ru - 5E+1 2E-8 8E-11 - -
Y,
see 94Ru - 1E+1 5E-9 2E-11 - -
45 Rhodium-99m D, all compounds except
those given for W and Y 2E+4 6E+4 2E-5 8E-8 2E-4 2E-3
W,
halides - 8E+4 3E-5 1E-7 - -
Y,
oxides and hydroxides - 7E+4 3E-5 9E-8 - -
45 Rhodium-99 D, see 99mRh 2E+3 3E+3 1E-6 4E-9 3E-5 3E-4
W,
see 99mRh - 2E+3 9E-7 3E-9 - -
Y,
see 99mRh - 2E+3 8E-7 3E-9 - -
Table
I Table
II Table III
Occupational
Values Effluent Releases to
Concentrations Sewers
Oral Monthly
Ingestion Inhalation Average
Atomic Radionuclide Class ALI ALI DAC Air Water Concentration
No. (μCi) (μCi) (μCi/ml) (μCi/ml) (μCi/ml) (μCi/ml)
45 Rhodium-100 D, see 99mRh 2E+3 5E+3 2E-6 7E-9 2E-5 2E-4
W,
see 99mRh - 4E+3 2E-6 6E-9 - -
Y,
see 99mRh - 4E+3 2E-6 5E-9 - -
45 Rhodium-101m D, see 99mRh 6E+3 1E+4 5E-6 2E-8 8E-5 8E-4
W,
see 99mRh - 8E+3 4E-6 1E-8 - -
Y,
see 99mRh - 8E+3 3E-6 1E-8 - -
45 Rhodium-101 D, see 99mRh 2E+3 5E+2 2E-7 7E-10 3E-5 3E-4
W,
see 99mRh - 8E+2 3E-7 1E-9 - -
Y,
see 99mRh - 2E+2 6E-8 2E-10 - -
45 Rhodium-102m D, see 99mRh 1E+3 5E+2 2E-7 7E-10 - -
LLI
wall
(1E+3) - - - 2E-5 2E-4
W,
see 99mRh - 4E+2 2E-7 5E-10 - -
Y,
see 99mRh - 1E+2 5E-8 2E-10 - -
45 Rhodium-102 D, see 99mRh 6E+2 9E+1 4E-8 1E-10 8E-6 8E-5
W,
see 99mRh - 2E+2 7E-8 2E-10 - -
Y,
see 99mRh - 6E+1 2E-8 8E-11 - -
45 Rhodium-103m2 D, see 99mRh 4E+5 1E+6 5E-4 2E-6 6E-3 6E-2
W,
see 99mRh - 1E+6 5E-4 2E-6 - -
Y,
see 99mRh - 1E+6 5E-4 2E-6 - -
45 Rhodium-105 D, see 99mRh 4E+3 1E+4 5E-6 2E-8 - -
LLI
wall
(4E+3) - - - 5E-5 5E-4
W,
see 99mRh - 6E+3 3E-6 9E-9 - -
Y,
see 99mRh - 6E+3 2E-6 8E-9 - -
45 Rhodium-106m D, see 99mRh 8E+3 3E+4 1E-5 4E-8 1E-4 1E-3
W,
see 99mRh - 4E+4 2E-5 5E-8 - -
Y,
see 99mRh - 4E+4 1E-5 5E-8 - -
45 Rhodium-1072 D, see 99mRh 7E+4 2E+5 1E-4 3E-7 - -
St
wall
(9E+4) - - - 1E-3 1E-2
W,
see 99mRh - 3E+5 1E-4 4E-7 - -
Y,
see 99mRh - 3E+5 1E-4 3E-7 - -
46 Palladium-100 D, all compounds except
those given for W and Y 1E+3 1E+3 6E-7 2E-9 2E-5 2E-4
W,
nitrates - 1E+3 5E-7 2E-9 - -
Y,
oxides and hydroxides - 1E+3 6E-7 2E-9 - -
46 Palladium-101 D, see 100Pd 1E+4 3E+4 1E-5 5E-8 2E-4 2E-3
W,
see 100Pd - 3E+4 1E-5 5E-8 - -
Y,
see 100Pd - 3E+4 1E-5 4E-8 - -
46 Palladium-103 D, see 100Pd 6E+3 6E+3 3E-6 9E-9 - -
LLI
wall
(7E+3) - - - 1E-4 1E-3
W,
see 100Pd - 4E+3 2E-6 6E-9 - -
Y,
see 100Pd - 4E+3 1E-6 5E-9 - -
Table
I Table
II Table III
Occupational
Values Effluent Releases to
Concentrations Sewers
Oral Monthly
Ingestion Inhalation Average
Atomic Radionuclide Class ALI ALI DAC Air Water Concentration
No. (μCi) (μCi) (μCi/ml) (μCi/ml) (μCi/ml) (μCi/ml)
46 Palladium-107 D, see 100Pd 3E+4 2E+4 9E-6 - - -
LLI
wall Kidneys
(4E+4) (2E+4) - 3E-8 5E-4 5E-3
W,
see 100Pd - 7E+3 3E-6 1E-8 - -
Y,
see 100Pd - 4E+2 2E-7 6E-10 - -
46 Palladium-109 D, see 100Pd 2E+3 6E+3 3E-6 9E-9 3E-5 3E-4
W,
see 100Pd - 5E+3 2E-6 8E-9 - -
Y,
see 100Pd - 5E+3 2E-6 6E-9 - -
47 Silver-1022 D, all compounds except
those given for W and Y 5E+4 2E+5 8E-5 2E-7 - -
St
wall
(6E+4) - - - 9E-4 9E-3
W,
nitrates and sulfides - 2E+5 9E-5 3E-7 - -
Y,
oxides and hydroxides - 2E+5 8E-5 3E-7 - -
47 Silver-1032 D, see 102Ag 4E+4 1E+5 4E-5 1E-7 5E-4 5E-3
W,
see 102Ag - 1E+5 5E-5 2E-7 - -
Y,
see 102Ag - 1E+5 5E-5 2E-7 - -
47 Silver-104m2 D, see 102Ag 3E+4 9E+4 4E-5 1E-7 4E-4 4E-3
W,
see 102Ag - 1E+5 5E-5 2E-7 - -
Y,
see 102Ag - 1E+5 5E-5 2E-7 - -
47 Silver-1042 D, see 102Ag 2E+4 7E+4 3E-5 1E-7 3E-4 3E-3
W,
see 102Ag - 1E+5 6E-5 2E-7 - -
Y,
see 102Ag - 1E+5 6E-5 2E-7 - -
47 Silver-105 D, see 102Ag 3E+3 1E+3 4E-7 1E-9 4E-5 4E-4
W,
see 102Ag - 2E+3 7E-7 2E-9 - -
Y,
see 102Ag - 2E+3 7E-7 2E-9 - -
47 Silver-106m D, see 102Ag 8E+2 7E+2 3E-7 1E-9 1E-5 1E-4
W,
see 102Ag - 9E+2 4E-7 1E-9 - -
Y,
see 102Ag - 9E+2 4E-7 1E-9 - -
47 Silver-1062 D, see 102Ag 6E+4 2E+5 8E-5 3E-7 - -
St.
wall
(6E+4) - - - 9E-4 9E-3
W,
see 102Ag - 2E+5 9E-5 3E-7 - -
Y,
see 102Ag - 2E+5 8E-5 3E-7 - -
47 Silver-108m D, see 102Ag 6E+2 2E+2 8E-8 3E-10 9E-6 9E-5
W,
see 102Ag - 3E+2 1E-7 4E-10 - -
Y,
see 102Ag - 2E+1 1E-8 3E-11 - -
47 Silver-110m D, see 102Ag 5E+2 1E+2 5E-8 2E-10 6E-6 6E-5
W,
see 102Ag - 2E+2 8E-8 3E-10 - -
Y,
see 102Ag - 9E+1 4E-8 1E-10 - -
47 Silver-111 D, see 102Ag 9E+2 2E+3 6E-7 - - -
LLI
wall Liver
(1E+3) (2E+3) - 2E-9 2E-5 2E-4
W,
see 102Ag - 9E+2 4E-7 1E-9 - -
Y,
see 102Ag - 9E+2 4E-7 1E-9 - -
Table
I Table
II Table III
Occupational
Values Effluent Releases to
Concentrations Sewers
Oral Monthly
Ingestion Inhalation Average
Atomic Radionuclide Class ALI ALI DAC Air Water Concentration
No. (μCi) (μCi) (μCi/ml) (μCi/ml) (μCi/ml) (μCi/ml)
47 Silver-112 D, see 102Ag 3E+3 8E+3 3E-6 1E-8 4E-5 4E-4
W,
see 102Ag - 1E+4 4E-6 1E-8 - -
Y,
see 102Ag - 9E+3 4E-6 1E-8 - -
47 Silver-1152 D, see 102Ag 3E+4 9E+4 4E-5 1E-7 - -
St
wall
(3E+4) - - - 4E-4 4E-3
W,
see 102Ag - 9E+4 4E-5 1E-7 - -
Y,
see 102Ag - 8E+4 3E-5 1E-7 - -
48 Cadmium-1042 D, all compounds except
those given for W and Y 2E+4 7E+4 3E-5 9E-8 3E-4 3E-3
W,
sulfides, halides,
and nitrates - 1E+5 5E-5 2E-7 - -
Y,
oxides and hydroxides - 1E+5 5E-5 2E-7 - -
48 Cadmium-107 D, see 104Cd 2E+4 5E+4 2E-5 8E-8 3E-4 3E-3
W,
see 104Cd - 6E+4 2E-5 8E-8 - -
Y,
see 104Cd - 5E+4 2E-5 7E-8 - -
48 Cadmium-109 D, see 104Cd 3E+2 4E+1 1E-8 - - -
Kidneys Kidneys
(4E+2) (5E+1) - 7E-11 6E-6 6E-5
W,
see 104Cd - 1E+2 5E-8 - - -
Kidneys
- (1E+2) - 2E-10 - -
Y,
see 104Cd - 1E+2 5E-8 2E-10 - -
48 Cadmium-113m D, see 104Cd 2E+1 2E+0 1E-9 - - -
Kidneys Kidneys
(4E+1) (4E+0) - 5E-12 5E-7 5E-6
W,
see 104Cd - 8E+0 4E-9 - - -
Kidneys
- (1E+1) - 2E-11 - -
Y,
see 104Cd - 1E+1 5E-9 2E-11 - -
48 Cadmium-113 D, see 104Cd 2E+1 2E+0 9E-10 - - -
Kidneys Kidneys
(3E+1) (3E+0) - 5E-12 4E-7 4E-6
W,
see 104Cd - 8E+0 3E-9 - - -
Kidneys
- (1E+1) - 2E-11 - -
Y,
see 104Cd - 1E+1 6E-9 2E-11 - -
48 Cadmium-115m D, see 104Cd 3E+2 5E+1 2E-8 - 4E-6 4E-5
Kidneys
- (8E+1) - 1E-10 - -
W,
see 104Cd - 1E+2 5E-8 2E-10 - -
Y,
see 104Cd - 1E+2 6E-8 2E-10 - -
48 Cadmium-115 D, see 104Cd 9E+2 1E+3 6E-7 2E-9 - -
LLI
wall
(1E+3) - - - 1E-5 1E-4
W,
see 104Cd - 1E+3 5E-7 2E-9 - -
Y,
see 104Cd - 1E+3 6E-7 2E-9 - -
48 Cadmium-117m D, see 104Cd 5E+3 1E+4 5E-6 2E-8 6E-5 6E-4
W,
see 104Cd - 2E+4 7E-6 2E-8 - -
Y,
see 104Cd - 1E+4 6E-6 2E-8 - -
Table
I Table
II Table III
Occupational
Values Effluent Releases to
Concentrations Sewers
Oral Monthly
Ingestion Inhalation Average
Atomic Radionuclide Class ALI ALI DAC Air Water Concentration
No. (μCi) (μCi) (μCi/ml) (μCi/ml) (μCi/ml) (μCi/ml)
48 Cadmium-117 D, see 104Cd 5E+3 1E+4 5E-6 2E-8 6E-5 6E-4
W,
see 104Cd - 2E+4 7E-6 2E-8 - -
Y,
see 104Cd - 1E+4 6E-6 2E-8 - -
49 Indium-109 D, all compounds except
those given for W 2E+4 4E+4 2E-5 6E-8 3E-4 3E-3
W,
oxides, hydroxides,
halides, and nitrates - 6E+4 3E-5 9E-8 - -
49 Indium-1102 D, see 109In 2E+4 4E+4 2E-5 6E-8 2E-4 2E-3
(69.1 min) W, see 109In - 6E+4 2E-5 8E-8 - -
49 Indium-110 D, see 109In 5E+3 2E+4 7E-6 2E-8 7E-5 7E-4
(4.9 h) W, see 109In - 2E+4 8E-6 3E-8 - -
49 Indium-111 D, see 109In 4E+3 6E+3 3E-6 9E-9 6E-5 6E-4
W,
see 109In - 6E+3 3E-6 9E-9 - -
49 Indium-1122 D, see 109In 2E+5 6E+5 3E-4 9E-7 2E-3 2E-2
W,
see 109In - 7E+5 3E-4 1E-6 - -
49 Indium-113m2 D, see 109In 5E+4 1E+5 6E-5 2E-7 7E-4 7E-3
W,
see 109In - 2E+5 8E-5 3E-7 - -
49 Indium-114m D, see 109In 3E+2 6E+1 3E-8 9E-11 - -
LLI
wall
(4E+2) - - - 5E-6 5E-5
W,
see 109In - 1E+2 4E-8 1E-10 - -
49 Indium-115m D, see 109In 1E+4 4E+4 2E-5 6E-8 2E-4 2E-3
W,
see 109In - 5E+4 2E-5 7E-8 - -
49 Indium-115 D, see 109In 4E+1 1E+0 6E-10 2E-12 5E-7 5E-6
W,
see 109In - 5E+0 2E-9 8E-12 - -
49 Indium-116m2 D, see 109In 2E+4 8E+4 3E-5 1E-7 3E-4 3E-3
W,
see 109In - 1E+5 5E-5 2E-7 - -
49 Indium-117m2 D, see 109In 1E+4 3E+4 1E-5 5E-8 2E-4 2E-3
W,
see 109In - 4E+4 2E-5 6E-8 - -
49 Indium-1172 D, see 109In 6E+4 2E+5 7E-5 2E-7 8E-4 8E-3
W,
see 109In - 2E+5 9E-5 3E-7 - -
49 Indium-119m2 D, see 109In 4E+4 1E+5 5E-5 2E-7 - -
St
wall
(5E+4) - - - 7E-4 7E-3
W,
see 109In - 1E+5 6E-5 2E-7 - -
50 Tin-110 D, all compounds except
those given for W 4E+3 1E+4 5E-6 2E-8 5E-5 5E-4
W,
sulfides, oxides,
hydroxides, halides,
nitrates, and stannic
phosphate - 1E+4 5E-6 2E-8 - -
50 Tin-1112 D, see 110Sn 7E+4 2E+5 9E-5 3E-7 1E-3 1E-2
W,
see 110Sn - 3E+5 1E-4 4E-7 - -
Table
I Table
II Table III
Occupational
Values Effluent Releases to
Concentrations Sewers
Oral Monthly
Ingestion Inhalation Average
Atomic Radionuclide Class ALI ALI DAC Air Water Concentration
No. (μCi) (μCi) (μCi/ml) (μCi/ml) (μCi/ml) (μCi/ml)
50 Tin-113 D, see 110Sn 2E+3 1E+3 5E-7 2E-9 - -
LLI
wall
(2E+3) - - - 3E-5 3E-4
W,
see 110Sn - 5E+2 2E-7 8E-10 - -
50 Tin-117m D, see 110Sn 2E+3 1E+3 5E-7 - - -
LLI
wall Bone surf
(2E+3) (2E+3) - 3E-9 3E-5 3E-4
W,
see 110Sn - 1E+3 6E-7 2E-9 - -
50 Tin-119m D, see 110Sn 3E+3 2E+3 1E-6 3E-9 - -
LLI
wall
(4E+3) - - - 6E-5 6E-4
W,
see 110Sn - 1E+3 4E-7 1E-9 - -
50 Tin-121m D, see 110Sn 3E+3 9E+2 4E-7 1E-9 - -
LLI
wall
(4E+3) - - - 5E-5 5E-4
W,
see 110Sn - 5E+2 2E-7 8E-10 - -
50 Tin-121 D, see 110Sn 6E+3 2E+4 6E-6 2E-8 - -
LLI
wall
(6E+3) - - - 8E-5 8E-4
W,
see 110Sn - 1E+4 5E-6 2E-8 - -
50 Tin-123m2 D, see 110Sn 5E+4 1E+5 5E-5 2E-7 7E-4 7E-3
W,
see 110Sn - 1E+5 6E-5 2E-7 - -
50 Tin-123 D, see 110Sn 5E+2 6E+2 3E-7 9E-10 - -
LLI
wall
(6E+2) - - - 9E-6 9E-5
W,
see 110Sn - 2E+2 7E-8 2E-10 - -
50 Tin-125 D, see 110Sn 4E+2 9E+2 4E-7 1E-9 - -
LLI
wall
(5E+2) - - - 6E-6 6E-5
W,
see 110Sn - 4E+2 1E-7 5E-10 - -
50 Tin-126 D, see 110Sn 3E+2 6E+1 2E-8 8E-11 4E-6 4E-5
W,
see 110Sn - 7E+1 3E-8 9E-11 - -
50 Tin-127 D, see 110Sn 7E+3 2E+4 8E-6 3E-8 9E-5 9E-4
W,
see 110Sn - 2E+4 8E-6 3E-8 - -
50 Tin-1282 D, see 110Sn 9E+3 3E+4 1E-5 4E-8 1E-4 1E-3
W,
see 110Sn - 4E+4 1E-5 5E-8 - -
51 Antimony-1152 D, all compounds except
those given for W 8E+4 2E+5 1E-4 3E-7 1E-3 1E-2
W,
oxides, hydroxides,
halides, sulfides,
sulfates, and nitrates - 3E+5 1E-4 4E-7 - -
51 Antimony-116m2 D, see 115Sb 2E+4 7E+4 3E-5 1E-7 3E-4 3E-3
W,
see 115Sb - 1E+5 6E-5 2E-7 - -
Table
I Table
II Table III
Occupational
Values Effluent Releases to
Concentrations Sewers
Oral Monthly
Ingestion Inhalation Average
Atomic Radionuclide Class ALI ALI DAC Air Water Concentration
No. (μCi) (μCi) (μCi/ml) (μCi/ml) (μCi/ml) (μCi/ml)
51 Antimony-1162 D, see 115Sb 7E+4 3E+5 1E-4 4E-7 - -
St
wall
(9E+4) - - - 1E-3 1E-2
W,
see 115Sb - 3E+5 1E-4 5E-7 - -
51 Antimony-117 D, see 115Sb 7E+4 2E+5 9E-5 3E-7 9E-4 9E-3
W,
see 115Sb - 3E+5 1E-4 4E-7 - -
51 Antimony-118m D, see 115Sb 6E+3 2E+4 8E-6 3E-8 7E-5 7E-4
W,
see 115Sb 5E+3 2E+4 9E-6 3E-8 - -
51 Antimony-119 D, see 115Sb 2E+4 5E+4 2E-5 6E-8 2E-4 2E-3
W,
see 115Sb 2E+4 3E+4 1E-5 4E-8 - -
51 Antimony-1202 D, see 115Sb 1E+5 4E+5 2E-4 6E-7 - -
(16 min) St
wall
(2E+5) - - - 2E-3 2E-2
W,
see 115Sb - 5E+5 2E-4 7E-7 - -
51 Antimony-120 D, see 115Sb 1E+3 2E+3 9E-7 3E-9 1E-5 1E-4
(5.76 d) W, see 115Sb 9E+2 1E+3 5E-7 2E-9 - -
51 Antimony-122 D, see 115Sb 8E+2 2E+3 1E-6 3E-9 - -
LLI
wall
(8E+2) - - - 1E-5 1E-4
W,
see 115Sb 7E+2 1E+3 4E-7 2E-9 - -
51 Antimony-124m2 D, see 115Sb 3E+5 8E+5 4E-4 1E-6 3E-3 3E-2
W,
see 115Sb 2E+5 6E+5 2E-4 8E-7 - -
51 Antimony-124 D, see 115Sb 6E+2 9E+2 4E-7 1E-9 7E-6 7E-5
W,
see 115Sb 5E+2 2E+2 1E-7 3E-10 - -
51 Antimony-125 D, see 115Sb 2E+3 2E+3 1E-6 3E-9 3E-5 3E-4
W,
see 115Sb - 5E+2 2E-7 7E-10 - -
51 Antimony-126m2 D, see 115Sb 5E+4 2E+5 8E-5 3E-7 - -
St
wall
(7E+4) - - - 9E-4 9E-3
W,
see 115Sb - 2E+5 8E-5 3E-7 - -
51 Antimony-126 D, see 115Sb 6E+2 1E+3 5E-7 2E-9 7E-6 7E-5
W,
see 115Sb 5E+2 5E+2 2E-7 7E-10 - -
51 Antimony-127 D, see 115Sb 8E+2 2E+3 9E-7 3E-9 - -
LLI
wall
(8E+2) - - - 1E-5 1E-4
W,
see 115Sb 7E+2 9E+2 4E-7 1E-9 - -
51 Antimony-1282 D, see 115Sb 8E+4 4E+5 2E-4 5E-7 - -
(10.4 min) St
wall
(1E+5) - - - 1E-3 1E-2
W,
see 115Sb - 4E+5 2E-4 6E-7 - -
51 Antimony-128 D, see 115Sb 1E+3 4E+3 2E-6 6E-9 2E-5 2E-4
(9.01 h) W, see 115Sb - 3E+3 1E-6 5E-9 - -
Table
I Table
II Table III
Occupational
Values Effluent Releases to
Concentrations Sewers
Oral Monthly
Ingestion Inhalation Average
Atomic Radionuclide Class ALI ALI DAC Air Water Concentration
No. (μCi) (μCi) (μCi/ml) (μCi/ml) (μCi/ml) (μCi/ml)
51 Antimony-129 D, see 115Sb 3E+3 9E+3 4E-6 1E-8 4E-5 4E-4
W,
see 115Sb - 9E+3 4E-6 1E-8 - -
51 Antimony-1302 D, see 115Sb 2E+4 6E+4 3E-5 9E-8 3E-4 3E-3
W,
see 115Sb - 8E+4 3E-5 1E-7 - -
51 Antimony-1312 D, see 115Sb 1E+4 2E+4 1E-5 - - -
Thyroid Thyroid
(2E+4) (4E+4) - 6E-8 2E-4 2E-3
W,
see 115Sb - 2E+4 1E-5 - -
Thyroid
- (4E+4) - 6E-8 - -
52 Tellurium-116 D, all compounds except
those given for W 8E+3 2E+4 9E-6 3E-8 1E-4 1E-3
W,
oxides, hydroxides,
and nitrates - 3E+4 1E-5 4E-8 - -
52 Tellurium-121m D, see 116Te 5E+2 2E+2 8E-8 - - -
Bone
surf Bone surf
(7E+2) (4E+2) - 5E-10 1E-5 1E-4
W,
see 116Te - 4E+2 2E-7 6E-10 - -
52 Tellurium-121 D, see 116Te 3E+3 4E+3 2E-6 6E-9 4E-5 4E-4
W,
see 116Te - 3E+3 1E-6 4E-9 - -
52 Tellurium-123m D, see 116Te 6E+2 2E+2 9E-8 - - -
Bone
surf Bone surf
(1E+3) (5E+2) - 8E-10 1E-5 1E-4
W,
see 116Te - 5E+2 2E-7 8E-10 - -
52 Tellurium-123 D, see 116Te 5E+2 2E+2 8E-8 - - -
Bone
surf Bone surf
(1E+3) (5E+2) - 7E-10 2E-5 2E-4
W,
see 116Te - 4E+2 2E-7 - - -
Bone
surf
- (1E+3) - 2E-9 - -
52 Tellurium-125m D, see 116Te 1E+3 4E+2 2E-7 - - -
Bone
surf Bone surf
(1E+3) (1E+3) - 1E-9 2E-5 2E-4
W,
see 116Te - 7E+2 3E-7 1E-9 - -
52 Tellurium-127m D, see 116Te 6E+2 3E+2 1E-7 - 9E-6 9E-5
Bone
surf
- (4E+2) - 6E-10 - -
W,
see 116Te - 3E+2 1E-7 4E-10 - -
52 Tellurium-127 D, see 116Te 7E+3 2E+4 9E-6 3E-8 1E-4 1E-3
W,
see 116Te - 2E+4 7E-6 2E-8 - -
52 Tellurium-129m D, see 116Te 5E+2 6E+2 3E-7 9E-10 7E-6 7E-5
W,
see 116Te - 2E+2 1E-7 3E-10 - -
52 Tellurium-1292 D, see 116Te 3E+4 6E+4 3E-5 9E-8 4E-4 4E-3
W,
see 116Te - 7E+4 3E-5 1E-7 - -
Table
I Table
II Table III
Occupational
Values Effluent Releases to
Concentrations Sewers
Oral Monthly
Ingestion Inhalation Average
Atomic Radionuclide Class ALI ALI DAC Air Water Concentration
No. (μCi) (μCi) (μCi/ml) (μCi/ml) (μCi/ml) (μCi/ml)
52 Tellurium-131m D, see 116Te 3E+2 4E+2 2E-7 - - -
Thyroid Thyroid
(6E+2) (1E+3) - 2E-9 8E-6 8E-5
W,
see 116Te - 4E+2 2E-7 - - -
Thyroid
- (9E+2) - 1E-9 - -
52 Tellurium-1312 D, see 116Te 3E+3 5E+3 2E-6 - - -
Thyroid Thyroid
(6E+3) (1E+4) - 2E-8 8E-5 8E-4
W,
see 116Te - 5E+3 2E-6 - - -
Thyroid
- (1E+4) - 2E-8 - -
52 Tellurium-132 D, see 116Te 2E+2 2E+2 9E-8 - - -
Thyroid Thyroid
(7E+2) (8E+2) - 1E-9 9E-6 9E-5
W,
see 116Te - 2E+2 9E-8 - - -
Thyroid
- (6E+2) - 9E-10 - -
52 Tellurium-133m2 D, see 116Te 3E+3 5E+3 2E-6 - - -
Thyroid Thyroid
(6E+3) (1E+4) - 2E-8 9E-5 9E-4
W,
see 116Te - 5E+3 2E-6 - - -
Thyroid
- (1E+4) - 2E-8 - -
52 Tellurium-1332 D, see 116Te 1E+4 2E+4 9E-6 - - -
Thyroid Thyroid
(3E+4) (6E+4) - 8E-8 4E-4 4E-3
W,
see 116Te - 2E+4 9E-6 - - -
Thyroid
- (6E+4) - 8E-8 - -
52 Tellurium-1342 D, see 116Te 2E+4 2E+4 1E-5 - - -
Thyroid Thyroid
(2E+4) (5E+4) - 7E-8 3E-4 3E-3
W,
see 116Te - 2E+4 1E-5 - - -
Thyroid
- (5E+4) - 7E-8 - -
53 Iodine-120m2 D, all compounds 1E+4 2E+4 9E-6 3E-8 - -
Thyroid
(1E+4) - - - 2E-4 2E-3
53 Iodine-1202 D, all compounds 4E+3 9E+3 4E-6 - - -
Thyroid Thyroid
(8E+3) (1E+4) - 2E-8 1E-4 1E-3
53 Iodine-121 D, all compounds 1E+4 2E+4 8E-6 - - -
Thyroid Thyroid
(3E+4) (5E+4) - 7E-8 4E-4 4E-3
53 Iodine-123 D, all compounds 3E+3 6E+3 3E-6 - - -
Thyroid Thyroid
(1E+4) (2E+4) - 2E-8 1E-4 1E-3
Table
I Table
II Table III
Occupational
Values Effluent Releases to
Concentrations Sewers
Oral Monthly
Ingestion Inhalation Average
Atomic Radionuclide Class ALI ALI DAC Air Water Concentration
No. (μCi) (μCi) (μCi/ml) (μCi/ml) (μCi/ml) (μCi/ml)
53 Iodine-124 D, all compounds 5E+1 8E+1 3E-8 - - -
Thyroid Thyroid
(2E+2) (3E+2) - 4E-10 2E-6 2E-5
53 Iodine-125 D, all compounds 4E+1 6E+1 3E-8 - - -
Thyroid Thyroid
(1E+2) (2E+2) - 3E-10 2E-6 2E-5
53 Iodine-126 D, all compounds 2E+1 4E+1 1E-8 - - -
Thyroid Thyroid
(7E+1) (1E+2) - 2E-10 1E-6 1E-5
53 Iodine-1282 D, all compounds 4E+4 1E+5 5E-5 2E-7 - -
St
wall
(6E+4) - - - 8E-4 8E-3
53 Iodine-129 D, all compounds 5E+0 9E+0 4E-9 - - -
Thyroid Thyroid
(2E+1) (3E+1) - 4E-11 2E-7 2E-6
53 Iodine-130 D, all compounds 4E+2 7E+2 3E-7 - - -
Thyroid Thyroid
(1E+3) (2E+3) - 3E-9 2E-5 2E-4
53 Iodine-131 D, all compounds 3E+1 5E+1 2E-8 - - -
Thyroid Thyroid
(9E+1) (2E+2) - 2E-10 1E-6 1E-5
53 Iodine-132m2 D, all compounds 4E+3 8E+3 4E-6 - - -
Thyroid Thyroid
(1E+4) (2E+4) - 3E-8 1E-4 1E-3
53 Iodine-132 D, all compounds 4E+3 8E+3 3E-6 - - -
Thyroid Thyroid
(9E+3) (1E+4) - 2E-8 1E-4 1E-3
53 Iodine-133 D, all compounds 1E+2 3E+2 1E-7 - - -
Thyroid Thyroid
(5E+2) (9E+2) - 1E-9 7E-6 7E-5
53 Iodine-1342 D, all compounds 2E+4 5E+4 2E-5 6E-8 - -
Thyroid
(3E+4) - - - 4E-4 4E-3
53 Iodine-135 D, all compounds 8E+2 2E+3 7E-7 - - -
Thyroid Thyroid
(3E+3) (4E+3) - 6E-9 3E-5 3E-4
54 Xenon-1202 Submersion1 - - 1E-5 4E-8 - -
54 Xenon-1212 Submersion1 - - 2E-6 1E-8 - -
54 Xenon-122 Submersion1 - - 7E-5 3E-7 - -
54 Xenon-123 Submersion1 - - 6E-6 3E-8 - -
54 Xenon-125 Submersion1 - - 2E-5 7E-8 - -
Table
I Table
II Table III
Occupational
Values Effluent Releases to
Concentrations Sewers
Oral Monthly
Ingestion Inhalation Average
Atomic Radionuclide Class ALI ALI DAC Air Water Concentration
No. (μCi) (μCi) (μCi/ml) (μCi/ml) (μCi/ml) (μCi/ml)
54 Xenon-127 Submersion1 - - 1E-5 6E-8 - -
54 Xenon-129m Submersion1 - - 2E-4 9E-7 - -
54 Xenon-131m Submersion1 - - 4E-4 2E-6 - -
54 Xenon-133m Submersion1 - - 1E-4 6E-7 - -
54 Xenon-133 Submersion1 - - 1E-4 5E-7 - -
54 Xenon-135m2 Submersion1 - - 9E-6 4E-8 - -
54 Xenon-135 Submersion1 - - 1E-5 7E-8 - -
54 Xenon-1382 Submersion1 - - 4E-6 2E-8 - -
55 Cesium-1252 D, all compounds 5E+4 1E+5 6E-5 2E-7 - -
St
wall
(9E+4) - - - 1E-3 1E-2
55 Cesium-127 D, all compounds 6E+4 9E+4 4E-5 1E-7 9E-4 9E-3
55 Cesium-129 D, all compounds 2E+4 3E+4 1E-5 5E-8 3E-4 3E-3
55 Cesium-1302 D, all compounds 6E+4 2E+5 8E-5 3E-7 - -
St
wall
(1E+5) - - - 1E-3 1E-2
55 Cesium-131 D, all compounds 2E+4 3E+4 1E-5 4E-8 3E-4 3E-3
55 Cesium-132 D, all compounds 3E+3 4E+3 2E-6 6E-9 4E-5 4E-4
55 Cesium-134m D, all compounds 1E+5 1E+5 6E-5 2E-7 - -
St
wall
(1E+5) - - - 2E-3 2E-2
55 Cesium-134 D, all compounds 7E+1 1E+2 4E-8 2E-10 9E-7 9E-6
55 Cesium-135m2 D, all compounds 1E+5 2E+5 8E-5 3E-7 1E-3 1E-2
55 Cesium-135 D, all compounds 7E+2 1E+3 5E-7 2E-9 1E-5 1E-4
55 Cesium-136 D, all compounds 4E+2 7E+2 3E-7 9E-10 6E-6 6E-5
55 Cesium-137 D, all compounds 1E+2 2E+2 6E-8 2E-10 1E-6 1E-5
55 Cesium-1382 D, all compounds 2E+4 6E+4 2E-5 8E-8 - -
St
wall
(3E+4) - - - 4E-4 4E-3
56 Barium-1262 D, all compounds 6E+3 2E+4 6E-6 2E-8 8E-5 8E-4
56 Barium-128 D, all compounds 5E+2 2E+3 7E-7 2E-9 7E-6 7E-5
56 Barium-131m2 D, all compounds 4E+5 1E+6 6E-4 2E-6 - -
St
wall
(5E+5) - - - 7E-3 7E-2
Table
I Table
II Table III
Occupational
Values Effluent Releases to
Concentrations Sewers
Oral Monthly
Ingestion Inhalation Average
Atomic Radionuclide Class ALI ALI DAC Air Water Concentration
No. (μCi) (μCi) (μCi/ml) (μCi/ml) (μCi/ml) (μCi/ml)
56 Barium-131 D, all compounds 3E+3 8E+3 3E-6 1E-8 4E-5 4E-4
56 Barium-133m D, all compounds 2E+3 9E+3 4E-6 1E-8 - -
LLI
wall
(3E+3) - - - 4E-5 4E-4
56 Barium-133 D, all compounds 2E+3 7E+2 3E-7 9E-10 2E-5 2E-4
56 Barium-135m D, all compounds 3E+3 1E+4 5E-6 2E-8 4E-5 4E-4
56 Barium-1392 D, all compounds 1E+4 3E+4 1E-5 4E-8 2E-4 2E-3
56 Barium-140 D, all compounds 5E+2 1E+3 6E-7 2E-9 - -
LLI
wall
(6E+2) - - - 8E-6 8E-5
56 Barium-1412 D, all compounds 2E+4 7E+4 3E-5 1E-7 3E-4 3E-3
56 Barium-1422 D, all compounds 5E+4 1E+5 6E-5 2E-7 7E-4 7E-3
57 Lanthanum-1312 D, all compounds except
those given for W 5E+4 1E+5 5E-5 2E-7 6E-4 6E-3
W,
oxides and hydroxides - 2E+5 7E-5 2E-7 - -
57 Lanthanum-132 D, see 131La 3E+3 1E+4 4E-6 1E-8 4E-5 4E-4
W,
see 131La - 1E+4 5E-6 2E-8 - -
57 Lanthanum-135 D, see 131La 4E+4 1E+5 4E-5 1E-7 5E-4 5E-3
W,
see 131La - 9E+4 4E-5 1E-7 - -
57 Lanthanum-137 D, see 131La 1E+4 6E+1 3E-8 - 2E-4 2E-3
Liver
- (7E+1) - 1E-10 - -
W,
see 131La - 3E+2 1E-7 - - -
Liver
- (3E+2) - 4E-10 - -
57 Lanthanum-138 D, see 131La 9E+2 4E+0 1E-9 5E-12 1E-5 1E-4
W,
see 131La - 1E+1 6E-9 2E-11 - -
57 Lanthanum-140 D, see 131La 6E+2 1E+3 6E-7 2E-9 9E-6 9E-5
W,
see 131La - 1E+3 5E-7 2E-9 - -
57 Lanthanum-141 D, see 131La 4E+3 9E+3 4E-6 1E-8 5E-5 5E-4
W,
see 131La - 1E+4 5E-6 2E-8 - -
57 Lanthanum-1422 D, see 131La 8E+3 2E+4 9E-6 3E-8 1E-4 1E-3
W,
see 131La - 3E+4 1E-5 5E-8 - -
57 Lanthanum-1432 D, see 131La 4E+4 1E+5 4E-5 1E-7 - -
St
wall
(4E+4) - - - 5E-4 5E-3
W,
see 131La - 9E+4 4E-5 1E-7 - -
Table
I Table
II Table III
Occupational
Values Effluent Releases to
Concentrations Sewers
Oral Monthly
Ingestion Inhalation Average
Atomic Radionuclide Class ALI ALI DAC Air Water Concentration
No. (μCi) (μCi) (μCi/ml) (μCi/ml) (μCi/ml) (μCi/ml)
58 Cerium-134 W, all compounds except
those given for Y 5E+2 7E+2 3E-7 1E-9 - -
LLI
wall
(6E+2) - - - 8E-6 8E-5
Y,
oxides, hydroxides,
and fluorides - 7E+2 3E-7 9E-10 - -
58 Cerium-135 W, see 134Ce 2E+3 4E+3 2E-6 5E-9 2E-5 2E-4
Y,
see 134Ce - 4E+3 1E-6 5E-9 - -
58 Cerium-137m W, see 134Ce 2E+3 4E+3 2E-6 6E-9 - -
LLI
wall
(2E+3) - - - 3E-5 3E-4
Y,
see 134Ce - 4E+3 2E-6 5E-9 - -
58 Cerium-137 W, see 134Ce 5E+4 1E+5 6E-5 2E-7 7E-4 7E-3
Y,
see 134Ce - 1E+5 5E-5 2E-7 - -
58 Cerium-139 W, see 134Ce 5E+3 8E+2 3E-7 1E-9 7E-5 7E-4
Y,
see 134Ce - 7E+2 3E-7 9E-10 - -
58 Cerium-141 W, see 134Ce 2E+3 7E+2 3E-7 1E-9 - -
LLI
wall
(2E+3) - - - 3E-5 3E-4
Y,
see 134Ce - 6E+2 2E-7 8E-10 - -
58 Cerium-143 W, see 134Ce 1E+3 2E+3 8E-7 3E-9 - -
LLI
wall
(1E+3) - - - 2E-5 2E-4
Y,
see 134Ce - 2E+3 7E-7 2E-9 - -
58 Cerium-144 W, see 134Ce 2E+2 3E+1 1E-8 4E-11 - -
LLI
wall
(3E+2) - - - 3E-6 3E-5
Y,
see 134Ce - 1E+1 6E-9 2E-11 - -
59 Praseodymium-1362 W, all compounds except
those given for Y 5E+4 2E+5 1E-4 3E-7 - -
St
wall
(7E+4) - - - 1E-3 1E-2
Y,
oxides, hydroxides,
carbides, and fluorides - 2E+5 9E-5 3E-7 - -
59 Praseodymium-1372 W, see 136Pr 4E+4 2E+5 6E-5 2E-7 5E-4 5E-3
Y,
see 136Pr - 1E+5 6E-5 2E-7 - -
59 Praseodymium-138m W, see 136Pr 1E+4 5E+4 2E-5 8E-8 1E-4 1E-3
Y,
see 136Pr - 4E+4 2E-5 6E-8 - -
59 Praseodymium-139 W, see 136Pr 4E+4 1E+5 5E-5 2E-7 6E-4 6E-3
Y,
see 136Pr - 1E+5 5E-5 2E-7 - -
59 Praseodymium-142m2 W, see 136Pr 8E+4 2E+5 7E-5 2E-7 1E-3 1E-2
Y,
see 136Pr - 1E+5 6E-5 2E-7 - -
Table
I Table
II Table III
Occupational
Values Effluent Releases to
Concentrations Sewers
Oral Monthly
Ingestion Inhalation Average
Atomic Radionuclide Class ALI ALI DAC Air Water Concentration
No. (μCi) (μCi) (μCi/ml) (μCi/ml) (μCi/ml) (μCi/ml)
59 Praseodymium-142 W, see 136Pr 1E+3 2E+3 9E-7 3E-9 1E-5 1E-4
Y,
see 136Pr - 2E+3 8E-7 3E-9 - -
59 Praseodymium-143 W, see 136Pr 9E+2 8E+2 3E-7 1E-9 - -
LLI
wall
(1E+3) - - - 2E-5 2E-4
Y,
see 136Pr - 7E+2 3E-7 9E-10 - -
59 Praseodymium-1442 W, see 136Pr 3E+4 1E+5 5E-5 2E-7 - -
St
wall
(4E+4) - - - 6E-4 6E-3
Y,
see 136Pr - 1E+5 5E-5 2E-7 - -
59 Praseodymium-145 W, see 136Pr 3E+3 9E+3 4E-6 1E-8 4E-5 4E-4
Y,
see 136Pr - 8E+3 3E-6 1E-8 - -
59 Praseodymium-1472 W, see 136Pr 5E+4 2E+5 8E-5 3E-7 - -
St
wall
(8E+4) - - - 1E-3 1E-2
Y,
see 136Pr - 2E+5 8E-5 3E-7 - -
60 Neodymium-1362 W, all compounds except
those given for Y 1E+4 6E+4 2E-5 8E-8 2E-4 2E-3
Y,
oxides, hydroxides,
carbides, and fluorides - 5E+4 2E-5 8E-8 - -
60 Neodymium-138 W, see 136Nd 2E+3 6E+3 3E-6 9E-9 3E-5 3E-4
Y,
see 136Nd - 5E+3 2E-6 7E-9 - -
60 Neodymium-139m W, see 136Nd 5E+3 2E+4 7E-6 2E-8 7E-5 7E-4
Y,
see 136Nd - 1E+4 6E-6 2E-8 - -
60 Neodymium-1392 W, see 136Nd 9E+4 3E+5 1E-4 5E-7 1E-3 1E-2
Y,
see 136Nd - 3E+5 1E-4 4E-7 - -
60 Neodymium-141 W, see 136Nd 2E+5 7E+5 3E-4 1E-6 2E-3 2E-2
Y,
see 136Nd - 6E+5 3E-4 9E-7 - -
60 Neodymium-147 W, see 136Nd 1E+3 9E+2 4E-7 1E-9 - -
LLI
wall
(1E+3) - - - 2E-5 2E-4
Y,
see 136Nd - 8E+2 4E-7 1E-9 - -
60 Neodymium-1492 W, see 136Nd 1E+4 3E+4 1E-5 4E-8 1E-4 1E-3
Y,
see 136Nd - 2E+4 1E-5 3E-8 - -
60 Neodymium-1512 W, see 136Nd 7E+4 2E+5 8E-5 3E-7 9E-4 9E-3
Y,
see 136Nd - 2E+5 8E-5 3E-7 - -
61 Promethium-1412 W, all compounds except
those given for Y 5E+4 2E+5 8E-5 3E-7 - -
St
wall
(6E+4) - - - 8E-4 8E-3
Y,
oxides, hydroxides,
carbides, and fluorides - 2E+5 7E-5 2E-7 - -
Table
I Table
II Table III
Occupational
Values Effluent Releases to
Concentrations Sewers
Oral Monthly
Ingestion Inhalation Average
Atomic Radionuclide Class ALI ALI DAC Air Water Concentration
No. (μCi) (μCi) (μCi/ml) (μCi/ml) (μCi/ml) (μCi/ml)
61 Promethium-143 W, see 141Pm 5E+3 6E+2 2E-7 8E-10 7E-5 7E-4
Y,
see 141Pm - 7E+2 3E-7 1E-9 - -
61 Promethium-144 W, see 141Pm 1E+3 1E+2 5E-8 2E-10 2E-5 2E-4
Y,
see 141Pm - 1E+2 5E-8 2E-10 - -
61 Promethium-145 W, see 141Pm 1E+4 2E+2 7E-8 - 1E-4 1E-3
Bone
surf
- (2E+2) - 3E-10 - -
Y,
see 141Pm - 2E+2 8E-8 3E-10 - -
61 Promethium-146 W, see 141Pm 2E+3 5E+1 2E-8 7E-11 2E-5 2E-4
Y,
see 141Pm - 4E+1 2E-8 6E-11 - -
61 Promethium-147 W, see 141Pm 4E+3 1E+2 5E-8 - - -
LLI
wall Bone surf
(5E+3) (2E+2) - 3E-10 7E-5 7E-4
Y,
see 141Pm - 1E+2 6E-8 2E-10 - -
61 Promethium-148m W, see 141Pm 7E+2 3E+2 1E-7 4E-10 1E-5 1E-4
Y,
see 141Pm - 3E+2 1E-7 5E-10 - -
61 Promethium-148 W, see 141Pm 4E+2 5E+2 2E-7 8E-10 - -
LLI
wall
(5E+2) - - - 7E-6 7E-5
Y,
see 141Pm - 5E+2 2E-7 7E-10 - -
61 Promethium-149 W, see 141Pm 1E+3 2E+3 8E-7 3E-9 - -
LLI
wall
(1E+3) - - - 2E-5 2E-4
Y,
see 141Pm - 2E+3 8E-7 2E-9 - -
61 Promethium-150 W, see 141Pm 5E+3 2E+4 8E-6 3E-8 7E-5 7E-4
Y,
see 141Pm - 2E+4 7E-6 2E-8 - -
61 Promethium-151 W, see 141Pm 2E+3 4E+3 1E-6 5E-9 2E-5 2E-4
Y,
see 141Pm - 3E+3 1E-6 4E-9 - -
62 Samarium-141m2 W, all compounds 3E+4 1E+5 4E-5 1E-7 4E-4 4E-3
62 Samarium-1412 W, all compounds 5E+4 2E+5 8E-5 2E-7 - -
St
wall
(6E+4) - - - 8E-4 8E-3
62 Samarium-1422 W, all compounds 8E+3 3E+4 1E-5 4E-8 1E-4 1E-3
62 Samarium-145 W, all compounds 6E+3 5E+2 2E-7 7E-10 8E-5 8E-4
62 Samarium-146 W, all compounds 1E+1 4E-2 1E-11 - - -
Bone
surf Bone surf
(3E+1) (6E-2) - 9E-14 3E-7 3E-6
62 Samarium-147 W, all compounds 2E+1 4E+2 2E-11 - - -
Bone
surf Bone surf
(3E+1) (7E-2) - 1E-13 4E-7 4E-6
Table
I Table
II Table III
Occupational
Values Effluent Releases to
Concentrations Sewers
Oral Monthly
Ingestion Inhalation Average
Atomic Radionuclide Class ALI ALI DAC Air Water Concentration
No. (μCi) (μCi) (μCi/ml) (μCi/ml) (μCi/ml) (μCi/ml)
62 Samarium-151 W, all compounds 1E+4 1E+2 4E-8 - - -
LLI
wall Bone surf
(1E+4) (2E+2) - 2E-10 2E-4 2E-3
62 Samarium-153 W, all compounds 2E+3 3E+3 1E-6 4E-9 - -
LLI
wall
(2E+3) - - - 3E-5 3E-4
62 Samarium-1552 W, all compounds 6E+4 2E+5 9E-5 3E-7 - -
St
wall
(8E+4) - - - 1E-3 1E-2
62 Samarium-156 W, all compounds 5E+3 9E+3 4E-6 1E-8 7E-5 7E-4
63 Europium-145 W, all compounds 2E+3 2E+3 8E-7 3E-9 2E-5 2E-4
63 Europium-146 W, all compounds 1E+3 1E+3 5E-7 2E-9 1E-5 1E-4
63 Europium-147 W, all compounds 3E+3 2E+3 7E-7 2E-9 4E-5 4E-4
63 Europium-148 W, all compounds 1E+3 4E+2 1E-7 5E-10 1E-5 1E-4
63 Europium-149 W, all compounds 1E+4 3E+3 1E-6 4E-9 2E-4 2E-3
63 Europium-150 W, all compounds 3E+3 8E+3 4E-6 1E-8 4E-5 4E-4
(12.62 h)
63 Europium-150 W, all compounds 8E+2 2E+1 8E-9 3E-11 1E-5 1E-4
(34.2 y)
63 Europium-152m W, all compounds 3E+3 6E+3 3E-6 9E-9 4E-5 4E-4
63 Europium-152 W, all compounds 8E+2 2E+1 1E-8 3E-11 1E-5 1E-4
63 Europium-154 W, all compounds 5E+2 2E+1 8E-9 3E-11 7E-6 7E-5
63 Europium-155 W, all compounds 4E+3 9E+1 4E-8 - 5E-5 5E-4
Bone
surf
- (1E+2) - 2E-10 - -
63 Europium-156 W, all compounds 6E+2 5E+2 2E-7 6E-10 8E-6 8E-5
63 Europium-157 W, all compounds 2E+3 5E+3 2E-6 7E-9 3E-5 3E-4
63 Europium-1582 W, all compounds 2E+4 6E+4 2E-5 8E-8 3E-4 3E-3
64 Gadolinium-1452 D, all compounds except
those given for W 5E+4 2E+5 6E-5 2E-7 - -
St
wall
(5E+4) - - - 6E-4 6E-3
W,
oxides, hydroxides,
and fluorides - 2E+5 7E-5 2E-7 - -
64 Gadolinium-146 D, see 145Gd 1E+3 1E+2 5E-8 2E-10 2E-5 2E-4
W,
see 145Gd - 3E+2 1E-7 4E-10 - -
64 Gadolinium-147 D, see 145Gd 2E+3 4E+3 2E-6 6E-9 3E-5 3E-4
W,
see 145Gd - 4E+3 1E-6 5E-9 - -
Table
I Table
II Table III
Occupational
Values Effluent Releases to
Concentrations Sewers
Oral Monthly
Ingestion Inhalation Average
Atomic Radionuclide Class ALI ALI DAC Air Water Concentration
No. (μCi) (μCi) (μCi/ml) (μCi/ml) (μCi/ml) (μCi/ml)
64 Gadolinium-148 D, see 145Gd 1E+1 8E+3 3E-12 - - -
Bone
surf Bone surf
(2E+1) (2E+2) - 2E-14 3E-7 3E-6
W,
see 145Gd - 3E-2 1E-11 - - -
Bone
surf
- (6E-2) - 8E-14 - -
64 Gadolinium-149 D, see 145Gd 3E+3 2E+3 9E-7 3E-9 4E-5 4E-4
W,
see 145Gd - 2E+3 1E-6 3E-9 - -
64 Gadolinium-151 D, see 145Gd 6E+3 4E+2 2E-7 - 9E-5 9E-4
Bone
surf
- (6E+2) - 9E-10 - -
W,
see 145Gd - 1E+3 5E-7 2E-9 - -
64 Gadolinium-152 D, see 145Gd 2E+1 1E-2 4E-12 - - -
Bone
surf Bone surf
(3E+1) (2E-2) - 3E-14 4E-7 4E-6
W,
see 145Gd - 4E-2 2E-11 - - -
Bone
surf
- (8E-2) - 1E-13 - -
64 Gadolinium-153 D, see 145Gd 5E+3 1E+2 6E-8 - 6E-5 6E-4
Bone
surf
- (2E+2) - 3E-10 - -
W,
see 145Gd - 6E+2 2E-7 8E-10 - -
64 Gadolinium-159 D, see 145Gd 3E+3 8E+3 3E-6 1E-8 4E-5 4E-4
W,
see 145Gd - 6E+3 2E-6 8E-9 - -
65 Terbium-1472 W, all compounds 9E+3 3E+4 1E-5 5E-8 1E-4 1E-3
65 Terbium-149 W, all compounds 5E+3 7E+2 3E-7 1E-9 7E-5 7E-4
65 Terbium-150 W, all compounds 5E+3 2E+4 9E-6 3E-8 7E-5 7E-4
65 Terbium-151 W, all compounds 4E+3 9E+3 4E-6 1E-8 5E-5 5E-4
65 Terbium-153 W, all compounds 5E+3 7E+3 3E-6 1E-8 7E-5 7E-4
65 Terbium-154 W, all compounds 2E+3 4E+3 2E-6 6E-9 2E-5 2E-4
65 Terbium-155 W, all compounds 6E+3 8E+3 3E-6 1E-8 8E-5 8E-4
65 Terbium-156m W, all compounds 2E+4 3E+4 1E-5 4E-8 2E-4 2E-3
(5.0 h)
65 Terbium-156m W, all compounds 7E+3 8E+3 3E-6 1E-8 1E-4 1E-3
(24.4 h)
65 Terbium-156 W, all compounds 1E+3 1E+3 6E-7 2E-9 1E-5 1E-4
65 Terbium-157 W, all compounds 5E+4 3E+2 1E-7 - - -
LLI
wall Bone surf
(5E+4) (6E+2) - 8E-10 7E-4 7E-3
65 Terbium-158 W, all compounds 1E+3 2E+1 8E-9 3E-11 2E-5 2E-4
Table
I Table
II Table III
Occupational
Values Effluent Releases to
Concentrations Sewers
Oral Monthly
Ingestion Inhalation Average
Atomic Radionuclide Class ALI ALI DAC Air Water Concentration
No. (μCi) (μCi) (μCi/ml) (μCi/ml) (μCi/ml) (μCi/ml)
65 Terbium-160 W, all compounds 8E+2 2E+2 9E-8 3E-10 1E-5 1E-4
65 Terbium-161 W, all compounds 2E+3 2E+3 7E-7 2E-9 - -
LLI
wall
(2E+3) - - - 3E-5 3E-4
66 Dysprosium-155 W, all compounds 9E+3 3E+4 1E-5 4E-8 1E-4 1E-3
66 Dysprosium-157 W, all compounds 2E+4 6E+4 3E-5 9E-8 3E-4 3E-3
66 Dysprosium-159 W, all compounds 1E+4 2E+3 1E-6 3E-9 2E-4 2E-3
66 Dysprosium-165 W, all compounds 1E+4 5E+4 2E-5 6E-8 2E-4 2E-3
66 Dysprosium-166 W, all compounds 6E+2 7E+2 3E-7 1E-9 - -
LLI
wall
(8E+2) - - - 1E-5 1E-4
67 Holmium-1552 W, all compounds 4E+4 2E+5 6E-5 2E-7 6E-4 6E-3
67 Holmium-1572 W, all compounds 3E+5 1E+6 6E-4 2E-6 4E-3 4E-2
67 Holmium-1592 W, all compounds 2E+5 1E+6 4E-4 1E-6 3E-3 3E-2
67 Holmium-161 W, all compounds 1E+5 4E+5 2E-4 6E-7 1E-3 1E-2
67 Holmium-162m2 W, all compounds 5E+4 3E+5 1E-4 4E-7 7E-4 7E-3
67 Holmium-1622 W, all compounds 5E+5 2E+6 1E-3 3E-6 - -
St
wall
(8E+5) - - - 1E-2 1E-1
67 Holmium-164m2 W, all compounds 1E+5 3E+5 1E-4 4E-7 1E-3 1E-2
67 Holmium-1642 W, all compounds 2E+5 6E+5 3E-4 9E-7 - -
St
wall
(2E+5) - - - 3E-3 3E-2
67 Holmium-166m W, all compounds 6E+2 7E+0 3E-9 9E-12 9E-6 9E-5
67 Holmium-166 W, all compounds 9E+2 2E+3 7E-7 2E-9 - -
LLI
wall
(9E+2) - - - 1E-5 1E-4
67 Holmium-167 W, all compounds 2E+4 6E+4 2E-5 8E-8 2E-4 2E-3
68 Erbium-161 W, all compounds 2E+4 6E+4 3E-5 9E-8 2E-4 2E-3
68 Erbium-165 W, all compounds 6E+4 2E+5 8E-5 3E-7 9E-4 9E-3
68 Erbium-169 W, all compounds 3E+3 3E+3 1E-6 4E-9 - -
LLI
wall
(4E+3) - - - 5E-5 5E-4
68 Erbium-171 W, all compounds 4E+3 1E+4 4E-6 1E-8 5E-5 5E-4
68 Erbium-172 W, all compounds 1E+3 1E+3 6E-7 2E-9 - -
LLI
wall
(E+3) - - - 2E-5 2E-4
Table
I Table
II Table III
Occupational
Values Effluent Releases to
Concentrations Sewers
Oral Monthly
Ingestion Inhalation Average
Atomic Radionuclide Class ALI ALI DAC Air Water Concentration
No. (μCi) (μCi) (μCi/ml) (μCi/ml) (μCi/ml) (μCi/ml)
69 Thulium-1622 W, all compounds 7E+4 3E+5 1E-4 4E-7 - -
St
wall
(7E+4) - - - 1E-3 1E-2
69 Thulium-166 W, all compounds 4E+3 1E+4 6E-6 2E-8 6E-5 6E-4
69 Thulium-167 W, all compounds 2E+3 2E+3 8E-7 3E-9 - -
LLI
wall
(2E+3) - - - 3E-5 3E-4
69 Thulium-170 W, all compounds 8E+2 2E+2 9E-8 3E-10 - -
LLI
wall
(1E+3) - - - 1E-5 1E-4
69 Thulium-171 W, all compounds 1E+4 3E+2 1E-7 - - -
LLI
wall Bone surf
(1E+4) (6E+2) - 8E-10 2E-4 2E-3
69 Thulium-172 W, all compounds 7E+2 1E+3 5E-7 2E-9 - -
LLI
wall
(8E+2) - - - 1E-5 1E-4
69 Thulium-173 W, all compounds 4E+3 1E+4 5E-6 2E-8 6E-5 6E-4
69 Thulium-1752 W, all compounds 7E+4 3E+5 1E-4 4E-7 - -
St
wall
(9E+4) - - - 1E-3 1E-2
70 Ytterbium-1622 W, all compounds except
those given for Y 7E+4 3E+5 1E-4 4E-7 1E-3 1E-2
Y,
oxides, hydroxides,
and fluorides - 3E+5 1E-4 4E-7 - -
70 Ytterbium-166 W, see 162Yb 1E+3 2E+3 8E-7 3E-9 2E-5 2E-4
Y,
see 162Yb - 2E+3 8E-7 3E-9 - -
70 Ytterbium-1672 W, see 162Yb 3E+5 8E+5 3E-4 1E-6 4E-3 4E-2
Y,
see 162Yb - 7E+5 3E-4 1E-6 - -
70 Ytterbium-169 W, see 162Yb 2E+3 8E+2 4E-7 1E-9 2E-5 2E-4
Y,
see 162Yb - 7E+2 3E-7 1E-9 - -
70 Ytterbium-175 W, see 162Yb 3E+3 4E+3 1E-6 5E-9 - -
LLI
wall
(3E+3) - - - 4E-5 4E-4
Y,
see 162Yb - 3E+3 1E-6 5E-9 - -
70 Ytterbium-1772 W, see 162Yb 2E+4 5E+4 2E-5 7E-8 2E-4 2E-3
Y,
see 162Yb - 5E+4 2E-5 6E-8 - -
70 Ytterbium-1782 W, see 162Yb 1E+4 4E+4 2E-5 6E-8 2E-4 2E-3
Y,
see 162Yb - 4E+4 2E-5 5E-8 - -
71 Lutetium-169 W, all compounds except
those given for Y 3E+3 4E+3 2E-6 6E-9 3E-5 3E-4
Y,
oxides, hydroxides,
and fluorides - 4E+3 2E-6 6E-9 - -
Table
I Table
II Table III
Occupational
Values Effluent Releases to
Concentrations Sewers
Oral Monthly
Ingestion Inhalation Average
Atomic Radionuclide Class ALI ALI DAC Air Water Concentration
No. (μCi) (μCi) (μCi/ml) (μCi/ml) (μCi/ml) (μCi/ml)
71 Lutetium-170 W, see 169Lu 1E+3 2E+3 9E-7 3E-9 2E-5 2E-4
Y,
see 169Lu - 2E+3 8E-7 3E-9 - -
71 Lutetium-171 W, see 169Lu 2E+3 2E+3 8E-7 3E-9 3E-5 3E-4
Y,
see 169Lu - 2E+3 8E-7 3E-9 - -
71 Lutetium-172 W, see 169Lu 1E+3 1E+3 5E-7 2E-9 1E-5 1E-4
Y,
see 169Lu - 1E+3 5E-7 2E-9 - -
71 Lutetium-173 W, see 169Lu 5E+3 3E+2 1E-7 - 7E-5 7E-4
Bone
surf
- (5E+2) - 6E-10 - -
Y,
see 169Lu - 3E+2 1E-7 4E-10 - -
71 Lutetium-174m W, see 169Lu 2E+3 2E+2 1E-7 - - -
LLI
wall Bone surf
(3E+3) (3E+2) - 5E-10 4E-5 4E-4
Y,
see 169Lu - 2E+2 9E-8 3E-10 - -
71 Lutetium-174 W, see 169Lu 5E+3 1E+2 5E-8 - 7E-5 7E-4
Bone
surf
- (2E+2) - 3E-10 - -
Y,
see 169Lu - 2E+2 6E-8 2E-10 - -
71 Lutetium-176m W, see 169Lu 8E+3 3E+4 1E-5 3E-8 1E-4 1E-3
Y,
see 169Lu - 2E+4 9E-6 3E-8 - -
71 Lutetium-176 W, see 169Lu 7E+2 5E+0 2E-9 - 1E-5 1E-4
Bone
surf
- (1E+1) - 2E-11 - -
Y,
see 169Lu - 8E+0 3E-9 1E-11 - -
71 Lutetium-177m W, see 169Lu 7E+2 1E+2 5E-8 - 1E-5 1E-4
Bone
surf
- (1E+2) - 2E-10 - -
Y,
see 169Lu - 8E+1 3E-8 1E-10 - -
71 Lutetium-177 W, see 169Lu 2E+3 2E+3 9E-7 3E-9 - -
LLI
wall
(3E+3) - - - 4E-5 4E-4
Y,
see 169Lu - 2E+3 9E-7 3E-9 - -
71 Lutetium-178m2 W, see 169Lu 5E+4 2E+5 8E-5 3E-7 - -
St.
wall
(6E+4) - - - 8E-4 8E-3
Y,
see 169Lu - 2E+5 7E-5 2E-7 - -
71 Lutetium-1782 W, see 169Lu 4E+4 1E+5 5E-5 2E-7 - -
St
wall
(4E+4) - - - 6E-4 6E-3
Y,
see 169Lu - 1E+5 5E-5 2E-7 - -
71 Lutetium-179 W, see 169Lu 6E+3 2E+4 8E-6 3E-8 9E-5 9E-4
Y,
see 169Lu - 2E+4 6E-6 3E-8 - -
72 Hafnium-170 D, all compounds except
those given for W 3E+3 6E+3 2E-6 8E-9 4E-5 4E-4
W,
oxides, hydroxides,
carbides, and nitrates - 5E+3 2E-6 6E-9 - -
Table
I Table
II Table III
Occupational
Values Effluent Releases to
Concentrations Sewers
Oral Monthly
Ingestion Inhalation Average
Atomic Radionuclide Class ALI ALI DAC Air Water Concentration
No. (μCi) (μCi) (μCi/ml) (μCi/ml) (μCi/ml) (μCi/ml)
72 Hafnium-172 D, see 170Hf 1E+3 9E+0 4E-9 - 2E-5 2E-4
Bone
surf
- (2E+1) - 3E-11 - -
W,
see 170Hf - 4E+1 2E-8 - - -
Bone
surf
- (6E+1) - 8E-11 - -
72 Hafnium-173 D, see 170Hf 5E+3 1E+4 5E-6 2E-8 7E-5 7E-4
W,
see 170Hf - 1E+4 5E-6 2E-8 - -
72 Hafnium-175 D, see 170Hf 3E+3 9E+2 4E-7 - 4E-5 4E-4
Bone
surf
- (1E+3) - 1E-9 - -
W,
see 170Hf - 1E+3 5E-7 2E-9 - -
72 Hafnium-177m2 D, see 170Hf 2E+4 6E+4 2E-5 8E-8 3E-4 3E-3
W,
see 170Hf - 9E+4 4E-5 1E-7 - -
72 Hafnium-178m D, see 170Hf 3E+2 1E+0 5E-10 - 3E-6 3E-5
Bone
surf
- (2E+0) - 3E-12 - -
W,
see 170Hf - 5E+0 2E-9 - - -
Bone
surf
- (9E+0) - 1E-11 - -
72 Hafnium-179m D, see 170Hf 1E+3 3E+2 1E-7 - 1E-5 1E-4
Bone
surf
- (6E+2) - 8E-10 - -
W,
see 170Hf - 6E+2 3E-7 8E-10 - -
72 Hafnium-180m D, see 170Hf 7E+3 2E+4 9E-6 3E-8 1E-4 1E-3
W,
see 170Hf - 3E+4 1E-5 4E-8 - -
72 Hafnium-181 D, see 170Hf 1E+3 2E+2 7E-8 - 2E-5 2E-4
Bone
surf
- (4E+2) - 6E-10 - -
W,
see 170Hf - 4E+2 2E-7 6E-10 - -
72 Hafnium-182m2 D, see 170Hf 4E+4 9E+4 4E-5 1E-7 5E-4 5E-3
W,
see 170Hf - 1E+5 6E-5 2E-7 - -
72 Hafnium-182 D, see 170Hf 2E+2 8E-1 3E-10 - - -
Bone
surf Bone surf
(4E+2) (2E+0) - 2E-12 5E-6 5E-5
W,
see 170Hf - 3E+0 1E-9 - - -
Bone
surf
- (7E+0) - 1E-11 - -
72 Hafnium-1832 D, see 170Hf 2E+4 5E+4 2E-5 6E-8 3E-4 3E-3
W,
see 170Hf - 6E+4 2E-5 8E-8 - -
72 Hafnium-184 D, see 170Hf 2E+3 8E+3 3E-6 1E-8 3E-5 3E-4
W,
see 170Hf - 6E+3 3E-6 9E-9 - -
Table
I Table
II Table III
Occupational
Values Effluent Releases to
Concentrations Sewers
Oral Monthly
Ingestion Inhalation Average
Atomic Radionuclide Class ALI ALI DAC Air Water Concentration
No. (μCi) (μCi) (μCi/ml) (μCi/ml) (μCi/ml) (μCi/ml)
73 Tantalum-1722 W, all compounds except
those given for Y 4E+4 1E+5 5E-5 2E-7 5E-4 5E-3
Y,
elemental Ta, oxides,
hydroxides, halides,
carbides, nitrates,
and nitrides - 1E+5 4E-5 1E-7 - -
73 Tantalum-173 W, see 172Ta 7E+3 2E+4 8E-6 3E-8 9E-5 9E-4
Y,
see 172Ta - 2E+4 7E-6 2E-8 - -
73 Tantalum-1742 W, see 172Ta 3E+4 1E+5 4E-5 1E-7 4E-4 4E-3
Y,
see 172Ta - 9E+4 4E-5 1E-7 - -
73 Tantalum-175 W, see 172Ta 6E+3 2E+4 7E-6 2E-8 8E-5 8E-4
Y,
see 172Ta - 1E+4 6E-6 2E-8 - -
73 Tantalum-176 W, see 172Ta 4E+3 1E+4 5E-6 2E-8 5E-5 5E-4
Y,
see 172Ta - 1E+4 5E-6 2E-8 - -
73 Tantalum-177 W, see 172Ta 1E+4 2E+4 8E-6 3E-8 2E-4 2E-3
Y,
see 172Ta - 2E+4 7E-6 2E-8 - -
73 Tantalum-178 W, see 172Ta 2E+4 9E+4 4E-5 1E-7 2E-4 2E-3
Y,
see 172Ta - 7E+4 3E-5 1E-7 - -
73 Tantalum-179 W, see 172Ta 2E+4 5E+3 2E-6 8E-9 3E-4 3E-3
Y,
see 172Ta - 9E+2 4E-7 1E-9 - -
73 Tantalum-180m W, see 172Ta 2E+4 7E+4 3E-5 9E-8 3E-4 3E-3
Y,
see 172Ta - 6E+4 2E-5 8E-8 - -
73 Tantalum-180 W, see 172Ta 1E+3 4E+2 2E-7 6E-10 2E-5 2E-4
Y,
see 172Ta - 2E+1 1E-8 3E-11 - -
73 Tantalum-182m2 W, see 172Ta 2E+5 5E+5 2E-4 8E-7 - -
St
wall
(2E+5) - - - 3E-3 3E-2
Y,
see 172Ta - 4E+5 2E-4 6E-7 - -
73 Tantalum-182 W, see 172Ta 8E+2 3E+2 1E-7 5E-10 1E-5 1E-4
Y,
see 172Ta - 1E+2 6E-8 2E-10 - -
73 Tantalum-183 W, see 172Ta 9E+2 1E+3 5E-7 2E-9 - -
LLI
wall
(1E+3) - - - 2E-5 2E-4
Y,
see 172Ta - 1E+3 4E-7 1E-9 - -
73 Tantalum-184 W, see 172Ta 2E+3 5E+3 2E-6 8E-9 3E-5 3E-4
Y,
see 172Ta - 5E+3 2E-6 7E-9 - -
73 Tantalum-1852 W, see 172Ta 3E+4 7E+4 3E-5 1E-7 4E-4 4E-3
Y,
see 172Ta - 6E+4 3E-5 9E-8 - -
73 Tantalum-1862 W, see 172Ta 5E+4 2E+5 1E-4 3E-7 - -
St
wall
(7E+4) - - - 1E-3 1E-2
Y,
see 172Ta - 2E+5 9E-5 3E-7 - -
74 Tungsten-176 D, all compounds 1E+4 5E+4 2E-5 7E-8 1E-4 1E-3
Table
I Table
II Table III
Occupational
Values Effluent Releases to
Concentrations Sewers
Oral Monthly
Ingestion Inhalation Average
Atomic Radionuclide Class ALI ALI DAC Air Water Concentration
No. (μCi) (μCi) (μCi/ml) (μCi/ml) (μCi/ml) (μCi/ml)
74 Tungsten-177 D, all compounds 2E+4 9E+4 4E-5 1E-7 3E-4 3E-3
74 Tungsten-178 D, all compounds 5E+3 2E+4 8E-6 3E-8 7E-5 7E-4
74 Tungsten-1792 D, all compounds 5E+5 2E+6 7E-4 2E-6 7E-3 7E-2
74 Tungsten-181 D, all compounds 2E+4 3E+4 1E-5 5E-8 2E-4 2E-3
74 Tungsten-185 D, all compounds 2E+3 7E+3 3E-6 9E-9 - -
LLI
wall
(3E+3) - - - 4E-5 4E-4
74 Tungsten-187 D, all compounds 2E+3 9E+3 4E-6 1E-8 3E-5 3E-4
74 Tungsten-188 D, all compounds 4E+2 1E+3 5E-7 2E-9 - -
LLI
wall
(5E+2) - - - 7E-6 7E-5
75 Rhenium-1772 D, all compounds except
those given for W 9E+4 3E+5 1E-4 4E-7 - -
St
wall
(1E+5) - - - 2E-3 2E-2
W,
oxides, hydroxides,
and nitrates - 4E+5 1E-4 5E-7 - -
75 Rhenium-1782 D, see 177Re 7E+4 3E+5 1E-4 4E-7 - -
St
wall
(1E+5) - - - 1E-3 1E-2
W,
see 177Re - 3E+5 1E-4 4E-7 - -
75 Rhenium-181 D, see 177Re 5E+3 9E+3 4E-6 1E-8 7E-5 7E-4
W,
see 177Re - 9E+3 4E-6 1E-8 - -
75 Rhenium-182 D, see 177Re 7E+3 1E+4 5E-6 2E-8 9E-5 9E-4
(12.7 h) W, see 177Re - 2E+4 6E-6 2E-8 - -
75 Rhenium-182 D, see 177Re 1E+3 2E+3 1E-6 3E-9 2E-5 2E-4
(64.0 h) W, see 177Re - 2E+3 9E-7 3E-9 - -
75 Rhenium-184m D, see 177Re 2E+3 3E+3 1E-6 4E-9 3E-5 3E-4
W,
see 177Re - 4E+2 2E-7 6E-10 - -
75 Rhenium-184 D, see 177Re 2E+3 4E+3 1E-6 5E-9 3E-5 3E-4
W,
see 177Re - 1E+3 6E-7 2E-9 - -
75 Rhenium-186m D, see 177Re 1E+3 2E+3 7E-7 - - -
(2E+3) (2E+3) - 3E-9 2E-5 2E-4
W,
see 177Re - 2E+2 6E-8 2E-10 - -
75 Rhenium-186 D, see 177Re 2E+3 3E+3 1E-6 4E-9 3E-5 3E-4
W,
see 177Re - 2E+3 7E-7 2E-9 - -
75 Rhenium-187 D, see 177Re 6E+5 8E+5 4E-4 - 8E-3 8E-2
St
wall
- (9E+5) - 1E-6 - -
W,
see 177Re - 1E+5 4E-5 1E-7 - -
Table
I Table
II Table III
Occupational
Values Effluent Releases to
Concentrations Sewers
Oral Monthly
Ingestion Inhalation Average
Atomic Radionuclide Class ALI ALI DAC Air Water Concentration
No. (μCi) (μCi) (μCi/ml) (μCi/ml) (μCi/ml) (μCi/ml)
75 Rhenium-188m2 D, see 177Re 8E+4 1E+5 6E-5 2E-7 1E-3 1E-2
W,
see 177Re - 1E+5 6E-5 2E-7 - -
75 Rhenium-188 D, see 177Re 2E+3 3E+3 1E-6 4E-9 2E-5 2E-4
W,
see 177Re - 3E+3 1E-6 4E-9 - -
75 Rhenium-189 D, see 177Re 3E+3 5E+3 2E-6 7E-9 4E-5 4E-4
W,
see 177Re - 4E+3 2E-6 6E-9 - -
76 Osmium-1802 D, all compounds except
those given for W and Y 1E+5 4E+5 2E-4 5E-7 1E-3 1E-2
W,
halides and nitrates - 5E+5 2E-4 7E-7 - -
Y,
oxides and hydroxides - 5E+5 2E-4 6E-7 - -
76 Osmium-1812 D, see 180Os 1E+4 4E+4 2E-5 6E-8 2E-4 2E-3
W,
see 180Os - 5E+4 2E-5 6E-8 - -
Y,
see 180Os - 4E+4 2E-5 6E-8 - -
76 Osmium-182 D, see 180Os 2E+3 6E+3 2E-6 8E-9 3E-5 3E-4
W,
see 180Os - 4E+3 2E-6 6E-9 - -
Y,
see 180Os - 4E+3 2E-6 6E-9 - -
76 Osmium-185 D, see 180Os 2E+3 5E+2 2E-7 7E-10 3E-5 3E-4
W,
see 180Os - 8E+2 3E-7 1E-9 - -
Y,
see 180Os - 8E+2 3E-7 1E-9 - -
76 Osmium-189m D, see 180Os 8E+4 2E+5 1E-4 3E-7 1E-3 1E-2
W,
see 180Os - 2E+5 9E-5 3E-7 - -
Y,
see 180Os - 2E+5 7E-5 2E-7 - -
76 Osmium-191m D, see 180Os 1E+4 3E+4 1E-5 4E-8 2E-4 2E-3
W,
see 180Os - 2E+4 8E-6 3E-8 - -
Y,
see 180Os - 2E+4 7E-6 2E-8 - -
76 Osmium-191 D, see 180Os 2E+3 2E+3 9E-7 3E-9 - -
LLI
wall
(3E+3) - - - 3E-5 3E-4
W,
see 180Os - 2E+3 7E-7 2E-9 - -
Y,
see 180Os - 1E+3 6E-7 2E-9 - -
76 Osmium-193 D, see 180Os 2E+3 5E+3 2E-6 6E-9 - -
LLI
wall
(2E+3) - - - 2E-5 2E-4
W,
see 180Os - 3E+3 1E-6 4E-9 - -
Y,
see 180Os - 3E+3 1E-6 4E-9 - -
76 Osmium-194 D, see 180Os 4E+2 4E+1 2E-8 6E-11 - -
LLI
wall
(6E+2) - - - 8E-6 8E-5
W,
see 180Os - 6E+1 2E-8 8E-11 - -
Y,
see 180Os - 8E+0 3E-9 1E-11 - -
77 Iridium-1822 D, all compounds except
those given for W and Y 4E+4 1E+5 6E-5 2E-7 - -
St
wall
(4E+4) - - - 6E-4 6E-3
W,
halides, nitrates,
and metallic iridium - 2E+5 6E-5 2E-7 - -
Y,
oxides and hydroxides - 1E+5 5E-5 2E-7 - -
Table
I Table
II Table III
Occupational
Values Effluent Releases to
Concentrations Sewers
Oral Monthly
Ingestion Inhalation Average
Atomic Radionuclide Class ALI ALI DAC Air Water Concentration
No. (μCi) (μCi) (μCi/ml) (μCi/ml) (μCi/ml) (μCi/ml)
77 Iridium-184 D, see 182Ir 8E+3 2E+4 1E-5 3E-8 1E-4 1E-3
W,
see 182Ir - 3E+4 1E-5 5E-8 - -
Y,
see 182Ir - 3E+4 1E-5 4E-8 - -
77 Iridium-185 D, see 182Ir 5E+3 1E+4 5E-6 2E-8 7E-5 7E-4
W,
see 182Ir - 1E+4 5E-6 2E-8 - -
Y,
see 182Ir - 1E+4 4E-6 1E-8 - -
77 Iridium-186 D, see 182Ir 2E+3 8E+3 3E-6 1E-8 3E-5 3E-4
W,
see 182Ir - 6E+3 3E-6 9E-9 - -
Y,
see 182Ir - 6E+3 2E-6 8E-9 - -
77 Iridium-187 D, see 182Ir 1E+4 3E+4 1E-5 5E-8 1E-4 1E-3
W,
see 182Ir - 3E+4 1E-5 4E-8 - -
Y,
see 182Ir - 3E+4 1E-5 4E-8 - -
77 Iridium-188 D, see 182Ir 2E+3 5E+3 2E-6 6E-9 3E-5 3E-4
W,
see 182Ir - 4E+3 1E-6 5E-9 - -
Y,
see 182Ir - 3E+3 1E-6 5E-9 - -
77 Iridium-189 D, see 182Ir 5E+3 5E+3 2E-6 7E-9 - -
LLI
wall
(5E+3) - - - 7E-5 7E-4
W,
see 182Ir - 4E+3 2E-6 5E-9 - -
Y,
see 182Ir - 4E+3 1E-6 5E-9 - -
77 Iridium-190m2 D, see 182Ir 2E+5 2E+5 8E-5 3E-7 2E-3 2E-2
W,
see 182Ir - 2E+5 9E-5 3E-7 - -
Y,
see 182Ir - 2E+5 8E-5 3E-7 - -
77 Iridium-190 D, see 182Ir 1E+3 9E+2 4E-7 1E-9 1E-5 1E-4
W,
see 182Ir - 1E+3 4E-7 1E-9 - -
Y,
see 182Ir - 9E+2 4E-7 1E-9 - -
77 Iridium-192m D, see 182Ir 3E+3 9E+1 4E-8 1E-10 4E-5 4E-4
W,
see 182Ir - 2E+2 9E-8 3E-10 - -
- 2E+1 6E-9 2E-11 - -
77 Iridium-192 D, see 182Ir 9E+2 3E+2 1E-7 4E-10 1E-5 1E-4
W,
see 182Ir - 4E+2 2E-7 6E-10 - -
Y,
see 182Ir - 2E+2 9E-8 3E-10 - -
77 Iridium-194m D, see 182Ir 6E+2 9E+1 4E-8 1E-10 9E-6 9E-5
W,
see 182Ir - 2E+2 7E-8 2E-10 - -
Y,
see 182Ir - 1E+2 4E-8 1E-10 - -
77 Iridium-194 D, see 182Ir 1E+3 3E+3 1E-6 4E-9 1E-5 1E-4
W,
see 182Ir - 2E+3 9E-7 3E-9 - -
Y,
see 182Ir - 2E+3 8E-7 3E-9 - -
77 Iridium-195m D, see 182Ir 8E+3 2E+4 1E-5 3E-8 1E-4 1E-3
W,
see 182Ir - 3E+4 1E-5 4E-8 - -
Y,
see 182Ir - 2E+4 9E-6 3E-8 - -
77 Iridium-195 D, see 182Ir 1E+4 4E+4 2E-5 6E-8 2E-4 2E-3
W,
see 182Ir - 5E+4 2E-5 7E-8 - -
Y,
see 182Ir - 4E+4 2E-5 6E-8 - -
Table
I Table
II Table III
Occupational
Values Effluent Releases to
Concentrations Sewers
Oral Monthly
Ingestion Inhalation Average
Atomic Radionuclide Class ALI ALI DAC Air Water Concentration
No. (μCi) (μCi) (μCi/ml) (μCi/ml) (μCi/ml) (μCi/ml)
78 Platinum-186 D, all compounds 1E+4 4E+4 2E-5 5E-8 2E-4 2E-3
78 Platinum-188 D, all compounds 2E+3 2E+3 7E-7 2E-9 2E-5 2E-4
78 Platinum-189 D, all compounds 1E+4 3E+4 1E-5 4E-8 1E-4 1E-3
78 Platinum-191 D, all compounds 4E+3 8E+3 4E-6 1E-8 5E-5 5E-4
78 Platinum-193m D, all compounds 3E+3 6E+3 3E-6 8E-9 - -
LLI
wall
(3E+4) - - - 4E-5 4E-4
78 Platinum-193 D, all compounds 4E+4 2E+4 1E-5 3E-8 - -
LLI
wall
(5E+4) - - - 6E-4 6E-3
78 Platinum-195m D, all compounds 2E+3 4E+3 2E-6 6E-9 - -
LLI
wall
(2E+3) - - - 3E-5 3E-4
78 Platinum-197m2 D, all compounds 2E+4 4E+4 2E-5 6E-8 2E-4 2E-3
78 Platinum-197 D, all compounds 3E+3 1E+4 4E-6 1E-8 4E-5 4E-4
78 Platinum-1992 D, all compounds 5E+4 1E+5 6E-5 2E-7 7E-4 7E-3
78 Platinum-200 D, all compounds 1E+3 3E+3 1E-6 5E-9 2E-5 2E-4
79 Gold-193 D, all compounds except
those given for W and Y 9E+3 3E+4 1E-5 4E-8 1E-4 1E-3
W,
halides and nitrates - 2E+4 9E-6 3E-8 - -
Y,
oxides and hydroxides - 2E+4 8E-6 3E-8 - -
79 Gold-194 D, see 193Au 3E+3 8E+3 3E-6 1E-8 4E-5 4E-4
W,
see 193Au - 5E+3 2E-6 8E-9 - -
Y,
see 193Au - 5E+3 2E-6 7E-9 - -
79 Gold-195 D, see 193Au 5E+3 1E+4 5E-6 2E-8 7E-5 7E-4
W,
see 193Au - 1E+3 6E-7 2E-9 - -
Y,
see 193Au - 4E+2 2E-7 6E-10 - -
79 Gold-198m D, see 193Au 1E+3 3E+3 1E-6 4E-9 1E-5 1E-4
W,
see 193Au - 1E+3 5E-7 2E-9 - -
Y,
see 193Au - 1E+3 5E-7 2E-9 - -
79 Gold-198 D, see 193Au 1E+3 4E+3 2E-6 5E-9 2E-5 2E-4
W,
see 193Au - 2E+3 8E-7 3E-9 - -
Y,
see 193Au - 2E+3 7E-7 2E-9 - -
79 Gold-199 D, see 193Au 3E+3 9E+3 4E-6 1E-8 - -
LLI
wall
(3E+3) - - - 4E-5 4E-4
W,
see 193Au - 4E+3 2E-6 6E-9 - -
Y,
see 193Au - 4E+3 2E-6 5E-9 - -
79 Gold-200m D, see 193Au 1E+3 4E+3 1E-6 5E-9 2E-5 2E-4
W,
see 193Au - 3E+3 1E-6 4E-9 - -
Y,
see 193Au - 2E+4 1E-6 3E-9 - -
Table
I Table
II Table III
Occupational
Values Effluent Releases to
Concentrations Sewers
Oral Monthly
Ingestion Inhalation Average
Atomic Radionuclide Class ALI ALI DAC Air Water Concentration
No. (μCi) (μCi) (μCi/ml) (μCi/ml) (μCi/ml) (μCi/ml)
79 Gold-2002 D, see 193Au 3E+4 6E+4 3E-5 9E-8 4E-4 4E-3
W,
see 193Au - 8E+4 3E-5 1E-7 - -
Y,
see 193Au - 7E+4 3E-5 1E-7 - -
79 Gold-2012 D, see 193Au 7E+4 2E+5 9E-5 3E-7 - -
St
wall
(9E+4) - - - 1E-3 1E-2
W,
see 193Au - 2E+5 1E-4 3E-7 - -
Y,
see 193Au - 2E+5 9E-5 3E-7 - -
80 Mercury-193m Vapor - 8E+3 4E-6 1E-8 - -
Organic
D 4E+3 1E+4 5E-6 2E-8 6E-5 6E-4
D,
sulfates 3E+3 9E+3 4E-6 1E-8 4E-5 4E-4
W,
oxides, hydroxides,
halides, nitrates, and
sulfides - 8E+3 3E-6 1E-8 - -
80 Mercury-193 Vapor - 3E+4 1E-5 4E-8 - -
Organic
D 2E+4 6E+4 3E-5 9E-8 3E-4 3E-3
D,
see 193mHg 2E+4 4E+4 2E-5 6E-8 2E-4 2E-3
W,
see 193mHg - 4E+4 2E-5 6E-8 - -
80 Mercury-194 Vapor - 3E+1 1E-8 4E-11 - -
Organic
D 2E+1 3E+1 1E-8 4E-11 2E-7 2E-6
D,
see 193mHg 8E+2 4E+1 2E-8 6E-11 1E-5 1E-4
W,
see 193mHg - 1E+2 5E-8 2E-10 - -
80 Mercury-195m Vapor - 4E+3 2E-6 6E-9 - -
Organic
D 3E+3 6E+3 3E-6 8E-9 4E-5 4E-4
D,
see 193mHg 2E+3 5E+3 2E-6 7E-9 3E-5 3E-4
W,
see 193mHg - 4E+3 2E-6 5E-9 - -
80 Mercury-195 Vapor - 3E+4 1E-5 4E-8 - -
Organic
D 2E+4 5E+4 2E-5 6E-8 2E-4 2E-3
D,
see 193mHg 1E+4 4E+4 1E-5 5E-8 2E-4 2E-3
W,
see 193mHg - 3E+4 1E-5 5E-8 - -
80 Mercury-197m Vapor - 5E+3 2E-6 7E-9 - -
Organic
D 4E+3 9E+3 4E-6 1E-8 5E-5 5E-4
D,
see 193mHg 3E+3 7E+3 3E-6 1E-8 4E-5 4E-4
W,
see 193mHg - 5E+3 2E-6 7E-9 - -
80 Mercury-197 Vapor - 8E+3 4E-6 1E-8 - -
Organic
D 7E+3 1E+4 6E-6 2E-8 9E-5 9E-4
D,
see 193mHg 6E+3 1E+4 5E-6 2E-8 8E-5 8E-4
W,
see 193mHg - 9E+3 4E-6 1E-8 - -
80 Mercury-199m2 Vapor - 8E+4 3E-5 1E-7 - -
Organic
D 6E+4 2E+5 7E-5 2E-7 - -
St
wall
(1E+5) - - - 1E-3 1E-2
D,
see 193mHg 6E+4 1E+5 6E-5 2E-7 8E-4 8E-3
W,
see 193mHg - 2E+5 7E-5 2E-7 - -
80 Mercury-203 Vapor - 8E+2 4E-7 1E-9 - -
Organic
D 5E+2 8E+2 3E-7 1E-9 7E-6 7E-5
D,
see 193mHg 2E+3 1E+3 5E-7 2E-9 3E-5 3E-4
W,
see 193mHg - 1E+3 5E-7 2E-9 - -
Table
I Table
II Table III
Occupational
Values Effluent Releases to
Concentrations Sewers
Oral Monthly
Ingestion Inhalation Average
Atomic Radionuclide Class ALI ALI DAC Air Water Concentration
No. (μCi) (μCi) (μCi/ml) (μCi/ml) (μCi/ml) (μCi/ml)
81 Thallium-194m2 D, all compounds 5E+4 2E+5 6E-5 2E-7 - -
St
wall
(7E+4) - - - 1E-3 1E-2
81 Thallium-1942 D, all compounds 3E+5 6E+5 2E-4 8E-7 - -
St
wall
(3E+5) - - - 4E-3 4E-2
81 Thallium-1952 D, all compounds 6E+4 1E+5 5E-5 2E-7 9E-4 9E-3
81 Thallium-197 D, all compounds 7E+4 1E+5 5E-5 2E-7 1E-3 1E-2
81 Thallium-198m2 D, all compounds 3E+4 5E+4 2E-5 8E-8 4E-4 4E-3
81 Thallium-198 D, all compounds 2E+4 3E+4 1E-5 5E-8 3E-4 3E-3
81 Thallium-199 D, all compounds 6E+4 8E+4 4E-5 1E-7 9E-4 9E-3
81 Thallium-200 D, all compounds 8E+3 1E+4 5E-6 2E-8 1E-4 1E-3
81 Thallium-201 D, all compounds 2E+4 2E+4 9E-6 3E-8 2E-4 2E-3
81 Thallium-202 D, all compounds 4E+3 5E+3 2E-6 7E-9 5E-5 5E-4
81 Thallium-204 D, all compounds 2E+3 2E+3 9E-7 3E-9 2E-5 2E-4
82 Lead-195m2 D, all compounds 6E+4 2E+5 8E-5 3E-7 8E-4 8E-3
82 Lead-198 D, all compounds 3E+4 6E+4 3E-5 9E-8 4E-4 4E-3
82 Lead-1992 D, all compounds 2E+4 7E+4 3E-5 1E-7 3E-4 3E-3
82 Lead-200 D, all compounds 3E+3 6E+3 3E-6 9E-9 4E-5 4E-4
82 Lead-201 D, all compounds 7E+3 2E+4 8E-6 3E-8 1E-4 1E-3
82 Lead-202m D, all compounds 9E+3 3E+4 1E-5 4E-8 1E-4 1E-3
82 Lead-202 D, all compounds 1E+2 5E+1 2E-8 7E-11 2E-6 2E-5
82 Lead-203 D, all compounds 5E+3 9E+3 4E-6 1E-8 7E-5 7E-4
82 Lead-205 D, all compounds 4E+3 1E+3 6E-7 2E-9 5E-5 5E-4
82 Lead-209 D, all compounds 2E+4 6E+4 2E-5 8E-8 3E-4 3E-3
82 Lead-210 D, all compounds 6E-1 2E-1 1E-10 - - -
Bone
surf Bone surf
(1E+0) (4E-1) - 6E-13 1E-8 1E-7
82 Lead-2112 D, all compounds 1E+4 6E+2 3E-7 9E-10 2E-4 2E-3
82 Lead-212 D, all compounds 8E+1 3E+1 1E-8 5E-11 - -
Bone
surf
(1E+2) - - - 2E-6 2E-5
82 Lead-2142 D, all compounds 9E+3 8E+2 3E-7 1E-9 1E-4 1E-3
Table
I Table
II Table III
Occupational
Values Effluent Releases to
Concentrations Sewers
Oral Monthly
Ingestion Inhalation Average
Atomic Radionuclide Class ALI ALI DAC Air Water Concentration
No. (μCi) (μCi) (μCi/ml) (μCi/ml) (μCi/ml) (μCi/ml)
83 Bismuth-2002 D, nitrates 3E+4 8E+4 4E-5 1E-7 4E-4 4E-3
W,
all other compounds - 1E+5 4E-5 1E-7 - -
83 Bismuth-2012 D, see 200Bi 1E+4 3E+4 1E-5 4E-8 2E-4 2E-3
W,
see 200Bi - 4E+4 2E-5 5E-8 - -
83 Bismuth-2022 D, see 200Bi 1E+4 4E+4 2E-5 6E-8 2E-4 2E-3
W,
see 200Bi - 8E+4 3E-5 1E-7 - -
83 Bismuth-203 D, see 200Bi 2E+3 7E+3 3E-6 9E-9 3E-5 3E-4
W,
see 200Bi - 6E+3 3E-6 9E-9 - -
83 Bismuth-205 D, see 200Bi 1E+3 3E+3 1E-6 3E-9 2E-5 2E-4
W,
see 200Bi - 1E+3 5E-7 2E-9 - -
83 Bismuth-206 D, see 200Bi 6E+2 1E+3 6E-7 2E-9 9E-6 9E-5
W,
see 200Bi - 9E+2 4E-7 1E-9 - -
83 Bismuth-207 D, see 200Bi 1E+3 2E+3 7E-7 2E-9 1E-5 1E-4
W,
see 200Bi - 4E+2 1E-7 5E-10 - -
83 Bismuth-210m D, see 200Bi 4E+1 5E+0 2E-9 - - -
Kidneys Kidneys
(6E+1) (6E+0) - 9E-12 8E-7 8E-6
W,
see 200Bi - 7E-1 3E-10 9E-13 - -
83 Bismuth-210 D, see 200Bi 8E+2 2E+2 1E-7 - 1E-5 1E-4
- Kidneys
- (4E+2) - 5E-10 - -
W,
see 200Bi - 3E+1 1E-8 4E-11 - -
83 Bismuth-2122 D, see 200Bi 5E+3 2E+2 1E-7 3E-10 7E-5 7E-4
W,
see 200Bi - 3E+2 1E-7 4E-10 - -
83 Bismuth-2132 D, see 200Bi 7E+3 3E+2 1E-7 4E-10 1E-4 1E-3
W,
see 200Bi - 4E+2 1E-7 5E-10 - -
83 Bismuth-2142 D, see 200Bi 2E+4 8E+2 3E-7 1E-9 - -
St
wall
(2E+4) - - - 3E-4 3E-3
W,
see 200Bi - 9E-2 4E-7 1E-9 - -
84 Polonium-2032 D, all compounds except
those given for W 3E+4 6E+4 3E-5 9E-8 3E-4 3E-3
W,
oxides, hydroxides,
and nitrates - 9E+4 4E-5 1E-7 - -
84 Polonium-2052 D, see 203Po 2E+4 4E+4 2E-5 5E-8 3E-4 3E-3
W,
see 203Po - 7E+4 3E-5 1E-7 - -
84 Polonium-207 D, see 203Po 8E+3 3E+4 1E-5 3E-8 1E-4 1E-3
W,
see 203Po - 3E+4 1E-5 4E-8 - -
84 Polonium-210 D, see 203Po 3E+0 6E-1 3E-10 9E-13 4E-8 4E-7
W,
see 203Po - 6E-1 3E-10 9E-13 - -
85 Astatine-2072 D, halides 6E+3 3E+3 1E-6 4E-9 8E-5 8E-4
W - 2E+3 9E-7 3E-9 - -
Table
I Table
II Table III
Occupational
Values Effluent Releases to
Concentrations Sewers
Oral Monthly
Ingestion Inhalation Average
Atomic Radionuclide Class ALI ALI DAC Air Water Concentration
No. (μCi) (μCi) (μCi/ml) (μCi/ml) (μCi/ml) (μCi/ml)
85 Astatine-211 D, halides 1E+2 8E+1 3E-8 1E-10 2E-6 2E-5
W - 5E+1 2E-8 8E-11 - -
86 Radon-220 With daughters removed - 2E+4 7E-6 2E-8 - -
With
daughters present - 2E+1 9E-9 3E-11 - -
(or
12 (or 1.0
working working
level level
months) months)
86 Radon-222 With daughters removed - 1E+4 4E-6 1E-8 - -
With
daughters present - 1E+2 3E-8 1E-10 - -
(or
4 (or 0.33
working working
level level
months) months)
87 Francium-2222 D, all compounds 2E+3 5E+2 2E-7 6E-10 3E-5 3E-4
87 Francium-2232 D, all compounds 6E+2 8E+2 3E-7 1E-9 8E-6 8E-5
88 Radium-223 W, all compounds 5E+0 7E-1 3E-10 9E-13 - -
Bone
surf
(9E+0) - - - 1E-7 1E-6
88 Radium-224 W, all compounds 8E+0 2E+0 7E-10 2E-12 - -
Bone
surf
(2E+1) - - - 2E-7 2E-6
88 Radium-225 W, all compounds 8E+0 7E-1 3E-10 9E-13 - -
Bone
surf
(2E+1) - - - 2E-7 2E-6
88 Radium-226 W, all compounds 2E+0 6E-1 3E-10 9E-13 - -
Bone
surf
(5E+0) - - - 6E-8 6E-7
88 Radium-2272 W, all compounds 2E+4 1E+4 6E-6 - - -
Bone
surf Bone surf
(2E+4) (2E+4) - 3E-8 3E-4 3E-3
88 Radium-228 W, all compounds 2E+0 1E+0 5E-10 2E-12 - -
Bone
surf
(4E+0) - - - 6E-8 6E-7
89 Actinium-224 D, all compounds except
those given for W and Y 2E+3 3E+1 1E-8 - - -
LLI
wall Bone surf
(2E+3) (4E+1) - 5E-11 3E-5 3E-4
W,
halides and nitrates - 5E+1 2E-8 7E-11 - -
Y,
oxides and hydroxides - 5E+1 2E-8 6E-11 - -
89 Actinium-225 D, see 224Ac 5E+1 3E-1 1E-10 - - -
LLI
wall Bone surf
(5E+1) (5E-1) - 7E-13 7E-7 7E-6
W,
see 224Ac - 6E-1 3E-10 9E-13 - -
Y,
see 224Ac - 6E-1 3E-10 9E-13 - -
Table
I Table
II Table III
Occupational
Values Effluent Releases to
Concentrations Sewers
Oral Monthly
Ingestion Inhalation Average
Atomic Radionuclide Class ALI ALI DAC Air Water Concentration
No. (μCi) (μCi) (μCi/ml) (μCi/ml) (μCi/ml) (μCi/ml)
89 Actinium-226 D, see 224Ac 1E+2 3E+0 1E-9 - - -
LLI
wall Bone surf
(1E+2) (4E+0) - 5E-12 2E-6 2E-5
W,
see 224Ac - 5E+0 2E-9 7E-12 - -
Y,
see 224Ac - 5E+0 2E-9 6E-12 - -
89 Actinium-227 D, see 224Ac 2E-1 4E-4 2E-13 - - -
Bone
surf Bone surf
(4E-1) (8E-4) - 1E-15 5E-9 5E-8
W,
see 224Ac - 2E-3 7E-13 - - -
Bone
surf
- (3E-3) - 4E-15 - -
Y,
see 224Ac - 4E-3 2E-12 6E-15 - -
89 Actinium-228 D, see 224Ac 2E+3 9E+0 4E-9 - 3E-5 3E-4
Bone
surf
- (2E+1) - 2E-11 - -
W,
see 224Ac - 4E+1 2E-8 - - -
Bone
surf
- (6E+1) - 8E-11 - -
Y,
see 224Ac - 4E+1 2E-8 6E-11 - -
90 Thorium-2262 W, all compounds except
those given for Y 5E+3 2E+2 6E-8 2E-10 - -
St
wall
(5E+3) - - - 7E-5 7E-4
Y,
oxides and hydroxides - 1E+2 6E-8 2E-10 - -
90 Thorium-227 W, see 226Th 1E+2 3E-1 1E-10 5E-13 2E-6 2E-5
Y,
see 226Th - 3E-1 1E-10 5E-13 - -
90 Thorium-228 W, see 226Th 6E+0 1E-2 4E-12 - - -
Bone
surf Bone surf
(1E+1) (2E-2) - 3E-14 2E-7 2E-6
Y,
see 226Th - 2E-2 7E-12 2E-14 - -
90 Thorium-229 W, see 226Th 6E-1 9E-4 4E-13 - - -
Bone
surf Bone surf
(1E+0) (2E-3) - 3E-15 2E-8 2E-7
Y,
see 226Th - 2E-3 1E-12 - - -
Bone
surf
- (3E-3) - 4E-15 - -
90 Thorium-230 W, see 226Th 4E+0 6E-3 3E-12 - - -
Bone
surf Bone surf
(9E+0) (2E-2) - 2E-14 1E-7 1E-6
Y,
see 226Th - 2E-2 6E-12 - - -
Bone
surf
- (2E-2) - 3E-14 - -
90 Thorium-231 W, see 226Th 4E+3 6E+3 3E-6 9E-9 5E-5 5E-4
Y,
see 226Th - 6E+3 3E-6 9E-9 - -
90 Thorium-232 W, see 226Th 7E-1 1E-3 5E-13 - - -
Bone
surf Bone surf
(2E+0) (3E-3) - 4E-15 3E-8 3E-7
Y,
see 226Th - 3E-3 1E-12 - - -
Bone
surf
- (4E-3) - 6E-15 - -
Table
I Table
II Table III
Occupational
Values Effluent Releases to
Concentrations Sewers
Oral Monthly
Ingestion Inhalation Average
Atomic Radionuclide Class ALI ALI DAC Air Water Concentration
No. (μCi) (μCi) (μCi/ml) (μCi/ml) (μCi/ml) (μCi/ml)
90 Thorium-234 W, see 226Th 3E+2 2E+2 8E-8 3E-10 - -
LLI
wall
(4E+2) - - - 5E-6 5E-5
Y,
see 226Th - 2E+2 6E-8 2E-10 - -
91 Protactinium-2272 W, all compounds except
those given for Y 4E+3 1E+2 5E-8 2E-10 5E-5 5E-4
Y,
oxides and hydroxides - 1E+2 4E-8 1E-10 - -
91 Protactinium-228 W, see 227Pa 1E+3 1E+1 5E-9 - 2E-5 2E-4
Bone
surf
- (2E+1) - 3E-11 - -
Y,
see 227Pa - 1E+1 5E-9 2E-11 - -
91 Protactinium-230 W, see 227Pa 6E+2 5E+0 2E-9 7E-12 - -
Bone
surf
(9E+2) - - - 1E-5 1E-4
Y,
see 227Pa - 4E+0 1E-9 5E-12 - -
91 Protactinium-231 W, see 227Pa 2E-1 2E-3 6E-13 - - -
Bone
surf Bone surf
(5E-1) (4E-3) - 6E-15 6E-9 6E-8
Y,
see 227Pa - 4E-3 2E-12 - - -
Bone
surf
- (6E-3) - 8E-15 - -
91 Protactinium-232 W, see 227Pa 1E+3 2E+1 9E-9 - 2E-5 2E-4
Bone
surf
- (6E+1) - 8E-11 - -
Y,
see 227Pa - 6E+1 2E-8 - - -
Bone
surf
- (7E+1) - 1E-10 - -
91 Protactinium-233 W, see 227Pa 1E+3 7E+2 3E-7 1E-9 - -
LLI
wall
(2E+3) - - - 2E-5 2E-4
Y,
see 227Pa - 6E+2 2E-7 8E-10 - -
91 Protactinium-234 W, see 227Pa 2E+3 8E+3 3E-6 1E-8 3E-5 3E-4
Y,
see 227Pa - 7E+3 3E-6 9E-9 - -
92 Uranium-230 D, UF6, UO2F2,
UO2
(NO3)2 4E+0 4E-1 2E-10 - - -
Bone
surf Bone surf
(6E+0) (6E-1) - 8E-13 8E-8 8E-7
W,
UO3, UF4, Ucl4 - 4E-1 1E-10 5E-13 - -
Y,
UO2, U3O8 - 3E-1 1E-10 4E-13 - -
92 Uranium-231 D, see 230U 5E+3 8E+3 3E-6 1E-8 - -
LLI
wall
(4E+3) - - - 6E-5 6E-4
W,
see 230U - 6E+3 2E-6 8E-9 - -
Y,
see 230U - 5E+3 2E-6 6E-9 - -
92 Uranium-232 D, see 230U 2E+0 2E-1 9E-11 - - -
Bone
surf Bone surf
(4E+0) (4E-1) - 6E-13 6E-8 6E-7
W,
see 230U - 4E-1 2E-10 5E-13 - -
Y,
see 230U - 8E-3 3E-12 1E-14 - -
Table
I Table
II Table III
Occupational
Values Effluent Releases to
Concentrations Sewers
Oral Monthly
Ingestion Inhalation Average
Atomic Radionuclide Class ALI ALI DAC Air Water Concentration
No. (μCi) (μCi) (μCi/ml) (μCi/ml) (μCi/ml) (μCi/ml)
92 Uranium-233 D, see 230U 1E+1 1E+0 5E-10 - - -
Bone
surf Bone surf
(2E+1) (2E+0) - 3E-12 3E-7 3E-6
W,
see 230U - 7E-1 3E-10 1E-12 - -
Y,
see 230U - 4E-2 2E-11 5E-14 - -
92 Uranium-2343 D, see 230U 1E+1 1E+0 5E-10 - - -
Bone
surf Bone surf
(2E+1) (2E+0) - 3E-12 3E-7 3E-6
W,
see 230U - 7E-1 3E-10 1E-12 - -
Y,
see 230U - 4E-2 2E-11 5E-14 - -
92 Uranium-2353 D, see 230U 1E+1 1E+0 6E-10 - - -
Bone
surf Bone surf
(2E+1) (2E+0) - 3E-12 3E-7 3E-6
W,
see 230U - 8E-1 3E-10 1E-12 - -
Y,
see 230U - 4E-2 2E-11 6E-14 - -
92 Uranium-236 D, see 230U 1E+1 1E+0 5E-10 - - -
Bone
surf Bone surf
(2E+1) (2E+0) - 3E-12 3E-7 3E-6
W,
see 230U - 8E-1 3E-10 1E-12 - -
Y,
see 230U - 4E-2 2E-11 6E-14 - -
92 Uranium-237 D, see 230U 2E+3 3E+3 1E-6 4E-9 - -
LLI
wall
(2E+3) - - - 3E-5 3E-4
W,
see 230U - 2E+3 7E-7 2E-9 - -
Y,
see 230U - 2E+3 6E-7 2E-9 - -
92 Uranium-2383 D, see 230U 1E+1 1E+0 6E-10 - - -
Bone
surf Bone surf
(2E+1) (2E+0) - 3E-12 3E-7 3E-6
W,
see 230U - 8E-1 3E-10 1E-12 - -
Y,
see 230U - 4E-2 2E-11 6E-14 - -
92 Uranium-2392 D, see 230U 7E+4 2E+5 8E-5 3E-7 9E-4 9E-3
W,
see 230U - 2E+5 7E-5 2E-7 - -
Y,
see 230U - 2E+5 6E-5 2E-7 - -
92 Uranium-240 D, see 230U 1E+3 4E+3 2E-6 5E-9 2E-5 2E-4
W,
see 230U - 3E+3 1E-6 4E-9 - -
Y,
see 230U - 2E+3 1E-6 3E-9 - -
92 Uranium-natural3 D, see 230U 1E+1 1E+0 5E-10 - - -
Bone
surf Bone surf
(2E+1) (2E+0) - 3E-12 3E-7 3E-6
W,
see 230U - 8E-1 3E-10 9E-13 - -
Y,
see 230U - 5E-2 2E-11 9E-14 - -
93 Neptunium-2322 W, all compounds 1E+5 2E+3 7E-7 - 2E-3 2E-2
Bone
surf
- (5E+2) - 6E-9 - -
93 Neptunium-2332 W, all compounds 8E+5 3E+6 1E-3 4E-6 1E-2 1E-1
93 Neptunium-234 W, all compounds 2E+3 3E+3 1E-6 4E-9 3E-5 3E-4
Table
I Table
II Table III
Occupational
Values Effluent Releases to
Concentrations Sewers
Oral Monthly
Ingestion Inhalation Average
Atomic Radionuclide Class ALI ALI DAC Air Water Concentration
No. (μCi) (μCi) (μCi/ml) (μCi/ml) (μCi/ml) (μCi/ml)
93 Neptunium-235 W, all compounds 2E+4 8E+2 3E-7 - - -
LLI wall Bone surf
(2E+4) (1E+3) - 2E-9 3E-4 3E-3
93 Neptunium-236 W, all compounds 3E+0 2E-2 9E-12 - - -
(1.15E+5 y) Bone
surf Bone surf
(6E+0) (5E-2) - 8E-14 9E-8 9E-7
93 Neptunium-236 W, all compounds 3E+3 3E+1 1E-8 - - -
(22.5 h) Bone
surf Bone surf
(4E+3) (7E+1) - 1E-10 5E-5 5E-4
93 Neptunium-237 W, all compounds 5E-1 4E-3 2E-12 - - -
Bone
surf Bone surf
(1E+0) (1E-2) - 1E-14 2E-8 2E-7
93 Neptunium-238 W, all compounds 1E+3 6E+1 3E-8 - 2E-5 2E-4
Bone
surf
- (2E+2) - 2E-10 - -
93 Neptunium-239 W, all compounds 2E+3 2E+3 9E-7 3E-9 - -
LLI
wall
(2E+3) - - - 2E-5 2E-4
93 Neptunium-2402 W, all compounds 2E+4 8E+4 3E-5 1E-7 3E-4 3E-3
94 Plutonium-234 W, all compounds
except PuO2 8E+3 2E+2 9E-8 3E-10 1E-4 1E-3
Y,
PuO2 - 2E+2 8E-8 3E-10 - -
94 Plutonium-2352 W, see 234Pu 9E+5 3E+6 1E-3 4E-6 1E-2 1E-1
Y,
see 234Pu - 3E+6 1E-3 3E-6 - -
94 Plutonium-236 W, see 234Pu 2E+0 2E-2 8E-12 - - -
Bone
surf Bone surf
(4E+0) (4E-2) - 5E-14 6E-8 6E-7
Y,
see 234Pu - 4E-2 2E-11 6E-14 - -
94 Plutonium-237 W, see 234Pu 1E+4 3E+3 1E-6 5E-9 2E-4 2E-3
Y,
see 234Pu - 3E+3 1E-6 4E-9 - -
94 Plutonium-238 W, see 234Pu 9E-1 7E-3 3E-12 - - -
Bone
surf Bone surf
(2E+0) (1E-2) - 2E-14 2E-8 2E-7
Y,
see 234Pu - 2E-2 8E-12 2E-14 - -
94 Plutonium-239 W, see 234Pu 8E-1 6E-3 3E-12 - - -
Bone
surf Bone surf
(1E+0) (1E-2) - 2E-14 2E-8 2E-7
Y,
see 234Pu - 2E-2 7E-12 - - -
Bone
surf
- (2E-2) - 2E-14 - -
94 Plutonium-240 W, see 234Pu 8E-1 6E-3 3E-12 - - -
Bone
surf Bone surf
(1E+0) (1E-2) - 2E-14 2E-8 2E-7
Y,
see 234Pu - 2E-2 7E-12 - - -
Bone
surf
(2E-2) - 2E-14 - -
Table
I Table
II Table III
Occupational
Values Effluent Releases to
Concentrations Sewers
Oral Monthly
Ingestion Inhalation Average
Atomic Radionuclide Class ALI ALI DAC Air Water Concentration
No. (μCi) (μCi) (μCi/ml) (μCi/ml) (μCi/ml) (μCi/ml)
94 Plutonium-241 W, see 234Pu 4E+1 3E-1 1E-10 - - -
Bone
surf Bone surf
(7E+1) (6E-1) - 8E-13 1E-6 1E-5
Y,
see 234Pu - 8E-1 3E-10 - - -
Bone
surf
- (1E+0) - 1E-12 - -
94 Plutonium-242 W, see 234Pu 8E-1 7E-3 3E-12 - - -
Bone
surf Bone surf
(1E+0) (1E-2) - 2E-14 2E-8 2E-7
Y,
see 234Pu - 2E-2 7E-12 - - -
Bone
surf
- (2E-2) - 2E-14 - -
94 Plutonium-243 W, see 234Pu 2E+4 4E+4 2E-5 5E-8 2E-4 2E-3
Y,
see 234Pu - 4E+4 2E-5 5E-8 - -
94 Plutonium-244 W, see 234Pu 8E-1 7E-3 3E-12 - - -
Bone
surf Bone surf
(2E+0) (1E-2) - 2E-14 2E-8 2E-7
Y,
see 234Pu - 2E-2 7E-12 - - -
Bone
surf
- (2E-2) - 2E-14 - -
94 Plutonium-245 W, see 234Pu 2E+3 5E+3 2E-6 6E-9 3E-5 3E-4
Y,
see 234Pu - 4E+3 2E-6 6E-9 - -
94 Plutonium-246 W, see 234Pu 4E+2 3E+2 1E-7 4E-10 - -
LLI
wall
(4E+2) - - - 6E-6 6E-5
Y,
see 234Pu - 3E+2 1E-7 4E-10 - -
95 Americium-2372 W, all compounds 8E+4 3E+5 1E-4 4E-7 1E-3 1E-2
95 Americium-2382 W, all compounds 4E+4 3E+3 1E-6 - 5E-4 5E-3
Bone
surf
- (6E+3) - 9E-9 - -
95 Americium-239 W, all compounds 5E+3 1E+4 5E-6 2E-8 7E-5 7E-4
95 Americium-240 W, all compounds 2E+3 3E+3 1E-6 4E-9 3E-5 3E-4
95 Americium-241 W, all compounds 8E-1 6E-3 3E-12 - - -
Bone
surf Bone surf
(1E+0) (1E-2) - 2E-14 2E-8 2E-7
95 Americium-242m W, all compounds 8E-1 6E-3 3E-12 - - -
Bone
surf Bone surf
(1E+0) (1E-2) - 2E-14 2E-8 2E-7
95 Americium-242 W, all compounds 4E+3 8E+1 4E-8 - 5E-5 5E-4
Bone
surf
- (9E+1) - 1E-10 - -
95 Americium-243 W, all compounds 8E-1 6E-3 3E-12 - - -
Bone
surf Bone surf
(1E+0) (1E-2) - 2E-14 2E-8 2E-7
Table
I Table
II Table III
Occupational
Values Effluent Releases to
Concentrations Sewers
Oral Monthly
Ingestion Inhalation Average
Atomic Radionuclide Class ALI ALI DAC Air Water Concentration
No. (μCi) (μCi) (μCi/ml) (μCi/ml) (μCi/ml) (μCi/ml)
95 Americium-244m2 W, all compounds 6E+4 4E+3 2E-6 - - -
St
wall Bone surf
(8E+4) (7E+3) - 1E-8 1E-3 1E-2
95 Americium-244 W, all compounds 3E+3 2E+2 8E-8 - 4E-5 4E-4
Bone
surf
- (3E+2) - 4E-10 - -
95 Americium-245 W, all compounds 3E+4 8E+4 3E-5 1E-7 4E-4 4E-3
95 Americium-246m2 W, all compounds 5E+4 2E+5 8E-5 3E-7 - -
St
wall
(6E+4) - - - 8E-4 8E-3
95 Americium-2462 W, all compounds 3E+4 1E+5 4E-5 1E-7 4E-4 4E-3
96 Curium-238 W, all compounds 2E+4 1E+3 5E-7 2E-9 2E-4 2E-3
96 Curium-240 W, all compounds 6E+1 6E-1 2E-10 - - -
Bone
surf Bone surf
(8E+1) (6E-1) - 9E-13 1E-6 1E-5
96 Curium-241 W, all compounds 1E+3 3E+1 1E-8 - 2E-5 2E-4
Bone
surf
- (4E+1) - 5E-11 - -
96 Curium-242 W, all compounds 3E+1 3E-1 1E-10 - - -
Bone
surf Bone surf
(5E+1) (3E-1) - 4E-13 7E-7 7E-6
96 Curium-243 W, all compounds 1E+0 9E-3 4E-12 - - -
Bone
surf Bone surf
(2E+0) (2E-2) - 2E-14 3E-8 3E-7
96 Curium-244 W, all compounds 1E+0 1E-2 5E-12 - - -
Bone
surf Bone surf
(3E+0) (2E-2) - 3E-14 3E-8 3E-7
96 Curium-245 W, all compounds 7E-1 6E-3 3E-12 - - -
Bone
surf Bone surf
(1E+0) (1E-2) - 2E-14 2E-8 2E-7
96 Curium-246 W, all compounds 7E-1 6E-3 3E-12 - - -
Bone
surf Bone surf
(1E+0) (1E-2) - 2E-14 2E-8 2E-7
96 Curium-247 W, all compounds 8E-1 6E-3 3E-12 - - -
Bone
surf Bone surf
(1E+0) (1E-2) - 2E-14 2E-8 2E-7
96 Curium-248 W, all compounds 2E-1 2E-3 7E-13 - - -
Bone
surf Bone surf
(4E-1) (3E-3) - 4E-15 5E-9 5E-8
96 Curium-2492 W, all compounds 5E+4 2E+4 7E-6 - 7E-4 7E-3
Bone
surf
- (3E+4) - 4E-8 - -
Table
I Table
II Table III
Occupational
Values Effluent Releases to
Concentrations Sewers
Oral Monthly
Ingestion Inhalation Average
Atomic Radionuclide Class ALI ALI DAC Air Water Concentration
No. (μCi) (μCi) (μCi/ml) (μCi/ml) (μCi/ml) (μCi/ml)
96 Curium-250 W, all compounds 4E-2 3E-4 1E-13 - - -
Bone
surf Bone surf
(6E-2) (5E-4) - 8E-16 9E-10 9E-9
97 Berkelium-245 W, all compounds 2E+3 1E+3 5E-7 2E-9 3E-5 3E-4
97 Berkelium-246 W, all compounds 3E+3 3E+3 1E-6 4E-9 4E-5 4E-4
97 Berkelium-247 W, all compounds 5E-1 4E-3 2E-12 - - -
Bone
surf Bone surf
(1E+0) (9E-3) - 1E-14 2E-8 2E-7
97 Berkelium-249 W, all compounds 2E+2 2E+0 7E-10 - - -
Bone
surf Bone surf
(5E+2) (4E+0) - 5E-12 6E-6 6E-5
97 Berkelium-250 W, all compounds 9E+3 3E+2 1E-7 - 1E-4 1E-3
Bone
surf
- (7E+2) - 1E-9 - -
98 Californium-2442 W, all compounds except
those given for Y 3E+4 6E+2 2E-7 8E-10 - -
St
wall
(3E+4) - - - 4E-4 4E-3
Y,
oxides and hydroxides - 6E+2 2E-7 8E-10 - -
98 Californium-246 W, see 244Cf 4E+2 9E+0 4E-9 1E-11 5E-6 5E-5
Y,
see 244Cf - 9E+0 4E-9 1E-11 - -
98 Californium-248 W, see 244Cf 8E+0 6E-2 3E-11 - - -
Bone
surf Bone surf
(2E+1) (1E-1) - 2E-13 2E-7 2E-6
Y,
see 244Cf - 1E-1 4E-11 1E-13 - -
98 Californium-249 W, see 244Cf 5E-1 4E-3 2E-12 - - -
Bone
surf Bone surf
(1E+0) (9E-3) - 1E-14 2E-8 2E-7
Y,
see 244Cf - 1E-2 4E-12 - - -
Bone
surf
- (1E-2) - 2E-14 - -
98 Californium-250 W, see 244Cf 1E+0 9E-3 4E-12 - - -
Bone
surf Bone surf
(2E+0) (2E-2) - 3E-14 3E-8 3E-7
Y,
see 244Cf - 3E-2 1E-11 4E-14 - -
98 Californium-251 W, see 244Cf 5E-1 4E-3 2E-12 - - -
Bone
surf Bone surf
(1E+0) (9E-3) - 1E-14 2E-8 2E-7
Y,
see 244Cf - 1E-2 4E-12 - - -
Bone
surf
- (1E-2) - 2E-14 - -
98 Californium-252 W, see 244Cf 2E+0 2E-2 8E-12 - - -
Bone
surf Bone surf
(5E+0) (4E-2) - 5E-14 7E-8 7E-7
Y,
see 244Cf - 3E-2 1E-11 5E-14 - -
Table
I Table
II Table III
Occupational
Values Effluent Releases to
Concentrations Sewers
Oral Monthly
Ingestion Inhalation Average
Atomic Radionuclide Class ALI ALI DAC Air Water Concentration
No. (μCi) (μCi) (μCi/ml) (μCi/ml) (μCi/ml) (μCi/ml)
98 Californium-253 W, see 244Cf 2E+2 2E+0 8E-10 3E-12 - -
Bone
surf
(4E+2) - - - 5E-6 5E-5
Y,
see 244Cf - 2E+0 7E-10 2E-12 - -
98 Californium-254 W, see 244Cf 2E+0 2E-2 9E-12 3E-14 3E-8 3E-7
Y,
see 244Cf - 2E-2 7E-12 2E-14 - -
99 Einsteinium-250 W, all compounds 4E+4 5E+2 2E-7 - 6E-4 6E-3
Bone
surf
- (1E+3) - 2E-9 - -
99 Einsteinium-251 W, all compounds 7E+3 9E+2 4E-7 - 1E-4 1E-3
Bone
surf
- (1E+3) - 2E-9 - -
99 Einsteinium-253 W, all compounds 2E+2 1E+0 6E-10 2E-12 2E-6 2E-5
99 Einsteinium-254m W, all compounds 3E+2 1E+1 4E-9 1E-11 - -
LLI
wall
(3E+2) - - - 4E-6 4E-5
99 Einsteinium-254 W, all compounds 8E+0 7E-2 3E-11 - - -
Bone
surf Bone surf
(2E+1) (1E-1) - 2E-13 2E-7 2E-6
100 Fermium-252 W, all compounds 5E+2 1E+1 5E-9 2E-11 6E-6 6E-5
100 Fermium-253 W, all compounds 1E+3 1E+1 4E-9 1E-11 1E-5 1E-4
100 Fermium-254 W, all compounds 3E+3 9E+1 4E-8 1E-10 4E-5 4E-4
100 Fermium-255 W, all compounds 5E+2 2E+1 9E-9 3E-11 7E-6 7E-5
100 Fermium-257 W, all compounds 2E+1 2E-1 7E-11 - - -
Bone
surf Bone surf
(4E+1) (2E-1) - 3E-13 5E-7 5E-6
101 Mendelevium-257 W, all compounds 7E+3 8E+1 4E-8 - 1E-4 1E-3
Bone
surf
- (9E+1) - 1E-10 - -
101 Mendelevium-258 W, all compounds 3E+1 2E-1 1E-10 - - -
Bone
surf Bone surf
(5E+1) (3E-1) - 5E-13 6E-7 6E-6
Any single radionuclide not
listed
above with decay mode other than
alpha emission or spontaneous fis-
sion
and with radioactive half-
life less than 2 hours Submersion1 - 2E+2 1E-7 1E-9 - -
Any single radionuclide not
listed
above with decay mode other than
alpha emission or spontaneous fis-
sion
and with radioactive half-
life greater than 2 hours .
. . . - 2E-1 1E-10 1E-12 1E-8 1E-7
Table
I Table
II Table III
Occupational
Values Effluent Releases to
Concentrations Sewers
Oral Monthly
Ingestion Inhalation Average
Atomic Radionuclide Class ALI ALI DAC Air Water Concentration
No. (μCi) (μCi) (μCi/ml) (μCi/ml) (μCi/ml) (μCi/ml)
Any single radionuclide not
listed
above that decays by alpha
emission
or spontaneous fission, or any
mix-
ture for
which either the identity
or the concentration of any
radio-
nuclide in the mixture is not
known - 4E-4 2E-13 1E-15 2E-9 2E-8
___________________________________________________________________________________________________________________
FOOTNOTES:
1
"Submersion" means that values given are for submersion in a
hemispherical semi-infinite cloud of airborne material.
2
These radionuclides have radiological half-lives of less than 2 hours. The total effective dose equivalent received
during operations with these radionuclides might include a significant
contribution from external exposure. The
DAC values for all radionuclides, other than those designated Class
"Submersion," are based upon the committed effective dose equivalent
due to the intake of the radionuclide into the body and do NOT include
potentially significant contributions to dose equivalent from external exposures. The licensee may substitute 1E-7 μCi/ml for the listed DAC to account for the
submersion dose prospectively, but should use individual monitoring devices or
other radiation measuring instruments that measure external exposure to
demonstrate compliance with the limits.
3
For soluble mixtures of U-238, U-234, and U-235 in air, chemical toxicity may
be the limiting factor. If the percent
by weight (enrichment) of U-235 is not greater than 5, the concentration value
for a 40-hour workweek is 0.2 milligrams uranium per cubic meter of air
average. For any enrichment, the product
of the average concentration and time of exposure during a 40-hour workweek
shall not exceed 8E-3 (SA) μCi-hr/ml, where SA
is the specific activity of the uranium inhaled. The specific activity for natural uranium is
6.77E-7 curies per
SA = 3.6E-7 curies/gram U U-depleted
SA = [0.4 + 0.38 (enrichment) +
0.0034 (enrichment)2] E-6 ,
enrichment > 0.72
where
enrichment is the percentage by weight of U-235, expressed as percent.
NOTES:
1. If the identity of each radionuclide in a
mixture is known but the concentration of one or more of the radionuclides in
the mixture is not known, the DAC for the mixture shall be the most restrictive
DAC of any radionuclide in the mixture.
2. If the identity of each radionuclide in the
mixture is not known, but it is known that certain radionuclides specified in
this appendix are not present in the mixture, the inhalation ALI, DAC, and
effluent and sewage concentrations for the mixture are the lowest values
specified in this appendix for any radionuclide that is not known to be absent
from the mixture; or
Table
I Table
II Table III
Occupational
Values Effluent Releases to
Concentrations Sewers
Oral Monthly
Ingestion Inhalation Average
Atomic Radionuclide Class ALI ALI DAC Air Water Concentration
No. (μCi) (μCi) (μCi/ml) (μCi/ml) (μCi/ml) (μCi/ml)
If
it is known that Ac-227-D and Cm-250-W are
not
present - 7E-4 3E-13 - - -
If,
in addition, it is known that Ac-227-W,Y,
Th-229-W,Y,
Th-230-W, Th-232-W,Y, Pa-231-W,Y,
Np-237-W,
Pu-239-W, Pu-240-W, Pu-242-W, Am-241-W,
Am-242m-W,
Am-243-W, Cm-245-W, Cm-246-W, Cm-247-W,
Cm-248-W,
Bk-247-W, Cf-249-W, and Cf-251-W
are
not present - 7E-3 3E-12 - - -
Table
I Table
II Table III
Occupational
Values Effluent Releases to
Concentrations Sewers
Oral Monthly
Ingestion Inhalation Average
Atomic Radionuclide Class ALI ALI DAC Air Water Concentration
No. (μCi) (μCi) (μCi/ml) (μCi/ml) (μCi/ml) (μCi/ml)
If,
in addition, it is known that Sm-146-W,
Sm-147-W,
Gd-148-D,W, Gd-152-D,W, Th-228-W,Y,
Th-230-Y,
U-232-Y, U-233-Y, U-234-Y, U-235-Y,
U-236-Y,
U-238-Y, Np-236-W, Pu-236-W,Y,
Pu-238-W,Y,
Pu-239-Y, Pu-240-Y, Pu-242-Y,
Pu-244-W,Y,
Cm-243-W, Cm-244-W, Cf-248-W,
Cf-249-Y,
Cf-250-W,Y, Cf-251-Y, Cf-252-W,Y,
and
Cf-254-W,Y are not present - 7E-2 3E-11 - - -
If,
in addition, it is known that Pb-210-D,
Bi-210m-W,
Po-210-D,W, Ra-223-W, Ra-225-W,
Ra-226-W,
Ac-225-D,W,Y, Th-227-W,Y, U-230-D,W,Y,
U-232-D,W,
Pu-241-W, Cm-240-W, Cm-242-W,
Cf-248-Y,
Es-254-W, Fm-257-W, and Md-258-W
are
not present - 7E-1 3E-10 - - -
If,
in addition, it is known that Si-32-Y,
Ti-44-Y,
Fe-60-D, Sr-90-Y, Zr-93-D,
Cd-113m-D,
Cd-113-D, In-115-D,W, La-138-D,
Lu-176-W,
Hf-178m-D,W, Hf-182-D,W, Bi-210m-D,
Ra-224-W,
Ra-228-W, Ac-226-D,W,Y, Pa-230-W,Y,
U-233-D,W,
U-234-D,W, U-235-D,W, U-236-D,W,
U-238-D,W,
Pu-241-Y, Bk-249-W, Cf-253-W,Y,
and
Es-253-W are not present - 7E+0 3E-9 - - -
If
it is known that Ac-227-D,W,Y, Th-229-W,Y,
Th-232-W,Y,
Pa-231-W,Y, Cm-248-W, and
Cm-250-W
are not present - - - 1E-14 - -
If,
in addition, it is known that Sm-146-W,
Gd-148-D,W,
Gd-152-D, Th-228-W,Y, Th-230-W,Y,
U-232-Y,
U-233-Y, U-234-Y, U-235-Y, U-236-Y,
U-238-Y,
U-Nat-Y, Np-236-W, Np-237-W, Pu-236-W,Y,
Pu-238-W,Y,
Pu-239-W,Y, Pu-240-W,Y, Pu-242-W,Y,
Pu-244-W,Y,
Am-241-W, Am-242m-W, Am-243-W,
Cm-243-W,
Cm-244-W, Cm-245-W, Cm-246-W,
Cm-247-W,
Bk-247-W, Cf-249-W,Y, Cf-250-W,Y,
Cf-251-W,Y,
Cf-252-W,Y, and Cf-254-W,Y
are
not present - - - 1E-13 - -
If,
in addition, it is known that Sm-147-W,
Gd-152-W,
Pb-210-D, Bi-210m-W, Po-210-D,W,
Ra-223-W,
Ra-225-W, Ra-226-W, Ac-225-D,W,Y,
Th-227-W,Y,
U-230-D,W,Y, U-232-D,W, U-Nat-W,
Pu-241-W,
Cm-240-W, Cm-242-W, Cf-248-W,Y,
Es-254-W,
Fm-257-W, and Md-258-W are not
present - - - 1E-12 -
If,
in addition it is known that Fe-60,
Sr-90,
Cd-113m, Cd-113, In-115, I-129,
Cs-134,
Sm-145, Sm-147, Gd-148, Gd-152,
Hg-194
(organic), Bi-210m, Ra-223, Ra-224,
Ra-225,
Ac-225, Th-228, Th-230, U-233, U-234,
U-235,
U-236, U-238, U-Nat, Cm-242, Cf-248,
Es-254,
Fm-257, and Md-258 are not present - - - - 1E-6 1E-5
3. If a mixture of radionuclides consists of
uranium and its daughters in ore dust (10 μm
AMAD particle distribution assumed) prior to chemical separation of the uranium
from the ore, the following values may be used for the DAC of the mixture: 6E-11 μCi of
gross alpha activity from uranium-238, uranium-234, thorium-230, and radium-226
per milliliter of air; 3E-11 μCi of natural
uranium per milliliter of air; or 45 micrograms of natural uranium per cubic
meter of air.
4. If the identity and concentration of each radionuclide
in a mixture are known, the limiting values should be derived as follows: determine, for each radionuclide in the
mixture, the ratio between the concentration present in the mixture and the
concentration otherwise established in this subsection for the specific
radionuclide when not in a mixture. The
sum of such ratios for all of the radionuclides in the
mixture may not exceed "1" (i.e., "unity").
Example: If radionuclides "A,"
"B," and "C" are present in concentrations CA, CB, and CC,
and if the applicable DACs are DACA, DACB, and DACC, respectively, then the
concentrations shall be limited so that the following relationship exists:
Source. #7959, eff 9-20-03; ss by #9981, eff 9-20-11;
ss by #13261, INTERIM, eff 9-17-21, EXPIRES: 3-16-22; ss by #13331, eff 1-22-22
PART He-P 4090
ANNUAL LIMITS ON INTAKE (ALI) AND DERIVED AIR CONCENTRATIONS (DAC) OF
RADIONUCLIDES FOR OCCUPATIONAL EXPOSURE, EFFLUENT CONCENTRATIONS,
CONCENTRATIONS FOR RELEASE TO SANITARY SEWAGE; AND LIST OF ELEMENTS
He-P
4090.02 List of Elements. The following Table 4090.2 is a list of 101
elements in alphabetical order:
Table 4090.2
List of Elements
Name |
Atomic |
|
Symbol |
No. |
|
Actinium |
Ac |
89 |
Aluminum |
Al |
13 |
Americium |
Am |
95 |
Antimony |
Sb |
51 |
Argon |
Ar |
18 |
Arsenic |
As |
33 |
Astatine |
At |
85 |
Barium |
Ba |
56 |
Berkelium |
Bk |
97 |
Beryllium |
Be |
4 |
Bismuth |
Bi |
83 |
Bromine |
Br |
35 |
Cadmium |
Cd |
48 |
Calcium |
Ca |
20 |
Californium |
Cf |
98 |
Carbon |
C |
6 |
Cerium |
Ce |
58 |
Cesium |
Cs |
55 |
Chlorine |
Cl |
17 |
Chromium |
Cr |
24 |
Cobalt |
Co |
27 |
Copper |
Cu |
29 |
Curium |
Cm |
96 |
Dysprosium |
Dy |
66 |
Einsteinium |
Es |
99 |
Erbium |
Er |
68 |
Europium |
Eu |
63 |
Fermium |
Fm |
100 |
Fluorine |
F |
9 |
Francium |
Fr |
87 |
Gadolinium |
Gd |
64 |
Gallium |
Ga |
31 |
Germanium |
Ge |
32 |
Gold |
Au |
79 |
Hafnium |
Hf |
72 |
Holmium |
Ho |
67 |
Hydrogen |
H |
1 |
Indium |
In |
49 |
Iodine |
I |
53 |
Iridium |
Ir |
77 |
Iron |
Fe |
26 |
Krypton |
Kr |
36 |
Lanthanum |
La |
57 |
Lead |
Pb |
82 |
Lutetium |
Lu |
71 |
Magnesium |
Mg |
12 |
Manganese |
Mn |
25 |
Mendelevium |
Md |
101 |
Mercury |
Hg |
80 |
Molybdenum |
Mo |
42 |
Neodymium |
Nd |
60 |
Neptunium |
Np |
93 |
Nickel |
Ni |
28 |
Niobium |
Nb |
41 |
Nitrogen |
N |
7 |
Osmium |
Os |
76 |
Oxygen |
O |
8 |
Palladium |
Pd |
46 |
Phosphorus |
P |
15 |
Platinum |
Pt |
78 |
Plutonium |
Pu |
94 |
Polonium |
|
84 |
Potassium |
K |
19 |
Praseodymium |
Pr |
59 |
Promethium |
Pm |
61 |
Protactinium |
Pa |
91 |
Radium |
Ra |
88 |
Radon |
Rn |
86 |
Rhenium |
Re |
75 |
Rhodium |
Rh |
45 |
Rubidium |
Rb |
37 |
Ruthenium |
Ru |
44 |
Samarium |
Sm |
62 |
Scandium |
Sc |
21 |
Selenium |
Se |
34 |
Silicon |
Si |
14 |
Silver |
Ag |
47 |
Sodium |
Na |
11 |
Strontium |
Sr |
38 |
Sulfur |
S |
16 |
Tantalum |
Ta |
73 |
Technetium |
Tc |
43 |
Tellurium |
Te |
52 |
Terbium |
Tb |
65 |
Thallium |
Tl |
81 |
Thorium |
Th |
90 |
Thulium |
Tm |
69 |
Tin |
Sn |
50 |
Titanium |
Ti |
22 |
Tungsten |
W |
74 |
Uranium |
U |
92 |
Vanadium |
V |
23 |
Xenon |
Xe |
54 |
Ytterbium |
Yb |
70 |
Yttrium |
Y |
39 |
Zinc |
Zn |
30 |
Zirconium |
Zr |
40 |
Source. #11106, eff 5-25-16
PART
He-P 4091 Quantities for Use With Decommissioning
He-P 4091.01 Quantities for Use With Decommissioning. The quantities for decommissioning of
licensed facilities as specified in He-P 4030.09(e) and He-P 4030.09 (i) through (r) inclusive shall be in
compliance with Table 4091.1 below.
Table
4091.1 Quantities for Use with Decommissioning
Material |
Activity
(µCi) 1 |
Americium-241 |
0.01 |
Antimony-122 |
100 |
Antimony-124 |
10 |
Antimony-125 |
10 |
Arsenic-73 |
100 |
Arsenic-74 |
10 |
Arsenic-76 |
10 |
Arsenic-77 |
100 |
Barium-131 |
10 |
Barium-133 |
10 |
Barium-140 |
10 |
Bismuth-210 |
1 |
Bromine-82 |
10 |
Cadmium-109 |
10 |
Cadmium-115m |
10 |
Cadmium-115 |
100 |
Calcium-45 |
10 |
Calcium-47 |
10 |
Carbon-14 |
100 |
Cerium-141 |
100 |
Cerium-143 |
100 |
Cerium-144 |
1 |
Cesium-131 |
1000 |
Cesium-134m |
100 |
Cesium-134 |
1 |
Cesium-135 |
10 |
Cesium-136 |
10 |
Cesium-137 |
10 |
Chlorine-36 |
10 |
Chlorine-38 |
10 |
Chromium-51 |
1000 |
Cobalt-58m |
10 |
Cobalt-58 |
10 |
Cobalt-60 |
1 |
Copper-64 |
100 |
Dysprosium-165 |
10 |
Dysprosium-166 |
100 |
Erbium-169 |
100 |
Erbium-171 |
100 |
Europium-152
(9.2 hrs) |
100 |
Europium-152
(13 yr) |
1 |
Europium-154 |
1 |
Europium-155 |
10 |
Fluorine-18 |
1000 |
Gadolinium-153 |
10 |
Gadolinium-159 |
100 |
Gallium-72 |
10 |
Germanium-71 Gold-198 Gold-199 |
100 100 100 |
Hafnium-181 |
10 |
Holmium-166 |
100 |
Hydrogen-3 |
1000 |
Indium-113m |
100 |
Indium-114m |
10 |
Indium-115m |
100 |
Indium-115 |
10 |
Iodine-125 |
1 |
Iodine-126 |
1 |
Iodine-129 |
0.1 |
Iodine-131 |
1 |
Iodine-132 |
10 |
Iodine-133 |
1 |
Iodine-134 |
10 |
Iodine-135 |
10 |
Iridium-192 |
10 |
Iridium-194 |
100 |
Iron-55 |
100 |
Iron-59 |
10 |
Krypton-85 |
100 |
Krypton-87 |
10 |
Lanthanum-140 |
10 |
Lutetium-177 |
100 |
Manganese-52 |
10 |
Manganese-54 |
10 |
Manganese-56 |
10 |
Mercury-197m |
100 |
Mercury-197 |
100 |
Mercury-203 |
10 |
Molbdenum-99 |
100 |
Neodymium-147 |
100 |
Neodymium-149 |
100 |
Nickel-59 |
100 |
Nickel-63 |
10 |
Nickel-65 |
100 |
Niobium-93m |
10 |
Niobium-95 |
10 |
Niobium-97 |
10 |
Osmium-185 |
10 |
Osmium-191m |
100 |
Osmium-191 |
100 |
Osmium-193 |
100 |
Palladium-103 |
100 |
Palladium-109 |
100 |
Phosphorus-32 |
10 |
Platinum-191 |
100 |
Platinum-193m |
100 |
Platnium-193 |
100 |
Platinum-197m |
100 |
Platinum-197 |
100 |
Plutonium-239 |
0.01 |
Polonium-210 |
0.1 |
Potassium-42 |
10 |
Praseodymium-142 |
100 |
Praseodymium-143 |
100 |
Promethium-147 |
10 |
Promethium-149 |
10 |
Radium-226 |
0.01 |
Rhenium-186 |
100 |
Rhenium-188 |
100 |
Rhodium-103m |
100 |
Rhodium-105 |
100 |
Rubidium-86 |
10 |
Rubidium-87 |
10 |
Ruthenium-97 |
100 |
Ruthenium-103 |
10 |
Ruthenium-105 |
10 |
Ruthenium-106 |
1 |
Samarium-151 |
10 |
Samarium-153 |
100 |
Scandium-46 |
10 |
Scandium-47 |
100 |
Scandium-48 |
10 |
Selenium-75 |
10 |
Silicon-31 |
100 |
Silver-105 |
10 |
Silver-110m |
1 |
Silver-111 |
100 |
Sodium-24 |
10 |
Strontium-85 |
10 |
Strontium-89 |
1 |
Strontium-90 |
0.1 |
Strontium-91 |
10 |
Strontium-92 |
10 |
Sulphur-35 |
100 |
Tantalum-182 |
10 |
Technetium-96 |
10 |
Technetium-97m |
100 |
Technetium-97 |
100 |
Technetium-99m |
100 |
Technetium-99 |
10 |
Tellurium-125m |
10 |
Tellurium-127m |
10 |
Tellurium-127 |
100 |
Tellurium-129m |
10 |
Tellurium-129 |
100 |
Tellurium-131m |
10 |
Tellurium-132 |
10 |
Terbium-160 |
10 |
Thallium-200 |
100 |
Thallium-201 |
100 |
Thallium-202 |
100 |
Thallium-204 |
10 |
Thorium
(nat.) |
100 |
Thulium-170 |
10 |
Thulium-171 |
10 |
Tin-113 |
10 |
Tin-125 |
10 |
Tungsten-181 |
10 |
Tungsten-185 |
10 |
Tungsten-187 |
100 |
Uranium
(nat) |
100 |
Uranium-233 |
0.01 |
Uranium-234 |
0.01 |
Uranium-235 |
0.01 |
Vandium-48 |
10 |
Xenon-131m |
1000 |
Xenon-133 |
100 |
Xenon-135 |
100 |
Ytterbium-175 |
100 |
Yttrium-90 |
10 |
Yttrium-91 |
10 |
Yttrium-92 |
100 |
Yttrium-93 |
100 |
Zinc-65 |
10 |
Zinc-69m |
100 |
Zinc-69 |
1000 |
Zirconium-93 |
10 |
Zirconium-95 |
10 |
Zirconium-97 |
10 |
Any
alpha emitting radionuclide not listed above or mixtures of alpha emitters of
unknown composition |
0.01 |
Any
radionuclide other than alpha emitting radionuclides, not listed above or
mixtures of beta emitters of unknown composition |
0.1 |
__________________________________________________________________
1
Convert µCi to kBq, multiply µCi by 37.
He-P 4091.02 Quantities for Use with Decommissioning for
Natural Thorium and Uranium. The
quantities for use with decommissioning for Natural thorium and Natural Uranium
shall be as follows:
(a)
Thorium-Natural shall be based on the alpha disintegration rate from
Thorium-232, Thorium-230,and their daughter products; and
(b)
Uranium-Natural shall be based on the alpha disintegration rate of
Uranium-238, Uranium-234, and Uranium-235.
Source. #7960, eff 9-20-03; ss by #9981, eff 9-20-11;
ss by#12874, INTERIM, eff 9-25-19, EXPIRED: 3-23-20
New. #13062, eff 6-25-20
He-P 4091.03 Combination of Isotopes. Where there is involved a combination of
isotopes in known amounts, the limit for the combination shall be derived as
follows:
(a)
Determine, for each isotope in the combination, the ratio between the
quantity present in the combination and the limit otherwise established for the
specific isotope when not in combination; and
(b)
The sum of the ratios for all the isotopes in the combination shall not
exceed unity.
Source. #7960, eff 9-20-03; ss by #9981, eff 9-20-11;
ss by#12874, INTERIM, eff 9-25-19, EXPIRED: 3-23-20
6-25-20
New.
#13062, eff 6-25-20
Part He-P 4092 Quantities Of Radioactive Material Requiring
Labeling
He-P 4092.01 Quantities of Radioactive Material
Requiring Labeling. The limits of
quantities of radioactive material which shall be labeled shall be in compliance with Table 4092.1 below:
Table
4092.1 Quantities1, 2 of Radioactive
Material Requiring Labeling
Atomic Number |
Radionuclide |
Quantity (mCi)
3 |
1 |
Hydrogen-3 |
1000 |
4 |
Beryllium-10 |
1 |
4 |
Beryllium-7 |
1000 |
6 |
Carbon-11
|
1000 |
6 |
Carbon-14 |
100 |
9 |
Fluorine-18 |
1000 |
11 |
Sodium-22 |
10 |
11 |
Sodium-24 |
100 |
12 |
Magnesium-28 |
100 |
13 |
Aluminum-26 |
10 |
14 |
Silicon-31 |
1000 |
14 |
Silicon-32 |
1 |
15 |
Phosphorus-32 |
10 |
15 |
Phosphorus-33 |
100 |
16 |
Sulfur-35 |
100 |
17 |
Chlorine-36 |
10 |
17 |
Chlorine-38 |
1000 |
17 |
Chlorine-39 |
1000 |
18 |
Argon-39 |
1000 |
18 |
Argon-41 |
1000 |
19 |
Potassium-40 |
100 |
19 |
Potassium-42 |
1000 |
19 |
Potassium-43 |
1000 |
19 |
Potassium-44 |
1000 |
19 |
Potassium-45 |
1000 |
20 |
Calcium-41 |
100 |
20 |
Calcium-45 |
100 |
20 |
Calcium-47 |
100 |
21 |
Scandium-43 |
1000 |
21 |
Scandium-44 |
100 |
21 |
Scandium-44m |
100 |
21 |
Scandium-46 |
10 |
21 |
Scandium-47 |
100 |
21 |
Scandium-48 |
100 |
21 |
Scandium-49 |
1000 |
22 |
Titanium-44 |
1 |
22 |
Titanium-45 |
1000 |
23 |
Vanadium-47 |
1000 |
23 |
Vanadium-48 |
100 |
23 |
Vanadium-49 |
1000 |
24 |
Chromium-48 |
1000 |
24 |
Chromium-49 |
1000 |
24 |
Chromium-51 |
1000 |
25 |
Manganese-51 |
1000 |
25 |
Manganese-52 |
100 |
25 |
Manganese-52m |
1000 |
25 |
Manganese-53 |
1000 |
25 |
Manganese-54 |
100 |
25 |
Manganese-56 |
1000 |
26 |
Iron-52 |
100 |
26 |
Iron-55 |
100 |
26 |
Iron-59 |
10 |
26 |
Iron-60 |
1 |
27 |
Cobalt-55 |
100 |
27 |
Cobalt-56 |
10 |
27 |
Cobalt-57 |
100 |
27 |
Cobalt-58 |
100 |
27 |
Cobalt-58m |
1000 |
27 |
Cobalt-60 |
1 |
27 |
Cobalt-60m |
1000 |
27 |
Cobalt-61 |
1000 |
27 |
Cobalt-62m |
1000 |
28 |
Nickel-56 |
100 |
28 |
Nickel-57 |
100 |
28 |
Nickel-59 |
100 |
28 |
Nickel-63 |
100 |
28 |
Nickel-65 |
1000 |
28 |
Nickel-66 |
10 |
29 |
Copper-60 |
1000 |
29 |
Copper-61 |
1000 |
29 |
Copper-64 |
1000 |
29 |
Copper-67 |
1000 |
30 |
Zinc-62 |
100 |
30 |
Zinc-63 |
1000 |
30 |
Zinc-65 |
10 |
30 |
Zinc-69 |
1000 |
30 |
Zinc-69m |
100 |
30 |
Zinc-71m |
1000 |
30 |
Zinc-72 |
100 |
31 |
Gallium-65 |
1000 |
31 |
Gallium-66 |
100 |
31 |
Gallium-67 |
1000 |
31 |
Gallium-68 |
1000 |
31 |
Gallium-70 |
1000 |
31 |
Gallium-72 |
100 |
31 |
Gallium-73 |
1000 |
32 |
Germanium-66 |
1000 |
32 |
Germanium-67 |
1000 |
32 |
Germanium-68 |
10 |
32 |
Germanium-69 |
1000 |
32 |
Germanium-71 |
1000 |
32 |
Germanium-75 |
1000 |
32 |
Germanium-77 |
1000 |
32 |
Germanium-78 |
1000 |
33 |
Arsenic-69 |
1000 |
33 |
Arsenic-70 |
1000 |
33 |
Arsenic-71 |
100 |
33 |
Arsenic-72 |
100 |
33 |
Arsenic-73 |
100 |
33 |
Arsenic-74 |
100 |
33 |
Arsenic-76 |
100 |
33 |
Arsenic-77 |
100 |
33 |
Arsenic-78 |
1000 |
34 |
Selenium-70 |
1000 |
34 |
Selenium-73 |
100 |
34 |
Selenium-73m |
1000 |
34 |
Selenium-75 |
100 |
34 |
Selenium-79 |
100 |
34 |
Selenium-81 |
1000 |
34 |
Selenium-81m |
1000 |
34 |
Selenium-83 |
1000 |
35 |
Bromine-74 |
1000 |
35 |
Bromine-74m |
1000 |
35 |
Bromine-75 |
1000 |
35 |
Bromine-76 |
100 |
35 |
Bromine-77 |
1000 |
35 |
Bromine-80 |
1000 |
35 |
Bromine-80m |
1000 |
35 |
Bromine-82 |
100 |
35 |
Bromine-83 |
1000 |
35 |
Bromine-84 |
1000 |
36 |
Krypton-74 |
1000 |
36 |
Krypton-76 |
1000 |
36 |
Krypton-77 |
1000 |
36 |
Krypton-79 |
1000 |
36 |
Krypton-81 |
1000 |
36 |
Krypton-83m |
1000 |
36 |
Krypton-85 |
1000 |
36 |
Krypton-85m |
1000 |
36 |
Krypton-87 |
1000 |
36 |
Krypton-88 |
1000 |
37 |
Rubidium-79 |
1000 |
37 |
Rubidium-81 |
1000 |
37 |
Rubidium-81m |
1000 |
37 |
Rubidium-82m |
1000 |
37 |
Rubidium-83 |
100 |
37 |
Rubidium-84 |
100 |
37 |
Rubidium-86 |
100 |
37 |
Rubidium-87 |
100 |
37 |
Rubidium-88 |
1000 |
37 |
Rubidium-89 |
1000 |
38 |
Strontium-80 |
100 |
38 |
Strontium-81 |
1000 |
38 |
Strontium-83 |
100 |
38 |
Strontium-85m |
1000 |
38 |
Strontium-85 |
100 |
38 |
Strontium-87m |
1000 |
38 |
Strontium-89 |
10 |
38 |
Strontium-90 |
0.1 |
38 |
Strontium-91 |
100 |
38 |
Strontium-92 |
100 |
39 |
Yttrium-86 |
100 |
39 |
Yttrium-86m |
1000 |
39 |
Yttrium-87 |
100 |
39 |
Yttrium-88 |
10 |
39 |
Yttrium-90 |
10 |
39 |
Yttrium-90m |
1000 |
39 |
Yttrium-91 |
10 |
39 |
Yttrium-91m |
1000 |
39 |
Yttrium-92 |
100 |
39 |
Yttrium-93 |
100 |
39 |
Yttrium-94 |
1000 |
39 |
Yttrium-95 |
1000 |
40 |
Zirconium-86 |
100 |
40 |
Zirconium-88 |
10 |
40 |
Zirconium-89 |
100 |
40 |
Zirconium-93 |
1 |
40 |
Zirconium-95 |
10 |
40 |
Zirconium-97 |
100 |
41 |
Niobium-88 |
1000 |
41 |
Niobium-89
(122 min) |
1000 |
41 |
Niobium-89m
(66 min) |
1000 |
41 |
Niobium-90 |
100 |
41 |
Niobium-93m |
10 |
41 |
Niobium-94 |
1 |
41 |
Niobium-95 |
100 |
41 |
Niobium-95m |
100 |
41 |
Niobium-96 |
100 |
41 |
Niobium-97 |
1000 |
41 |
Niobium-98 |
1000 |
42 |
Molybdenum-101 |
1000 |
42 |
Molybdenum-90 |
100 |
42 |
Molybdenum-93 |
10 |
42 |
Molybdenum-93m |
100 |
42 |
Molybdenum-99 |
100 |
43 |
Technetium-101 |
1000 |
43 |
Technetium-104 |
1000 |
43 |
Technetium-93 |
1000 |
43 |
Technetium-93m |
1000 |
43 |
Technetium-94 |
1000 |
43 |
Technetium-94m |
1000 |
43 |
Technetium-96 |
100 |
43 |
Technetium-96m |
1000 |
43 |
Technetium-97 |
1000 |
43 |
Technetium-97m |
100 |
43 |
Technetium-98 |
10 |
43 |
Technetium-99 |
100 |
43 |
Technetium-99m |
1000 |
44 |
Ruthenium-103 |
100 |
44 |
Ruthenium-105 |
1000 |
44 |
Ruthenium-106 |
1 |
44 |
Ruthenium-94 |
1000 |
44 |
Ruthenium-97 |
1000 |
45 |
Rhodium-100 |
100 |
45 |
Rhodium-101 |
10 |
45 |
Rhodium-101m |
1000 |
45 |
Rhodium-102 |
10 |
45 |
Rhodium-102m |
10 |
45 |
Rhodium-103m |
1000 |
45 |
Rhodium-105 |
100 |
45 |
Rhodium-106m |
1000 |
45 |
Rhodium-107 |
1000 |
45 |
Rhodium-99 |
100 |
45 |
Rhodium-99m |
1000 |
46 |
Palladium-100 |
100 |
46 |
Palladium-101 |
1000 |
46 |
Palladium-103 |
100 |
46 |
Palladium-107 |
10 |
46 |
Palladium-109 |
100 |
47 |
Silver-102 |
1000 |
47 |
Silver-103 |
1000 |
47 |
Silver-104 |
1000 |
47 |
Silver-104m |
1000 |
47 |
Silver-105 |
100 |
47 |
Silver-106 |
1000 |
47 |
Silver-106m |
100 |
47 |
Silver-108m |
1 |
47 |
Silver-111 |
100 |
47 |
Silver-112 |
100 |
47 |
Silver-115 |
1000 |
47 |
Silver-11Om |
10 |
48 |
Cadmium-104 |
1000 |
48 |
Cadmium-107 |
1000 |
48 |
Cadmium-109 |
1 |
48 |
Cadmium-113 |
100 |
48 |
Cadmium-113m |
0.1 |
48 |
Cadmium-115 |
100 |
48 |
Cadmium-115m |
10 |
48 |
Cadmium-117 |
1000 |
48 |
Cadmium-117m |
1000 |
49 |
Indium-109 |
1000 |
49 |
Indium-110
(69.1 min) |
1000 |
49 |
Indium-111 |
100 |
49 |
Indium-112 |
1000 |
49 |
Indium-113m |
1000 |
49 |
Indium-114m |
10 |
49 |
Indium-115 |
100 |
49 |
Indium-115m |
1000 |
49 |
Indium-116m |
1000 |
49 |
Indium-117 |
1000 |
49 |
Indium-117m |
1000 |
49 |
Indium-119m |
1000 |
49 |
Indium-110
(4.9 h) |
1000 |
50 |
Tin-110 |
100 |
50 |
Tin-111 |
1000 |
50 |
Tin-113 |
100 |
50 |
Tin-117m |
100 |
50 |
Tin-119m |
100 |
50 |
Tin-121 |
1000 |
50 |
Tin-121m |
100 |
50 |
Tin-123 |
10 |
50 |
Tin-123m |
1000 |
50 |
Tin-125 |
10 |
50 |
Tin-126 |
10 |
50 |
Tin-127 |
1000 |
50 |
Tin-128 |
1000 |
51 |
Antimony-115 |
1000 |
51 |
Antimony-116 |
1000 |
51 |
Antimony-116m |
1000 |
51 |
Antimony-117 |
1000 |
51 |
Antimony-118m |
1000 |
51 |
Antimony-119 |
1000 |
51 |
Antimony-120
(5.76 d) |
100 |
51 |
Antimony-120
(16 min) |
1000 |
51 |
Antimony-122 |
100 |
51 |
Antimony-124 |
10 |
51 |
Antimony-124m |
1000 |
51 |
Antimony-125 |
100 |
51 |
Antimony-126 |
100 |
51 |
Antimony-126m |
1000 |
51 |
Antimony-127 |
100 |
51 |
Antimony-128
(10.4 min) |
1000 |
51 |
Antimony-128
(9.01 h) |
100 |
51 |
Antimony-129 |
100 |
51 |
Antimony-130 |
1000 |
51 |
Antimony-131 |
1000 |
52 |
Tellurium-116 |
1000 |
52 |
Tellurium-121 |
100 |
52 |
Tellurium-121m |
10 |
52 |
Tellurium-123 |
100 |
52 |
Tellurium-123m |
10 |
52 |
Tellurium-125m |
10 |
52 |
Tellurium-127 |
1000 |
52 |
Tellurium-127m |
10 |
52 |
Tellurium-129 |
1000 |
52 |
Tellurium-129m |
10 |
52 |
Tellurium-131 |
100 |
52 |
Tellurium-131m |
10 |
52 |
Tellurium-132 |
10 |
52 |
Tellurium-133 |
1000 |
52 |
Tellurium-133m |
100 |
52 |
Tellurium-134 |
1000 |
53 |
Iodine-120 |
100 |
53 |
Iodine-120m |
1000 |
53 |
Iodine-121 |
1000 |
53 |
Iodine-123 |
100 |
53 |
Iodine-124 |
10 |
53 |
Iodine-125 |
1 |
53 |
Iodine-126 |
1 |
53 |
Iodine-128 |
1000 |
53 |
Iodine-129 |
1 |
53 |
Iodine-130 |
10 |
53 |
Iodine-131 |
1 |
53 |
Iodine-132 |
100 |
53 |
Iodine-132m |
100 |
53 |
Iodine-133 |
10 |
53 |
Iodine-134 |
1000 |
53 |
Iodine-135 |
100 |
54 |
Xenon-120 |
1000 |
54 |
Xenon-121 |
1000 |
54 |
Xenon-122 |
1000 |
54 |
Xenon-123 |
1000 |
54 |
Xenon-125 |
1000 |
54 |
Xenon-127 |
1000 |
54 |
Xenon-129m |
1000 |
54 |
Xenon-131m |
1000 |
54 |
Xenon-133 |
1000 |
54 |
Xenon-133m |
1000 |
54 |
Xenon-135 |
1000 |
54 |
Xenon-135m |
1000 |
54 |
Xenon-138 |
1000 |
55 |
Cesium-125 |
1000 |
55 |
Cesium-127 |
1000 |
55 |
Cesium-129 |
1000 |
55 |
Cesium-130 |
1000 |
55 |
Cesium-131 |
1000 |
55 |
Cesium-132 |
100 |
55 |
Cesium-134 |
10 |
55 |
Cesium-134m |
1000 |
55 |
Cesium-135 |
100 |
55 |
Cesium-135m |
1000 |
55 |
Cesium-136 |
10 |
55 |
Cesium-137 |
10 |
55 |
Cesium-138 |
1000 |
56 |
Barium-126 |
1000 |
56 |
Barium-128 |
100 |
56 |
Barium-131 |
100 |
56 |
Barium-131m |
1000 |
56 |
Barium-133 |
100 |
56 |
Barium-133m |
100 |
56 |
Barium-135m |
100 |
56 |
Barium-139 |
1000 |
56 |
Barium-140 |
100 |
56 |
Barium-141 |
1000 |
56 |
Barium-142 |
1000 |
57 |
Lanthanum-131 |
1000 |
57 |
Lanthanum-132 |
100 |
57 |
Lanthanum-135 |
1000 |
57 |
Lanthanum-137 |
10 |
57 |
Lanthanum-138 |
100 |
57 |
Lanthanum-140 |
100 |
57 |
Lanthanum-141 |
100 |
57 |
Lanthanum-142 |
1000 |
57 |
Lanthanum-143 |
1000 |
58 |
Cerium-134 |
100 |
58 |
Cerium-135 |
100 |
58 |
Cerium-137 |
1000 |
58 |
Cerium-137m |
100 |
58 |
Cerium-139 |
100 |
58 |
Cerium-141 |
100 |
58 |
Cerium-143 |
100 |
58 |
Cerium-144 |
1 |
59 |
Praseodymium-136 |
1000 |
59 |
Praseodymium-137 |
1000 |
59 |
Praseodymium-138m |
1000 |
59 |
Praseodymium-139 |
1000 |
59 |
Praseodymium-142 |
100 |
59 |
Praseodymium-142m |
1000 |
59 |
Praseodymium-143 |
100 |
59 |
Praseodymium-144 |
1000 |
59 |
Praseodymium-145 |
100 |
59 |
Praseodymium-147 |
1000 |
60 |
Neodymium-136 |
1000 |
60 |
Neodymium-138 |
100 |
60 |
Neodymium-139 |
1000 |
60 |
Neodymium-139m |
1000 |
60 |
Neodymium-141 |
1000 |
60 |
Neodymium-147 |
100 |
60 |
Neodymium-149 |
1000 |
60 |
Neodymium-151 |
1000 |
61 |
Promethium-141 |
1000 |
61 |
Promethium-143 |
100 |
61 |
Promethium-144 |
10 |
61 |
Promethium-145 |
10 |
61 |
Promethium-146 |
1 |
61 |
Promethium-147 |
10 |
61 |
Promethium-148 |
10 |
61 |
Promethium-148m |
10 |
61 |
Promethium-149 |
100 |
61 |
Promethium-150 |
1000 |
61 |
Promethium-151 |
100 |
62 |
Samarium-141 |
1000 |
62 |
Samarium-141m |
1000 |
62 |
Samarium-142 |
1000 |
62 |
Samarium-145 |
100 |
62 |
Samarium-146 |
1 |
62 |
Samarium-147 |
100 |
62 |
Samarium-151 |
10 |
62 |
Samarium-153 |
100 |
62 |
Samarium-155 |
1000 |
62 |
Samarium-156 |
1000 |
63 |
Europium-145 |
100 |
63 |
Europium-146 |
100 |
63 |
Europium-147 |
100 |
63 |
Europium-148 |
10 |
63 |
Europium-149 |
100 |
63 |
Europium-150
(12.62 h) |
100 |
63 |
Europium-150
(34.2 y) |
1 |
63 |
Europium-152 |
1 |
63 |
Europium-152m |
100 |
63 |
Europium-154 |
1 |
63 |
Europium-155 |
10 |
63 |
Europium-156 |
100 |
63 |
Europium-157 |
100 |
63 |
Europium-158 |
1000 |
64 |
Gadolinium-145 |
1000 |
64 |
Gadolinium-146 |
10 |
64 |
Gadolinium-147 |
100 |
64 |
Gadolinium-148 |
0.001 |
64 |
Gadolinium-149 |
100 |
64 |
Gadolinium-151 |
10 |
64 |
Gadolinium-152 |
100 |
64 |
Gadolinium-153 |
10 |
64 |
Gadolinium-159 |
100 |
65 |
Terbium-147 |
1000 |
65 |
Terbium-149 |
100 |
65 |
Terbium-150 |
1000 |
65 |
Terbium-151 |
100 |
65 |
Terbium-153 |
1000 |
65 |
Terbium-154 |
100 |
65 |
Terbium-155 |
1000 |
65 |
Terbium-156 |
100 |
65 |
Terbium-156m
(24.4 h) |
1000 |
65 |
Terbium-156m
(5.0 h) |
1000 |
65 |
Terbium-157 |
10 |
65 |
Terbium-158 |
1 |
65 |
Terbium-160 |
10 |
65 |
Terbium-161 |
100 |
66 |
Dysprosium-155 |
1000 |
66 |
Dysprosium-157 |
1000 |
66 |
Dysprosium-159 |
100 |
66 |
Dysprosium-165 |
1000 |
66 |
Dysprosium-166 |
100 |
67 |
Holmium-155 |
1000 |
67 |
Holmium-157 |
1000 |
67 |
Holmium-159 |
1000 |
67 |
Holmium-161 |
1000 |
67 |
Holmium-162 |
1000 |
67 |
Holmium-162m |
1000 |
67 |
Holmium-164 |
1000 |
67 |
Holmium-164m |
1000 |
67 |
Holmium-166 |
100 |
67 |
Holmium-166m |
1 |
67 |
Holmium-167 |
1000 |
68 |
Erbium-161 |
1000 |
68 |
Erbium-165 |
1000 |
68 |
Erbium-169 |
100 |
68 |
Erbium-171 |
100 |
68 |
Erbium-172 |
100 |
69 |
Thulium-162 |
1000 |
69 |
Thulium-166 |
100 |
69 |
Thulium-167 |
100 |
69 |
Thulium-170 |
10 |
69 |
Thulium-171 |
10 |
69 |
Thulium-172 |
100 |
69 |
Thulium-173 |
100 |
69 |
Thulium-175 |
1000 |
70 |
Ytterbium
-175 |
100 |
70 |
Ytterbium-162 |
1000 |
70 |
Ytterbium-166 |
100 |
70 |
Ytterbium-167 |
1000 |
70 |
Ytterbium-169 |
100 |
70 |
Ytterbium-177 |
1000 |
70 |
Ytterbium-178 |
1000 |
71 |
Lutetium-169 |
100 |
71 |
Lutetium-170 |
100 |
71 |
Lutetium-171 |
100 |
71 |
Lutetium-172 |
100 |
71 |
Lutetium-173 |
10 |
71 |
Lutetium-174 |
10 |
71 |
Lutetium-174m |
10 |
71 |
Lutetium-176 |
100 |
71 |
Lutetium-176m |
1000 |
71 |
Lutetium-177 |
100 |
71 |
Lutetium-177m |
10 |
71 |
Lutetium-178 |
1000 |
71 |
Lutetium-178m |
1000 |
71 |
Lutetium-179 |
1000 |
72 |
Hafnium-
170 |
100 |
72 |
Hafnium-172 |
1 |
72 |
Hafnium-173 |
1000 |
72 |
Hafnium-175 |
100 |
72 |
Hafnium-177m |
1000 |
72 |
Hafnium-178m |
0.1 |
72 |
Hafnium-179m |
10 |
72 |
Hafnium-180m |
1000 |
72 |
Hafnium-181 |
10 |
72 |
Hafnium-182 |
0.1 |
72 |
Hafnium-182m |
1000 |
72 |
Hafnium-183 |
1000 |
72 |
Hafnium-184 |
100 |
73 |
Tantalum-172 |
1000 |
73 |
Tantalum-173 |
1000 |
73 |
Tantalum-174 |
1000 |
73 |
Tantalum-175 |
1000 |
73 |
Tantalum-176 |
100 |
73 |
Tantalum-177 |
1000 |
73 |
Tantalum-178 |
1000 |
73 |
Tantalum-179 |
100 |
73 |
Tantalum-180 |
100 |
73 |
Tantalum-180m |
1000 |
73 |
Tantalum-182 |
10 |
73 |
Tantalum-182m |
1000 |
73 |
Tantalum-183 |
100 |
73 |
Tantalum-184 |
100 |
73 |
Tantalum-185 |
1000 |
73 |
Tantalum-186 |
1000 |
74 |
Tungsten-176 |
1000 |
74 |
Tungsten-177 |
1000 |
74 |
Tungsten-178 |
1000 |
74 |
Tungsten-179 |
1000 |
74 |
Tungsten-181 |
1000 |
74 |
Tungsten-185 |
100 |
74 |
Tungsten-187 |
100 |
74 |
Tungsten-188 |
10 |
75 |
Rhenium-177 |
1000 |
75 |
Rhenium-178 |
1000 |
75 |
Rhenium-181 |
1000 |
75 |
Rhenium-182
(12.7 h) |
1000 |
75 |
Rhenium-182
(64.0 h) |
100 |
75 |
Rhenium-184 |
100 |
75 |
Rhenium-184m |
10 |
75 |
Rhenium-186 |
100 |
75 |
Rhenium-186m |
10 |
75 |
Rhenium-187 |
1000 |
75 |
Rhenium-188 |
100 |
75 |
Rhenium-188m |
1000 |
75 |
Rhenium-189 |
100 |
76 |
Osmium-180 |
1000 |
76 |
Osmium-181 |
1000 |
76 |
Osmium-182 |
100 |
76 |
Osmium-185 |
100 |
76 |
Osmium-189m |
1000 |
76 |
Osmium-191 |
100 |
76 |
Osmium-191m |
1000 |
76 |
Osmium-193 |
100 |
76 |
Osmium-194 |
1 |
77 |
Iridium-182 |
1000 |
77 |
Iridium-184 |
1000 |
77 |
Iridium-185 |
1000 |
77 |
Iridium-186 |
100 |
77 |
Iridium-187 |
1000 |
77 |
Iridium-188 |
100 |
77 |
Iridium-189 |
100 |
77 |
Iridium-190 |
100 |
77 |
Iridium-190m |
1000 |
77 |
Iridium-192 |
1 |
77 |
Iridium-192m
(1.4 m) |
100 |
77 |
Iridium-194 |
100 |
77 |
Iridium-194m |
10 |
77 |
Iridium-195 |
1000 |
77 |
Iridium-195m |
1000 |
78 |
Platinum-186 |
1000 |
78 |
Platinum-188 |
100 |
78 |
Platinum-189 |
1000 |
78 |
Platinum-191 |
100 |
78 |
Platinum-193 |
1000 |
78 |
Platinum-193m |
100 |
78 |
Platinum-195m |
100 |
78 |
Platinum-197 |
100 |
78 |
Platinum-197m |
1000 |
78 |
Platinum-199 |
1000 |
78 |
Platinum-200 |
100 |
79 |
Gold-193 |
1000 |
79 |
Gold-194 |
100 |
79 |
Gold-195 |
10 |
79 |
Gold-198 |
100 |
79 |
Gold-198m |
100 |
79 |
Gold-199 |
100 |
79 |
Gold-200 |
1000 |
79 |
Gold-200m |
100 |
79 |
Gold-201 |
1000 |
80 |
Mercury-193 |
1000 |
80 |
Mercury-193m |
100 |
80 |
Mercury-194 |
1 |
80 |
Mercury-195 |
1000 |
80 |
Mercury-195m |
100 |
80 |
Mercury-197 |
1000 |
80 |
Mercury-197m |
100 |
80 |
Mercury-199m |
1000 |
80 |
Mercury-203 |
100 |
81 |
Thallium-194 |
1000 |
81 |
Thallium-194m |
1000 |
81 |
Thallium-195 |
1000 |
81 |
Thallium-197 |
1000 |
81 |
Thallium-198 |
1000 |
81 |
Thallium-198m |
1000 |
81 |
Thallium-199 |
1000 |
81 |
Thallium-200 |
1000 |
81 |
Thallium-201 |
1000 |
81 |
Thallium-202 |
100 |
81 |
Thallium-204 |
100 |
82 |
Lead-195m |
1000 |
82 |
Lead-198 |
1000 |
82 |
Lead-199 |
1000 |
82 |
Lead-200 |
100 |
82 |
Lead-201 |
1000 |
82 |
Lead-202 |
10 |
82 |
Lead-202m |
1000 |
82 |
Lead-203 |
1000 |
82 |
Lead-205 |
100 |
82 |
Lead-209 |
1000 |
82 |
Lead-210 |
0.01 |
82 |
Lead-211 |
100 |
82 |
Lead-212 |
1 |
82 |
Lead-214 |
100 |
83 |
Bismuth-200 |
1000 |
83 |
Bismuth-201 |
1000 |
83 |
Bismuth-202 |
1000 |
83 |
Bismuth-203 |
100 |
83 |
Bismuth-205 |
100 |
83 |
Bismuth-206 |
100 |
83 |
Bismuth-207 |
10 |
83 |
Bismuth-210 |
1 |
83 |
Bismuth-210m |
0.1 |
83 |
Bismuth-212 |
10 |
83 |
Bismuth-213 |
10 |
83 |
Bismuth-214 |
100 |
84 |
Polonium-203 |
1000 |
84 |
Polonium-205 |
1000 |
84 |
Polonium-207 |
1000 |
84 |
Polonium-210 |
0.1 |
85 |
Astatine-207 |
100 |
85 |
Astatine-211 |
10 |
86 |
Radon-220 |
1 |
86 |
Radon-222 |
1 |
87 |
Francium-222 |
100 |
87 |
Francium-223 |
100 |
88 |
Radium-223 |
0.1 |
88 |
Radium-224 |
0.1 |
88 |
Radium-225 |
0.1 |
88 |
Radium-226 |
0.1 |
88 |
Radium-227 |
1000 |
88 |
Radium-228 |
0.1 |
89 |
Actinium-224 |
1 |
89 |
Actinium-225 |
0.01 |
89 |
Actinium-226 |
0.1 |
89 |
Actinium-227 |
0.001 |
89 |
Actinium-228 |
1 |
90 |
Thorium-226 |
10 |
90 |
Thorium-227 |
0.01 |
90 |
Thorium-228 |
0.001 |
90 |
Thorium-229 |
0.001 |
90 |
Thorium-230 |
0.001 |
90 |
Thorium-231 |
100 |
90 |
Thorium-232 |
100 |
90 |
Thorium-234 |
10 |
90 |
Thorium-natural |
100 |
91 |
Protactinium-227 |
10 |
91 |
Protactinium-228 |
1 |
91 |
Protactinium-230 |
0.01 |
91 |
Protactinium-231 |
0.001 |
91 |
Protactinium-232 |
1 |
91 |
Protactinium-233 |
100 |
91 |
Protactinium-234 |
100 |
92 |
Uranium-230 |
0.01 |
92 |
Uranium-231 |
100 |
92 |
Uranium-232 |
0.001 |
92 |
Uranium-233 |
0.001 |
92 |
Uranium-234 |
0.001 |
92 |
Uranium-235 |
0.001 |
92 |
Uranium-236 |
0.001 |
92 |
Uranium-237 |
100 |
92 |
Uranium-238 |
100 |
92 |
Uranium-239 |
1000 |
92 |
Uranium-240 |
100 |
92 |
Uranium-natural |
100 |
93 |
Neptunium
236 (22.5 h) |
1 |
93 |
Neptunium-232 |
100 |
93 |
Neptunium-233 |
1000 |
93 |
Neptunium-234 |
100 |
93 |
Neptunium-235 |
100 |
93 |
Neptunium-236
(1.15E+5 y) |
0.001 |
93 |
Neptunium-237 |
0.001 |
93 |
Neptunium-238 |
10 |
93 |
Neptunium-239 |
100 |
93 |
Neptunium-240 |
1000 |
94 |
Plutonium-234 |
10 |
94 |
Plutonium-235 |
1000 |
94 |
Plutonium-236 |
0.001 |
94 |
Plutonium-237 |
100 |
94 |
Plutonium-238 |
0.001 |
94 |
Plutonium-239 |
0.001 |
94 |
Plutonium-240 |
0.001 |
94 |
Plutonium-241 |
0.01 |
94 |
Plutonium-242 |
0.001 |
94 |
Plutonium-243 |
1000 |
94 |
Plutonium-244 |
0.001 |
94 |
Plutonium-245 |
100 |
95 |
Americium-237 |
1000 |
95 |
Americium-238 |
100 |
95 |
Americium-239 |
1000 |
95 |
Americium-240 |
100 |
95 |
Americium-241 |
0.001 |
95 |
Americium-242 |
10 |
95 |
Americium-242m |
0.001 |
95 |
Americium-243 |
0.001 |
95 |
Americium-244 |
10 |
95 |
Americium-244m |
100 |
95 |
Americium-245 |
1000 |
95 |
Americium-246 |
1000 |
95 |
Americium-246m |
1000 |
96 |
Curium-238 |
100 |
96 |
Curium-240 |
0.1 |
96 |
Curium-241 |
1 |
96 |
Curium-242 |
0.01 |
96 |
Curium-243 |
0.001 |
96 |
Curium-244 |
0.001 |
96 |
Curium-245 |
0.001 |
96 |
Curium-246 |
0.001 |
96 |
Curium-247 |
0.001 |
96 |
Curium-248 |
0.001 |
96 |
Curium-249 |
1000 |
97 |
Berkelium-245 |
100 |
97 |
Berkelium-246 |
100 |
97 |
Berkelium-247 |
0.001 |
97 |
Berkelium-249 |
0.1 |
97 |
Berkelium-250 |
10 |
98 |
Californium-244 |
100 |
98 |
Californium-246 |
1 |
98 |
Californium-248 |
0.01 |
98 |
Californium-249 |
0.001 |
98 |
Californium-250 |
0.001 |
98 |
Californium-251 |
0.001 |
98 |
Californium-252 |
0.001 |
98 |
Californium-253 |
0.1 |
98 |
Californium-254 |
0.001 |
99 |
Einsteinium-250 |
100 |
99 |
Einsteinium-251 |
100 |
99 |
Einsteinium-253 |
0.1 |
99 |
Einsteinium-254 |
0.01 |
99 |
Einsteinium-254m |
1 |
100 |
Fermium-252 |
1 |
100 |
Fermium-253 |
1 |
100 |
Fermium-254 |
10 |
100 |
Fermium-255 |
1 |
100 |
Fermium-257 |
0.01 |
101 |
Mendelevium-257 |
10 |
101 |
Mendelevium-258 |
0.01 |
|
Any alpha-emitting radionuclide not listed above or mixtures of alpha emitters of unknown composition |
0.001 |
|
Any radionuclide other than alpha emitting radionuclides not listed above, or mixtures of beta emitters of unknown composition |
0.01 |
1
For purposes of He-P 4022.11(e), He-P 4022.14(a), and He-P 4021.12(b), where
there is involved a combination of radionuclides in known amounts, the limit
for the combination shall be derived by determining for each radionuclide in
the combination, the ratio between the quantity present in the combination and
the limit otherwise established for the specific radionuclide when not in
combination. The sum of such ratios for
all radionuclides in the combination may not exceed "one".
2
The quantities listed above were derived by taking 1/10th of the most
restrictive ALI listed in He-P 4090, Table 4090.1, Table I, Columns 1 and 2, of He-P 4090, rounding to the nearest factor of 10, and
constraining the values listed between 37 Bq and 37
MBq (0.001 and 1000 µCi). Values of 3.7
MBq (100 µCi) have been assigned for radionuclides having a radioactive
half-life in excess of E+9 years, except rhenium, 37
MBq (1000 µCi), to take into account their low specific activity.
3
To convert mCi to kBq,
multiply the mCi value
by 37.
Source.
#7961, eff 9-20-03; ss by #9981, eff 9-20-11; ss by #12875, INTERIM, eff
9-25-19, EXPIRED: 3-23-20
New. #13062, eff 6-25-20
PART
He-P 4093 EXEMPT CONCENTRATIONS
Revision Note:
Doc. #6942, effective 2-1-99, repealed
Parts He-P 2030, 2031, 2032, 2033, 2034, 2035, 2042 and 2093 relative to
Radiation and Radioactive Material and adopted new rules to replace them and
renumbered them as He-P 4030, 4031, 4032, 4033, 4034, 4035, 4093 and 4096.
PART He-P 4093 EXEMPT
CONCENTRATIONS
He-P 4093.01 Exempt
Concentrations. This part
establishes limits of radioactive isotopes in gas, liquid, and solid concentrations
which shall be exempt from He-P 4000 as specified in Table 4093.1 below:
Table 4093.1 Exempt
Concentrations
Element (Atomic Number) |
Radionuclide |
Column 1 Gas Concentration mCi/ml1 |
Column 2 Liquid and Solid Concentration mCi/ml2 |
Antimony (51) |
Sb-122 Sb-124 Sb-125 |
|
3´10-4 2´10-4 1´10-3 |
Argon (18) |
Ar-37 Ar-41 |
1´10-3 4´10-7 |
|
Arsenic (33) |
As-73 As-74 As-76 As-77 |
|
5´10-3 5´10-4 2´10-4 8´10-4 |
Barium (56) |
Ba-131 Ba-140 |
|
2´10-3 3´10-4 |
Beryllium (4) |
Be-7 |
|
2´10-2 |
Bismuth (83) |
Bi-206 |
|
4´10-4 |
Bromine (35) |
Br-82 |
4´10-7 |
3´10-3 |
Cadmium (48) |
Cd-109 Cd-115m Cd-115 |
|
2´10-3 3´10-4 3´10-4 |
Calcium (20) |
Ca-45 Ca-47 |
|
9´10-5 5´10-4 |
Carbon (6) |
C-14 |
1´10-6 |
8´10-3 |
Cerium (58) |
Ce-141 Ce-143 Ce-144 |
|
9´10-4 4´10-4 1´10-4 |
Cesium (55) |
Cs-131 Cs-134m Cs-134 |
|
2´10-2 6´10-2 9´10-5 |
Chlorine (17) |
Cl-38 |
9´10-7 |
4´10-3 |
Chromium (24) |
Cr-51 |
|
2´10-2 |
Cobalt (27) |
Co-57 Co-58 Co-60 |
|
5´10-3 1´10-3 5´10-4 |
Copper (29) |
Cu-64 |
|
3´10-3 |
Dysprosium (66) |
Dy-165 Dy-166 |
|
4´10-3 4´10-4 |
Erbium (68) |
Er-169 Er-171 |
|
9´10-4 1´10-3 |
Europium (63) |
Eu-152 (9.2 h) Eu-155 |
|
6´10-4 2´10-3 |
Fluorine (9) |
F-18 |
2´10-6 |
8´10-3 |
Gadolinium (64) |
Gd-153 Gd-159 |
|
2´10-3 8´10-4 |
Gallium (31) |
Ga-72 |
|
4´10-4 |
Germanium (32) |
Ge-71 |
|
2´10-2 |
Gold (79) |
Au-196 Au-198 Au-199 |
|
2´10-3 5´10-4 2´10-3 |
Hafnium (72) |
Hf-181 |
|
7´10-4 |
Hydrogen (1) |
H-3 |
5´10-6 |
3´10-2 |
Indium (49) |
In-113m In-114m |
|
1´10-2 2´10-4 |
Iodine (53) |
I-126 I-131 I-132 I-133 I-134 |
3´10-9 3´10-9 8´10-8 1´10-8 2´10-7 |
2´10-5 2´10-5 6´10-4 7´10-5 1´10-3 |
Iridium (77) |
Ir-190 Ir-192 Ir-194 |
|
2´10-3 4´10-4 3´10-4 |
Iron (26) |
Fe-55 Fe-59 |
|
8´10-3 6´10-4 |
Krypton (36) |
Kr-85m Kr-85 |
1´10-6 3´10-6 |
|
Lanthanum (57) |
La-140 |
|
2´10-4 |
Lead (82) |
Pb-203 |
|
4´10-3 |
Lutetium (71) |
Lu-177 |
|
1´10-3 |
Manganese (25) |
Mn-52 Mn-54 Mn-56 |
|
3´10-4 1´10-3 1´10-3 |
Mercury (80) |
Hg-197m Hg-197 Hg-203 |
|
2´10-3 3´10-3 2´10-4 |
Molybdenum (42) |
Mo-99 |
|
2´10-3 |
Neodymium (60) |
Nd-147 Nd-149 |
|
6´10-4 3´10-3 |
Nickel (28) |
Ni-65 |
|
1´10-3 |
Niobium (Columbium) (41) |
Nb-95 Nb-97 |
|
1´10-3 9´10-3 |
Osmium (76) |
Os-185 Os-191m Os-191 Os-193 |
|
7´10-4 3´10-2 2´10-3 6´10-4 |
Palladium (46) |
Pd-103 Pd-109 |
|
3´10-3 9´10-4 |
Phosphorus (15) |
P-32 |
|
2´10-4 |
Platinum (78) |
Pt-191 Pt-193m Pt-197m Pt-197 |
|
1´10-3 1´10-2 1´10-2 1´10-3 |
Potassium (19) |
K-42 |
|
3´10-3 |
Praseodymium (59) |
Pr-142 Pr-143 |
|
3´10-4 5´10-4 |
Promethium (61) |
Pm-147 Pm-149 |
|
2´10-3 4´10-4 |
Rhenium (75) |
Re-183 Re-186 Re-188 |
|
6´10-3 9´10-4 6´10-4 |
Rhodium (45) |
Rh-103m Rh-105 |
|
1´10-1 1´10-3 |
Rubidium (37) |
Rb-86 |
|
7´10-4 |
Ruthenium (44) |
Ru-97 Ru-103 Ru-105 Ru-106 |
|
4´10-4 8´10-4 1´10-3 1´10-4 |
Samarium (62) |
Sm-153 |
|
8´10-4 |
Scandium (21) |
Sc-46 Sc-47 Sc-48 |
|
4´10-4 9´10-4 3´10-4 |
Selenium (34) |
Se-75 |
|
3´10-3 |
Silicon (14) |
Si-31 |
|
9´10-3 |
Silver (47) |
Ag-105 Ag-110m Ag-111 |
|
1´10-3 3´10-4 4´10-4 |
Sodium (11) |
Na-24 |
|
2´10-3 |
Strontium (38) |
Sr-85 Sr-89 Sr-91 Sr-92 |
|
1´10-4 1´10-4 7´10-4 7´10-4 |
Sulfur (16) |
S-35 |
9´10-8 |
6´10-4 |
Tantalum (73) |
Ta-182 |
|
4´10-4 |
Technetium (43) |
Tc-96m Tc-96 |
|
1´10-1 1´10-3 |
Tellurium (52) |
Te-125m Te-127m Te-127 Te-129m Te-131m Te-132 |
|
2´10-3 6´10-4 3´10-3 3´10-4 6´10-4 3´10-4 |
Terbium(65) |
Tb-160 |
|
4x10-4 |
Thallium (81) |
Tl-200 Tl-201 Tl-202 Tl-204 |
|
4´10-3 3´10-3 1´10-3 1´10-3 |
Thulium (69) |
Tm-170 Tm-171 |
|
5´10-4 5´10-3 |
Tin (50) |
Sn-113 Sn-125 |
|
9´10-4 2´10-4 |
Tungsten (Wolfram) (74) |
W-181 W-187 |
|
4´10-3 7´10-4 |
Vanadium (23) |
V-48 |
|
3´10-4 |
Xenon (54) |
Xe-131m Xe-133 Xe-135 |
4´10-6 3´10-6 1´10-6 |
|
Ytterbium (70) |
Yb-175 |
|
1´10-3 |
Yttrium (39) |
Y-90 Y-91m Y-91 Y-92 Y-93 |
|
2´10-4 3´10-2 3´10-4 6´10-4 3´10-4 |
Zinc (30) |
Zn-65 Zn-69m Zn-69 |
|
1´10-3 7´10-4 2´10-2 |
Zirconium (40) |
Zr-95 Zr-97 |
|
6´10-4 2´10-4 |
Beta- and/or gamma-emitting byproduct material not listed above with half-life of less than 3
years. |
1´10-10 |
1´10-6 |
Note 1: Many radionuclides
transform into other radionuclides. In expressing the concentrations in He‑P
4093 Table 4093.1, the activity stated is that of the parent radionuclide and takes into account the radioactive decay products.
Note 2: Where
there is involved a combination of radionuclides, the limit for the combination
should be derived as follows: Determine for each radionuclide in the
product the ratio between the radioactivity concentration present in the
product and the exempt radioactivity concentration established in He‑P
4093 Table 4093.1 for the specific radionuclide when not in combination. The sum of such ratios may not exceed “1”.
Example:
Note 3: To
convert mCi/ml to SI units of megabecquerels
per liter, multiply the above values by 37.
Example: Zirconium (40) Zr-97
Source. (See Revision Note at part heading for He-P
4093) #6942, eff 2-1-99;
ss by #8800, eff 2-1-07, EXPIRED:
7-31-07
New. #8959, eff 8-7-07; ss by #10938, eff 9-22-15
PART He-P
4094 Reserved
PART
He-P 4095 ASSIGNED PROTECTION FACTORS
FOR RESPIRATORS
Statutory
Authority RSA 125-F:5,V
He-P 4095.01 Assigned Protection Factors for
Respirators. Assigned protection factors
for respirators for use by licensees shall be in accordance with Table 4095.1
below:
Table
4095.1 Assigned Protection Factors (APF)
for Respirators
|
Operating Mode |
Assigned Protection Factors |
|
|
I. Air purifying respirators (Particulate only) Filtering faceplate disposableu ---------------- |
|
|
|
|
II. Atmosphere supplying respirators (Particulate, gases, and vaporsw) 1: Air-line respirator: 2: Self-contained breathing apparatus
(SCBA): |
|
|
|
|
III. Combination respirators: Any combination of air-purifying
and atmosphere-supplying respirators |
|
|
|
|
Source. #8393, eff 7-23-05; ss by
#10492, eff 12-24-13
He-P 4095.02 Additional Requirements for Protection
Factors for Respirators. The
licensee shall use the following to determine compliance with He-P 4095.01:
(a) The assigned protection factors specified in
Table 4095.1 shall apply:
(1) Only in a respiratory protection program that
meets the requirements of He-P 4022 and He-P 4095; and
(2) Only to airborne radiological hazards, and
may not be appropriate to circumstances when chemical or other respiratory
hazards exist instead of, or in addition to, radioactive hazards.
(b) Selection and use of respirators for
circumstances described in He-P 4095.02(a)(2) shall also comply with United
States Department of Labor regulations.
(c) For radioactive
contaminants for which the concentration values in Table 1, column 3 of He-P
4090 are based on internal dose due to inhalation and may, in addition, present
external exposure hazards at higher concentrations, the licensee shall consider
whether limitations on occupancy be governed by external dose limits.
(d) Air purifying respirators with APF <100
shall be equipped with particulate filters that are at least 95 percent
efficient.
(e) Air purifying respirators with APF = 100
shall be equipped with particulate filters that are at least 99 percent
efficient.
(f) Air purifying respirators with APF >100
shall be equipped with particulate filters that are at least 99.97 percent
efficient.
(g) In addition to the use of air purifying
respirators for protection against radioactive particulates, the licensee may
apply to the DHHS/RHS for the use of an APF greater than one for sorbent
cartridges in an air purifying respirator as protection against airborne
radioactive gases and vapors, for example, radioiodine.
(h) Items in Table 4095.1 marked with superscript
u shall be an appropriate protection factor which shall be determined for use
by individuals who may or may have not been medically screened or fit tested on
the device provided that:
(1) No credit shall be taken for their use in estimating
intake or dose; and
(2) All other respiratory protection program
requirements specified in He‑P 4022.08 apply.
(i) Notwithstanding the requirement of (h) above,
insofar as an assigned protection factor has not been assigned for filtering
faceplate disposable air purifying respirators, an APF equal to 10 may be used
only if the licensee can demonstrate a fit factor of at least 100 by use of a
validated or evaluated, qualitative or quantitative fit test.
(j) The items in Table 4095.1 marked with the
superscript v shall be for under-chin type only, with no distinction made in
this part between elastomeric half-masks with replaceable cartridges and those
designed with the filter medium as an integral part of the facepiece (e.g., disposable or reusable disposable). Both types shall be
acceptable so long as:
(1) The seal area of a half-mask designed with
the filter medium as an integral part of the facepiece contains some substantial
type of seal enhancing material such as rubber or plastic;
(2) The 2 or more suspension straps are
adjustable;
(3) The filter medium is at least 95 percent
efficient; and
(4) All other requirements of He-P 4022.08 and
He-P 4095 are met.
(k) Items in Table 4095.1 marked with superscript
w shall indicate that the assigned protection factors
for gases and vapors shall not be applicable to radioactive contaminants that
present an absorption or submersion hazard.
(l) A protection factor of 3 shall be assigned
when atmosphere-supplying respirators are used to protect against tritium
oxide.
(m) Protective actions for radioactive noble
gases shall be based on external (submersion) dose considerations.
(n) Items in Table 4095.1 marked with superscript
x shall be an appropriate protection factor which may be used in an acceptable
respiratory protection program, only if all the other minimum respiratory
program requirements contained in He-P 4022 and He-P
4095, with the exception of fit testing, are met.
(o) For use of the items in Table 4095.1 marked
with superscript y, the licensee shall be implement
institutional controls to assure that these devices are not used in areas
immediately dangerous to life or health.
(p) Items in Table 4095.1 marked with superscript
z shall be the type of respirator which may be used as an emergency device in
unknown concentrations for protection against inhalation hazards. External radiation hazards and other
limitations to permitted exposure, such as skin absorption, shall be taken into account in such circumstances.
(q) The device specified in (p) above shall not
be used by any individual who experiences perceptible outward leakage of
breathing gas while wearing the device.
Source. #8393, eff 7-23-05; ss by
#10492, eff 12-24-13
PART He-P 4096
EXEMPT QUANTITIES
He-P 4096.01
Exempt Quantities. The exempt
quantities authorized in this chapter shall be as stated in Table 4096.1 below:
Table 4096.1
Exempt Quantities
Byproduct Material |
Microcuries |
Antimony-122 (Sb-122) |
100 |
Antimony-124 (Sb-124) |
10 |
Antimony-125 (Sb-125) |
10 |
Arsenic-73 (As-73) |
100 |
Arsenic-74 (As-74) |
10 |
Arsenic-76 (As-76) |
10 |
Arsenic-77 (As-77) |
100 |
Barium-131 (Ba-131) |
10 |
Barium-133 (Ba-133) |
10 |
Barium-140 (Ba-140) |
10 |
Bismuth-210 (Bi-210) |
1 |
Bromine-82 (Br-82) |
10 |
Cadmium-109 (Cd-109) |
10 |
Cadmium-115m (Cd-115m) |
10 |
Cadmium-115 (Cd-115) |
100 |
Calcium-45 (Ca-45) |
10 |
Calcium-47 (Ca-47) |
10 |
Carbon-14 (C-14) |
100 |
Cerium-141 (Ce-141) |
100 |
Cerium-143 (Ce-143) |
100 |
Cerium-144 (Ce-144) |
1 |
Cesium-129 (Cs-129) |
100 |
Cesium-131 (Cs-131) |
1,000 |
Cesium-134m (Cs-134m) |
100 |
Cesium-134 (Cs-134) |
1 |
Cesium-135 (Cs-135) |
10 |
Cesium-136 (Cs-136) |
10 |
Cesium-137 (Cs-137) |
10 |
Chlorine-36 (Cl-36) |
10 |
Chlorine-38 (Cl-38) |
10 |
Chromium-51 (Cr-51) |
1,000 |
Cobalt-57 (Co-57) |
100 |
Cobalt-58m (Co-58m) |
10 |
Cobalt-58 (Co-58) |
10 |
Cobalt-60 (Co-60) |
1 |
Copper-64 (Cu-64) |
100 |
Dysprosium-165-(Dy 165) |
10 |
Dysprosium-166-(Dy 166) |
100 |
Erbium-169 (Er-169) |
100 |
Erbium-171 (Er-171) |
100 |
Europium-152 (Eu-152)9.2h |
100 |
Europium-152 (Eu-152)13 yr |
1 |
Europium-154 (Eu-154) |
1 |
Europium-155 (Eu-155) |
10 |
Fluorine-18 (F-18) |
1,000 |
Gadolinium-153 (Gd-153) |
10 |
Gadolinium-159 (Gd-159) |
100 |
Gallium-67 (Ga-67) |
100 |
Gallium-72 (Ga-72) |
10 |
Germanium-68 (Ge-68) |
10 |
Germanium-71 (Ge-71) |
100 |
Gold-195 (Au-195) |
10 |
Gold-198 (Au-198) |
100 |
Gold-199 (Au-199) |
100 |
Hafnium-181 (Hf-181) |
10 |
Holmium-166 (Ho-166) |
100 |
Hydrogen-3 (H-3) |
1,000 |
Indium-111 (In-111) |
100 |
Indium-113m (In-113m) |
100 |
Indium-114m (In-114m) |
10 |
Indium-115m (In-115m) |
100 |
Indium-115 (In-115) |
10 |
Iodine-123 (I-123) |
100 |
Iodine-125 (I-125) |
1 |
Iodine-126 (I-126) |
1 |
Iodine-129 (I-129) |
0.1 |
Iodine-131 (I-131) |
1 |
Iodine-132 (I-132) |
10 |
Iodine-133 (I-133) |
1 |
Iodine-134 (I-134) |
10 |
Iodine-135 (I-135) |
10 |
Iridium-192 (Ir-192) |
10 |
Iridium-194 (Ir-194) |
100 |
Iron-52 (Fe-52) |
10 |
Iron-55 (Fe-55) |
100 |
Iron-59 (Fe-59) |
10 |
Krypton-85 (Kr-85) |
100 |
Krypton-87 (Kr-87) |
10 |
Lanthanum-140 (La-140) |
10 |
Lutetium-177 (Lu-177) |
100 |
Manganese-52 (Mn-52) |
10 |
Manganese-54 (Mn-54) |
10 |
Manganese-56 (Mn-56) |
10 |
Mercury-197m (Hg-197m) |
100 |
Mercury-197 (Hg-197) |
100 |
Mercury-203 (Hg-203) |
10 |
Molybdenum-99 (Mo-99) |
100 |
Neodymium-147 (Nd-147) |
100 |
Neodymium-149 (Nd-149) |
100 |
Nickel-59 (Ni-59) |
100 |
Nickel-63 (Ni-63) |
10 |
Nickel-65 (Ni-65) |
100 |
Niobium-93m (Nb-93m) |
10 |
Niobium-95 (Nb-95) |
10 |
Niobium-97 (Nb-97) |
10 |
Osmium-185 (Os-185) |
10 |
Osmium-191m (Os-191m) |
100 |
Osmium-191 (Os-191) |
100 |
Osmium-193 (Os-193) |
100 |
Palladium-103 (Pd-103) |
100 |
Palladium-109 (Pd-109) |
100 |
Phosphorus-32 (P-32) |
10 |
Platinum-191 (Pt-191) |
100 |
Platinum-193m (Pt-193m) |
100 |
Platinum-193 (Pt-193) |
100 |
Platinum-197m (Pt-197m) |
100 |
Platinum-197 (Pt-197) |
100 |
Polonium-210 (Po-210) |
0.1 |
Potassium-42 (K-42) |
10 |
Potassium-43 (K-43) |
10 |
Praseodymium-142 (Pr-142) |
100 |
Praseodymium-143 (Pr-143) |
100 |
Promethium-147 (Pm-147) |
10 |
Promethium-149 (Pm-149) |
10 |
Rhenium-186 (Re-186) |
100 |
Rhenium-188 (Re-188) |
100 |
Rhodium-103m (Rh-103m) |
100 |
Rhodium-105 (Rh-105) |
100 |
Rubidium-81 (Rb-81) |
10 |
Rubidium-86 (Rb-86) |
10 |
Rubidium-87 (Rb-87) |
10 |
Ruthenium-97 (Ru-97) |
100 |
Ruthenium-103 (Ru-103) |
10 |
Ruthenium-105 (Ru-105) |
10 |
Ruthenium-106 (Ru-106) |
1 |
Samarium-151 (Sm-151) |
10 |
Samarium-153 (Sm-153) |
100 |
Scandium-46 (Sc-46) |
10 |
Scandium-47 (Sc-47) |
100 |
Scandium-48 (Sc-48) |
10 |
Selenium-75 (Se-75) |
10 |
Silicon-31 (Si-31) |
100 |
Silver-105 (Ag-105) |
10 |
Silver-110m (Ag-110m) |
1 |
Silver-111 (Ag-111) |
100 |
Sodium-22 (Na-22) |
10 |
Sodium-24 (Na-24) |
10 |
Strontium-85 (Sr-85) |
10 |
Strontium-89 (Sr-89) |
1 |
Strontium-90 (Sr-90) |
0.1 |
Strontium-91 (Sr-91) |
10 |
Strontium-92 (Sr-92) |
10 |
Sulphur-35 (S-35) |
100 |
Tantalum-182 (Ta-182) |
10 |
Technetium-96 (Tc-96) |
10 |
Technetium-97m (Tc-97m) |
100 |
Technetium-97 (Tc-97) |
100 |
Technetium-99m (Tc-99m) |
100 |
Technetium-99 (Tc-99) |
10 |
Tellurium-125m (Te-125m) |
10 |
Tellurium-127m (Te-127m) |
10 |
Tellurium-127 (Te-127) |
100 |
Tellurium-129m (Te-129m) |
10 |
Tellurium-129 (Te-129) |
100 |
Tellurium-131m (Te-131m) |
10 |
Tellurium-132 (Te-132) |
10 |
Terbium-160 (Tb-160) |
10 |
Thallium-200 (Tl-200) |
100 |
Thallium-201 (Tl-201) |
100 |
Thallium-202 (Tl-202) |
100 |
Thallium-204 (Tl-204) |
10 |
Thulium-170 (Tm-170) |
10 |
Thulium-171 (Tm-171) |
10 |
Tin-113 (Sn-113) |
10 |
Tin-125 (Sn-125) |
10 |
Tungsten-181 (W-181) |
10 |
Tungsten-185 (W-185) |
10 |
Tungsten-187 (W-187) |
100 |
Vanadium-48 (V-48) |
10 |
Xenon-131m (Xe-131m) |
1,000 |
Xenon-133 (Xe-133) |
100 |
Xenon-135 (Xe-135) |
100 |
Ytterbium-175 (Yb-175) |
100 |
Yttrium-87 (Y-87) |
10 |
Yttrium-88 (Y-88) |
10 |
Yttrium-90 (Y-90) |
10 |
Yttrium-91 (Y-91) |
10 |
Yttrium-92 (Y-92) |
100 |
Yttrium-93 (Y-93) |
100 |
Zinc-65 (Zn-65) |
10 |
Zinc-69m (Zn-69m) |
100 |
Zinc-69 (Zn-69) |
1,000 |
Zirconium-93 (Zr-93) |
10 |
Zirconium-95 (Zr-95) |
10 |
Zirconium-97 (Zr-97) |
10 |
Any byproduct material not listed above other than alpha-emitting byproduct material |
0.1 |
Source. #6942, eff
2-1-99;
ss by #8800, INTERIM, eff
2-1-07, EXPIRED: 7-31-07
New. #8959, eff 8-7-07; ss by #10938, eff 9-22-15
He-P 4096.02 Derivation of Combination Limits.
(a) Where there is involved a combination of radionuclides,
the limit for the combination shall be derived as follows:
(1) Determine the amount of each radionuclide
possessed and 1,000 times the amount in Table 4096.1 for each of those
radionuclides when not in combination; and
(2) The sum of the ratios of those quantities
determined in He-P 4096.02(a) shall not exceed 1.
Example:
(b) To convert microcuries (mCi) to SI units of
kilobecquerels (kBq), multiply the values determined
in He-P 4096.02 by 37 kBq/mCi.
Example: Zirconium-97
10 mCi ×( 37 kBq/mCi) = 370 kBq
Source. #6942, eff
2-1-99;
ss by #8800, INTERIM, eff
2-1-07, EXPIRED: 7-31-07
New. #8959, eff 8-7-07; ss by #10938, eff 9-22-15
PART He-P
4097 NATIONALLY TRACKED SOURCE
THRESHOLDS
He-P 4097.01 Nationally Tracked Source Thresholds. The threshold quantities tracked in this
chapter shall be as stated in Table 4097.1 below.
Radioactive
Material |
Category 1 (TBq) |
Category 1 (Ci) |
Category 2 (TBq) |
Category 2 (Ci) |
Actinium-227 |
20 |
540 |
0.2 |
5.4 |
Americium-241 |
60 |
1,600 |
0.6 |
16 |
Americium-241
/Be |
60 |
1,600 |
0.6 |
16 |
Californium-252 |
20 |
540 |
0.2 |
5.4 |
Cobalt-60 |
30 |
810 |
0.3 |
8.1 |
Curium-244 |
50 |
1,400 |
0.5 |
14 |
Cesium-137 |
100 |
2,700 |
1 |
27 |
Gadolinium-153 |
1,000 |
27,000 |
10 |
270 |
Iridium-192 |
80 |
2,200 |
0.8 |
22 |
Plutonium-238 |
60 |
1,600 |
0.6 |
16 |
Plutonium-239
/Be |
60 |
1,600 |
0.6 |
16 |
Polonium-210 |
60 |
1,600 |
0.6 |
16 |
Promethium-147 |
40,000 |
1,100,000 |
400 |
11,000 |
Radium-226 |
40 |
1,100 |
0.4 |
11 |
Selenium-75 |
200 |
5,400 |
2 |
54 |
Strontium-90 |
1,000 |
27,000 |
10 |
270 |
Thorium-228 |
20 |
540 |
0.2 |
5.4 |
Thorium-229 |
20 |
540 |
0.2 |
5.4 |
Thulium-170 |
20,000 |
540,000 |
200 |
5,400 |
Ytterbium-169 |
300 |
8100 |
3 |
81 |
Source. #10604, eff 5-23-14
He-P 4097.02 Conversion Between Units. The terabecquerel (TBq)
values in Table 4097.1 shall be the regulatory standards. The curie (Ci) values specified are obtained
by converting from the TBq value. The curie values are provided for practical
usefulness only and are rounded after conversion.
Source. #10604, eff 5-23-14
Appendix A
Incorporation by Reference Information
Rule |
Title |
Publisher; How to Obtain; and Cost |
He-P
4034.06(a) |
American
National Standard Institute, N432; “Radiological Safety for the Design and
Construction of Apparatus for Gamma Radiography,” published as NBS Handbook
136, issued January 1981. |
This
publication can be purchased at: American
National Standards Institute, Inc. 25
West 43rd Street New
York, New York 10036 Telephone:
(212) 642-4900 Copies
of the document are available for inspection at the Nuclear Regulatory
Commission Library 11545
Rockville Pike Rockville,
Maryland 20852 A
copy of this document is also on file at the National Archived and Records
Administration (NARA). For information on the availability of this material
at NARA, call (202) 741-6030 or go to: https://www.archives.gov/federal-register/cfr/ibr-locations.html |
He-P 4047.06(q)(3) |
“Dosimetry of X-Ray and Gamma –Ray Beams for
Radiation Therapy in |
National Council on Radiation Protection
(NCRP), 7910 Woodmount
Ave., Suite 400, Bethesda, MD 20814-3095, NCRPpubs@NCRonline.org Cost: $374. |
He-P 4047.06(q)(3) |
“High Dose-Rate Brachytherapy Treatment Delivery”
(1998) |
American Association of Physicists in Medicine
(AAPM) Radiation Task Group 59, One Physics Ellipse, |
He-P 4047.06(q)(3) |
“AAPM Protocol for 40-300 kV X-ray Beam Dosimetry in
Radiotherapy and Radiobiology” (2001) |
American Association of Physicists in Medicine
(AAPM) Radiation Task Group 61, One Physics Ellipse, |
He-P 4047.07(e) & (o)(5) |
International Electrotechnical Commission (IEC)
Document 60601-2-1 |
International Electrotechnical Commission (IEC),
Regional Center for North America, 446 Main Street, 16th Floor,
Worcester, MA 01068, www.601.help.com/other_601_standard.html. Cost: $185.00 (pdf) and $213.00 (hardcopy). |
He-P 4047.07(u)(2) & (5) |
“AAPM Code of Practice for Radiotherapy
Accelerators.” (1994) |
American Association of Physicists in Medicine
(AAPM) Radiation Task Group 45, One Physics Ellipse, |
He-P 4047.07 (u) (4)&(u)(6) (v)(1) & (v)(2)
&(v)(7) & He-P 4047.10(c) |
“Comprehensive QA for Radiation Oncology” (1994) (As
Updated by Table II.) |
American Association of Physicists in Medicine
(AAPM) Radiation Task Group 40, One Physics Ellipse, |
He-P 4047.07(w)(2) |
“Guidance Document on Delivery, Treatment Planning
and Clinical Implementation of IMRT: Report of the IMRT Subcommittee of the
AAPM Radiation Therapy Committee.” (2003) |
American Association of Physicists in Medicine
(AAPM), Radiation Therapy Committee, IMRT Subcommittee, One Physics Ellipse, |
He-P 4047.10(d) |
“Quality Assurance for Computed-Tomography
Simulators and the Computed-Tomography-Simulation Process.” (2003) |
American Association of Physicists in Medicine
(AAPM) Radiation Task Group 66 One Physics Ellipse, |
He-P 4047.11(d)(4) a. |
International Electrotechnical Commission (IEC)
Document 60601-1:1998 +A1 +A2: 1995 |
International Electrotechnical Commission (IEC),
Regional Center for North America, 446 Main Street, 16th Floor,
Worcester, MA 01608, www.601help.com/other_601_standard/other_601_standard.html. Cost:
$185.00 (pdf) and $213.00 (hardcopy). |
He-P 4047.11(d)(4) b. |
International Electrotechnical Commission (IEC)
Document 60601-1-2: 2001 |
International Electrotechnical Commission (IEC) Regional Center for North America, 446 Main Street,
16th Floor, Worcester, MA
01608, www.601help.com/other_601_standard/other_601_standard.html. Cost:
$185.00 (pdf) and $213.00 (hardcopy). |
He-P 4047.11(d)(4) c. |
International Electrotechnical Commission (IEC)
Document 60601-2-8:1999 |
International Electrotechnical Commission (IEC) |
He-P 4047.11(d)(4) d. |
International Electrotechnical Commission (IEC)
Document 60601-2-17:2004 |
International Electrotechnical Commission (IEC),
Regional Center for North America, 446 Main Street, 16th Floor,
Worcester, MA 01608, www.601help.com/other_601_standard/other_601_standard.html. Cost:
$185.00 (pdf) and $213.00 (hardcopy). |
Appendix
B
Rule |
State
or Federal Statute or Federal Regulation Implemented |
He-P
4001, 4019, 4022 (specific provisions implementing specific statutes are
given below), |
RSA
125-F:1; RSA 125-F:2; and RSA 125-F:5, II, IV, and V |
He-P 4001 |
RSA 125-F:1, RSA
125-F:2, and RSA 125-F:5, II, IV, and V, Section 274 of
the Atomic Energy Act of 1954, as amended, and Title 10 CFR |
He-P 4001.01 |
RSA 125-F:1,
F:2, F:5 II & V; 10 CFR 19.2 & 20.1002 |
He-P 4001.02 |
10 CFR 30.12,
40.11, 70.11 |
He-P 4001.03 |
10 CFR 30.51,
40.61, 70.51 |
He-P 4001.04 |
10 CFR 30.52,
40.62, 70.55 |
He-P 4001.05 |
10 CFR 30.53,
40.63, 70.56, 34.27, 35.67, 39.35 |
He-P 4001.06 |
RSA 125-F:1,
F:2, F:5 II & V |
He-P 4001.07 |
10 CFR 30.10,
40.10, 70.10 |
He-P 4001.08 |
RSA 125-F:1, RSA
125-F:2, and RSA 125-F:5, II, IV, and V, Section 274 of
the Atomic Energy Act of 1954, as amended, and 10 CFR 30.6, 40.5, and 70.5 |
He-P 4001.09 |
10 CFR 20.1004 |
He-P 4001.10 |
10 CFR 20.1005 |
He-P 4001.11 |
10 CFR 20.1003 |
He-P 4001.12 |
RSA 125-F:5, 7,
17, 19 & RSA 541-A |
|
|
He-P
4003.01 |
10
CFR 20.1003 and 10 CFR 30.4 |
He-P
4003.01 (o), (v) intro., (v)(5) intro., (v)(5)a.,(ae), (co), (ed), (er),(fk), (fr) & (fw) |
10
CFR 20.1003; 10 CFR 30.4; and 10 CFR 40.4 |
|
|
He-P 4019
|
Section 274 of the Atomic Energy Act of 1954, as
amended, and Title 10, Code of Federal Regulations (CFR) |
He-P 4019.01 |
Section 274 of
the Atomic Energy Act of 1954, as amended and 10 CFR 19.1 |
He-P 4019.02 |
10 CFR 19.2 |
He-P 4019.03 |
10 CFR 19.11 |
He-P 4019.04 |
10 CFR 19.12 |
He-P 4019.05 |
10 CFR 19.13 |
He-P 4019.06 |
10 CFR 19.14 |
He-P 4019.07 |
10 CFR 19.15 |
He-P 4019.08 |
10 CFR 19.16 |
He-P 4019.09 |
10 CFR 19.17 |
|
|
He-P
4020.01 |
10
CFR 20.1001 |
He-P
4020.02 |
10
CFR 20.1002 |
He-P
4020.03 |
10
CFR 20.1008 |
He-P
4020.04 |
10
CFR 20.1101 |
He-P
4020.05 |
10
CFR 20.1201 |
He-P
4020.06 |
10
CFR 20.1202 |
He-P
4020.07 |
10
CFR 20.1203 |
He-P
4020.08 |
10
CFR 20.1204 |
He-P
4020.09 |
10
CFR 20.2104 |
He-P
4020.10 |
10
CFR 20.1206 |
He-P
4020.11 |
10
CFR 20.1207 |
He-P
4020.12 |
10
CFR 20.1208 |
He-P
4020.13 |
10
CFR 20.1301 |
He-P
4020.14 |
10
CFR 20.1302 |
|
|
He-P
4021.01 |
10
CFR 20.2101 |
He-P
4021.02 |
10
CFR 20.2102 |
He-P
4021.03 |
10
CFR 20.2103 |
He-P
4021.04 |
RSA
125-F:2 |
He-P
4021.05 |
10
CFR 20.2104 |
He-P
4021.06 |
10
CFR 20.2105 |
He-P
4021.07 |
10
CFR 20.2106 |
He-P
4021.08 |
10
CFR 20.2107 |
He-P
4021.09 |
10
CFR 20.2108 |
He-P
4021.10 |
10
CFR 36.81 |
He-P
4021.11 |
10
CFR 20.2110 |
He-P
4021.12 |
10
CFR 20.2201 |
He-P
4021.13 |
10
CFR 20.2202 |
He-P
4021.14 |
10
CFR 20.2203 |
He-P
4021.15 |
10
CFR 20.2204 |
He-P
4021.16 |
10
CFR 20.2205 |
He-P
4021.17 |
10
CFR 20.2206 |
He-P
4021.18 |
10
CFR 20.2206 |
He-P
4021.19 |
10
CFR 36.81(h) |
He-P
4021.20 |
NRC
Appendix U |
He-P
4021.21 |
NRC
Appendix U |
He-P 4021.22 |
10
CFR 20.2207 |
|
|
He-P 4022
|
Section 274 of the Atomic Energy Act of 1954, as amended, and Title 10,
Code of Federal Regulations (CFR) |
He-P 4022.01 |
10 CFR 20.1501 |
He-P 4022.02 |
10 CFR 20.1502 |
He-P 4022.03 |
10 CFR 20.02 |
He-P 4022.04 |
10
CFR 20.1601 |
He-P 4022.05 |
10 CFR
20.1602 |
He-P 4022.06 |
10
CFR 36.23, 20.1602, 835.502 |
He-P 4022.07 |
10 CFR 20.1701
and 20.1702 |
He-P 4022.08 |
10 CFR 20.1703,
20.1704 and 20.1705 |
He-P 4022.09 |
10
CFR 20.1801 |
He-P 4022.10 |
10
CFR 20.1802 |
He-P 4022.11 |
10
CFR 20.1901 |
He-P 4022.12 |
10
CFR 20.1902 |
He-P 4022.13 |
10 CFR 20.1903 |
He-P 4022.14 |
10
CFR 20.1904; 21 CFR 1020.30, 21 CFR 1020.31, 21
CFR 1020.32, 21 CFR 1020.40 |
He-P 4022.15 |
10
CFR 20.1905 |
He-P 4022.16 |
10
CFR 20.1906, 10 CFR 71.4, and 10 CFR 71- Appendix |
|
|
He-P
4023.01 |
10
CFR 20.2001 |
He-P
4023.02 |
10
CFR 20.2002 |
He-P
4023.03 |
10
CFR 20.2003 |
He-P
4023.04 |
10
CFR 20.2004 |
He-P
4023.05 |
10
CFR 20.2005 |
He-P
4023.06 |
10
CFR 20.2006 |
He-P
4023.07 |
10
CFR 20.2007 |
He-P
4023.08 |
10
CFR 20.2008 |
|
|
He-P 4024 (specific
provisions implementing specific statutes as specified below) |
RSA 125-F:1, RSA
125-F:2, & RSA 125-F:5, II and V; Section 274 of the Atomic Energy Act of
1954, as amended |
He-P 4024.01 |
10 CFR 20.1401 |
He-P 4024.02 |
10 CFR 20.1401 |
He-P 4024.03 |
10 CFR 20.1401 |
He-P 4024.04 |
10 CFR 10.1406 |
He-P 4024.05 |
10 CFR 30.36,
40.42, and 70.38 |
He-P 4024.06 |
10 CFR 30.36,
40.42, and 70.38 |
He-P 4024.07 |
10 CFR 30.36,
40.42, and 70.38 |
He-P 4024.08 |
10 CFR 30.36,
40.42, and 70.38 |
He-P 4024.09 |
10 CFR 20.1402 |
He-P 4024.10 |
10 CFR 20.1403 |
He-P 4024.11 |
10 CFR 20.1404 |
He-P 4024.12 |
10 CFR 20.1401 |
He-P 4024.13 |
10 CFR 20.1405 |
He-P 4024.14 |
10 CFR 20.1401 |
|
|
He-P 4030
(various sections) |
RSA 125-F:1; RSA
125-F:2; and RSA 125‑F:5, II IV, and V; Section 274 of the Atomic Energy Act (AEA) of 1954, as amended, and
Title 10, Code of Federal Regulations (CFR) |
He‑P 4030 |
Section 274 of the AEA of 1954, as amended, and Title 10 CFR Parts 30,
40 and 70 |
He‑P
4030.01 |
10 CFR 30.3,
40.3, 70.3 |
He‑P
4030.02 |
10 CFR 40.13,
40.14 |
He-P 4030.03 |
10 CFR 30.11,
30.14, 30.15, 30.18, 30.19, 30.20 |
He-P 4030.04 |
10 CFR 30.12,
40.11, 70.11 |
He-P 4030.05 |
10 CFR 30.21 |
He-P 4030.06 |
10 CFR 30.31 |
He-P 4030.07 |
10 CFR 30.32, 40.31,
10 CFR 32.210 |
He-P 4030.08 |
10 CFR 30.72,
Schedule C; 10 CFR 40.31; 10 CFR 70.22 |
He‑P
4030.09 |
10 CFR 30.33,
30.34, 30.35, 40.32, 40.34, 40.35, 40.36, 40.41, 70.23 |
He-P 4030.10 |
10 CFR 30.34 |
He-P 4030.11 |
10 CFR 30.36,
40.42, 70.38 |
He-P 4030.12 |
10 CFR 30.37,
40.43, 70.33 |
He-P 4030.13 |
10 CFR 30.38,
40.44, 70.34 |
He-P 4030.14 |
10 CFR 30.39,
40.45, 70.35 |
He-P 4030.15 |
10 CFR 30.34,
40.46, 70.36 |
He-P 4030.16 |
10 CFR 30.41,
40.51, 70.42 |
He-P 4030.17 |
10 CFR 30.61,
40.71, 70.81 |
He-P 4030.18 |
10 CFR 150.20 |
He-P
4030.19 |
10
CFR 40.54 |
He-P
4030.20 |
10
CFR 40.55 |
|
|
He-P
4031.01 |
10
CFR 31.1 |
He-P
4031.02 |
10
CFR 31.2 |
He-P
4031.03 |
10
CFR 40.21, 40.22, 40.25 |
He-P 4031.04 |
10 CFR 31.3, 31.4,
31.5, 31.7, 31.8, 31.9, and 31.10 |
He-P 4031.05 |
10 CFR 31.6 |
He-P
4031.06 |
10
CFR 31.12 |
|
|
He-P 4032 |
Section 274 of the AEA of 1954, as amended, and Title 10 CFR Part 32 |
He-P 4032.01 |
10 CFR 32.1 |
He-P 4032.02 |
10 CFR 32.1(b) |
He-P 4032.03 |
10 CFR 32.51 |
He-P 4032.04 |
10 CFR 32.11 |
He-P 4032.05 |
10 CFR 32.72 |
He-P 4032.06 |
10 CFR 32.72 |
He-P 4032.07 |
10 CFR 32.74 |
He-P 4032.08 |
10 CFR 32.53 |
He-P 4032.09 |
10 CFR 32.18 |
He-P 4032.10 |
10 CFR 32.26 |
He-P 4032.11 |
10 CFR 32.14 |
He-P 4032.12 |
10 CFR 32.13 |
He-P 4032.13 |
10 CFR 32.201 |
He-P 4032.14 |
10 CFR 32.57 |
He-P 4032.15 |
10 CFR 32.51 |
He-P 4032.16 |
10 CFR 32.61, 10 CFR 32.62 |
|
|
He-P 4033 |
Section 274 of the AEA of 1954, as amended, and Title 10 CFR Part 33 |
He-P 4033.01 |
10 CFR 33.1 |
He-P 4033.02 |
10 CFR 33.1 |
He-P 4033.03 |
10 CFR 33.11 |
He-P 4033.04 |
10 CFR 33.12 |
He-P 4033.05 |
10 CFR 33.13,
33.14, 33.15 |
He-P 4033.06 |
10 CFR 33.17 |
He-P 4033.07 |
10 CFR 33.100,
Schedule A |
|
|
He-P 4034 |
Section 274 of the AEA of 1954, as amended, and Title 10 CFR Part 34;
Title 21 CFR Part 1020 |
He-P 4034.01 |
10 CFR 34.1 |
He-P 4034.02 |
10 CFR 34.1 |
He-P 4034.03 |
10 CFR 34.3, 21
CFR 1020.40 |
He-P 4034.04 |
10 CFR Part 34,
Subpart G (10 CFR 34.111); 21 CFR 1020.40 |
He-P 4034.05 |
10 CFR Part
34.11, 34.13 |
He-P 4034.06 |
10 CFR 34.20 |
He-P 4034.07 |
10 CFR 34.21 |
He-P 4034.08 |
10 CFR 34.23 |
He-P 4034.09 |
10 CFR 34.25 |
He-P 4034.10 |
10 CFR 34.27 |
He-P 4034.11 |
10 CFR 34.29 |
He-P 4034.12 |
10 CFR 34.31 |
He-P 4034.13 |
10 CFR 34.33 |
He-P 4034.14 |
10 CFR 34.35 |
He-P 4034.15 |
10 CFR 34.41 |
He-P 4034.16 |
10 CFR 34.42 |
He-P 4034.17 |
10 CFR 34.43 |
He-P 4034.18 |
10 CFR 34.45 |
He‑P
4034.19 |
10 CFR 34.46 |
He‑P 4034.20 |
10 CFR 34.47 |
He-P 4034.21 |
10 CFR 34.49 |
He-P 4034.22 |
10 CFR 34.51 |
He-P 4034.23 |
10 CFR 34.53 |
He-P 4034.24 |
10 CFR 34.61 |
He-P 4034.25 |
10 CFR 34.63 |
He-P 4034.26 |
10 CFR 34.65 |
He-P 4034.27 |
10 CFR 34.67 |
He-P 4034.28 |
10 CFR 34.69 |
He-P 4034.29 |
10 CFR 34.71 |
He-P 4034.30 |
10 CFR 34.73 |
He-P 4034.31 |
10 CFR Part 34,
Subpart E (10 CFR 34.75) |
He-P 4034.32 |
10 CFR 34.79 |
He-P 4034.33 |
10 CFR 34.81 |
He-P 4034.34 |
10 CFR 34.83 |
He-P 4034.35 |
10 CFR 34.85 |
He-P 4034.36 |
10 CFR 34.87 |
He-P 4034.37 |
10 CFR 34.89 |
He-P 4034.38 |
10 CFR 34.101 |
He-P 4034.39 |
10 CFR 34.41 |
He-P 4034
Appendix A |
10 CFR Part 34,
Appendix A |
|
|
He-P 4035
(various sections below) |
Section 274 of the AEA of 1954, as amended, and Title 10, Code of
Federal Regulations (CFR), Part 35 |
He-P 4035.01-
He-P 4035.02 |
10 CFR 35.1 |
He-P 4035.02 |
10 CFR 35.1 |
He-P 4035.03 |
10 CFR 35.2 |
He-P 4035.04 |
10 CFR 35.11,
35.6 |
He-P 4035.05 |
10 CFR 35.12,
35.13 |
He-P 4035.06 |
10 CFR 35.14 |
He-P 4035.07 |
10 CFR 35.24,
35.26, 35.2026 |
He-P 4035.08 |
10 CFR 35.24 |
He-P 4035.09 |
10 CFR 35.24 |
He-P 4035.10 |
10 CFR 35.24,
35.2024 |
He-P 4035.11 |
10 CFR 35.27 |
He-P 4035.12 |
10 CFR 35.80,
35.2080 |
He-P 4035.13(b)
intro. & (b)(4) |
10 CFR 35.40,
35.41, 35.100, 35.2040, 35.2041 |
He-P 4035.14 |
10 CFR 35.3045 |
He-P 4035.15 |
10 CFR 35.49 |
He-P 4035.16 |
10 CFR 35.60,
35.2060 |
He-P 4035.17 |
10 CFR 35.60,
35.2060 |
He-P 4035.18 |
10 CFR 35.61,
35.2061 |
He-P 4035.19 |
10 CFR 35.63,
35.2063 |
He-P 4035.20 |
10 CFR 35.65 |
He-P 4035.21 |
10 CFR 35.67,
35.2067, 35.3067 |
He-P 4035.22
Reserved |
|
He-P 4035.23 |
10 CFR 35.69 |
He-P 4035.24 |
10 CFR 35.70,
35.2070 |
He-P 4035.25 |
10 CFR 35.75,
35.2075 |
He-P 4035.26 |
10 CFR 35.80,
2080 |
He-P 4035.27 |
10 CFR 35.100 |
He-P 4035.28 |
10 CFR 35.92,
35.2092 |
He-P 4035.29 |
10 CFR 35.1000 |
He-P 4035.30
Reserved |
|
He-P 4035.31 |
10 CFR 35.200 |
He-P 4035.32 |
10 CFR 35.204,
35.2204 |
He-P 4035.33 |
RSA 125-F:5, V |
He-P 4035.34 Reserved |
|
He-P 4035.35 |
10 CFR 35.300 |
He-P 4035.36 |
10 CFR 35.310,
35.2310 |
He-P 4035.37 |
10 CFR 35.315 |
He-P 4035.38 |
10 CFR 35.3047 |
He-P 4035.39 |
10 CFR 35.500 |
He-P 4035.40
Reserved |
10 CFR 35.457 |
He-P 4035.41 |
10 CFR 35.400 |
He-P 4035.42 |
10 CFR 35.410,
35.2310 |
He-P 4035.43 |
10 CFR 35.415 |
He-P 4035.44 |
10 CFR 35.406,
35.2406 |
He-P 4035.45 |
10 CFR 35.404,
35.604, 35.2404 |
He-P 4035.46 |
10 CFR 35.432,
35.2432 |
He-P 4035.47 |
10 CFR 35.600 |
He-P 4035.48 |
10 CFR 35.605,
35.2605 |
He-P 4035.49 |
10 CFR 35.12,
35.13 |
He-P 4035.50 |
10 CFR 35.610,
35.2310, 35.2610 |
He-P 4035.51 |
10 CFR 35.615 |
He-P 4035.52 |
10 CFR 35.647 |
He-P 4035.53 |
10 CFR 35.630,
35.2630 |
He-P 4035.54 |
10 CFR 35.632,
35.632, 35.633, 35.635 |
He-P 4035.55 |
10 CFR 35.642,
35.643, 35.645, 35.2642, 35.2643, 35.2645 |
He-P 4035.56 |
10 CFR 35.652,
35.2652 |
He-P 4035.57 |
10 CFR 35.657 |
He-P 4035.58
Reserved |
|
He-P 4035.59 |
10 CFR 35.690 |
He-P 4035.60 |
10 CFR 35.655,
35.2655 |
He-P 4035.61 |
10 CFR 35.50 |
He‑P
4035.62 Reserved |
|
He‑P
4035.63 |
10 CFR 35.190 |
He‑P
4035.64 |
10 CFR 35.290 |
He‑P
4035.65 |
10 CFR 35.390 |
He‑P
4035.66 |
10 CFR 35.392,
35.394, 35.396 |
He‑P
4035.67 |
10 CFR 35.433,
35.491 |
He‑P
4035.68 |
10 CFR 35.590 |
He‑P
4035.69 |
10 CFR 35.490 |
He‑P
4035.70 |
10 CFR 35.51 |
He‑P
4035.71 |
10 CFR 35.57 |
He‑P
4035.72 Reserved |
|
He‑P
4035.73 |
10 CFR 35.59 |
He‑P
4035.74 |
10 CFR 35.44 |
He‑P
4035.75 Reserved |
|
|
|
He-P 4036.01 -
4036.03 |
RSA 125-F:1,
125-F:2 & 125-F:5, II; Section 274 of the Atomic Energy Act of 1954 as
amended; 10 CFR Part 36 |
He-P 4036.04 |
RSA 125-F:1,
125-F:2 & 125-F:5, II & 125-F:14; Section 274 of the Atomic Energy
Act of 1954 as amended; 10 CFR Part 36 |
|
|
He-P 4037.01 |
RSA 125-F:1, RSA
125-F:2, & RSA 125-F:5 II and V; Section 274 of the Atomic Energy Act of
1954, as amended; and Title 10 CFR, Part 71, Section 71.0 |
He-P 4037.02 |
RSA 125-F:1, RSA
125-F:2, & RSA 125-F:5 II and V; Section 274 of the Atomic Energy Act of
1954, as amended; and Title 10 CFR, Part 71, Section 71.0 |
He-P 4037.03 |
RSA 125-F:1, RSA
125-F:2, & RSA 125-F:5 II and V; Section 274 of the Atomic Energy Act of
1954, as amended; and Title 10 CFR 71.4 |
He-P 4037.04 |
RSA 125-F:1, RSA
125-F:2, & RSA 125-F:5 II and V; Section 274 of the Atomic Energy Act of
1954, as amended; and Title 10 CFR, Part 71 (effectively, Sections 10 CFR
71.1-71.3, 71.5-71.137 and Appendix A to Part 71.) |
|
|
He-P 4038 (specific
provisions implementing specific statutes are given below) |
RSA 125-F:1; RSA
125-F:2; and RSA 125-F:5, II, IV, and V; Section 274 of the Atomic Energy Act
of 1954, as amended |
He-P 4038.01 |
10
CFR 37.1 |
He-P 4038.02 |
10 CFR 37.2 |
He-P 4038.03 |
10
CFR 37.5 |
He-P 4038.04 |
10 CFR 37.7 |
He-P 4038.04
intro., & (b) |
10 CFR 37.7 |
He-P 4038.05 |
10 CFR 37.9 |
He-P 4038.06 |
10
CFR 37.11 |
He-P 4038.06(a) |
10
CFR 37.11(a) |
He-P 4038.07 |
10 CFR 37.21 |
He-P 4038.08 |
10 CFR 37.23 |
He-P
4038.08(d), (f), (j) intro., (j)(1), & (k) |
10 CFR 37.23(b)(1), (b)(2), (f), (e),
& (g) |
He-P 4038.09 |
10
CFR 37.25 |
He-P 4038.10 |
10 CFR 37.27 |
He-P
4038.10(a) intro., & (a)(1) |
10 CFR 37.27 |
He-P 4038.11 |
10 CFR 37.29 |
He-P
4038.11(a) intro., (a)(10), (a)(12), (a)(13), & (b) intro. |
10 CFR 37.29(a) & (b) |
He-P 4038.12 |
10 CFR 37.31 |
He-P 4038.13 |
10
CFR 37.33 |
He-P 4038.13(a)
intro., (a)(3), (b) intro., & (b)(3) |
10
CFR 37.33 |
He-P 4038.14 |
10 CFR 37.41 |
He-P 4038.14(a)
intro., & (a)(2) |
10 CFR 37.41(a) |
He-P 4038.15 |
10 CFR 37.43 |
He-P 4038.15(a)
intro., (a)(1), (a)(4), (c) intro., (c)(1) intro., (c)(1)b., & (d) |
10 CFR 37.43(a),
(c)(1), and (d)(1)-(d)(8) |
He-P 4038.16 |
10
CFR 37.45 |
He-P 4038.16(b)
intro. |
10
CFR 37.45(a) & (b) |
He-P 4038.17 |
10 CFR 37.47 |
He-P 4038.18 |
10 CFR 37.49 |
He-P 4038.19 |
10
CFR 37.51 |
He-P 4038.20 |
10 CFR 37.53 |
He-P 4038.21 |
10 CFR 37.55 |
He-P 4038.21(a) intro., & (a)(2) |
10 CFR 37.55 |
He-P 4038.22 |
10 CFR 37.57 |
He-P 4038.22 |
10 CFR 37.57 |
He-P 4038.23 |
10
CFR 37.71 |
He-P 4038.24 |
10 CFR 37.73 |
He-P 4038.24 |
10 CFR 37.73 |
He-P 4038.25 |
10 CFR 37.75 |
He-P 4038.26 |
10
CFR 37.77 |
He-P 4038.27 |
10 CFR 37.79 |
He-P 4038.28 |
10 CFR 37.81 |
He-P 4038.28(b), (c), (d), (e), &
(f) |
10 CFR 37.81(a)-(f) |
He-P 4038.29 |
10
CFR 37.101 |
He-P 4038.30 |
10 CFR 37.103 |
He-P 4038.31 |
10
CFR 37.105 |
|
|
He-P 4039.01 -
4039.03 |
RSA 125-F:1,
125-F:2 & 125-F:5, II; Section 274 of the Atomic Energy Act of 1954 as
amended; 10 CFR Part 39 |
He-P 4039.04 |
RSA 125-F:1,
125-F:2 & 125-F:5, II & 125-F:14; Section 274 of the Atomic Energy
Act of 1954 as amended; 10 CFR Part 39 |
|
|
He-P 4040.01 -
4040.12 |
RSA 125-F:5, IV
& V; RSA 125-F:7, II-IV, F: 13 |
He-P 4040.06(i) |
RSA 125-F:5, IV
& V; RSA 125-F:7, II-IV, and RSA 125-F:13 |
He-P 4040.13 |
RSA 541-A:22, IV |
He-P 4041, 4043,
4044, 4045, 4046, and 4047 (specific provisions implementing specific
statutes are given below), |
RSA 125-F:1; RSA
125-F:2; and RSA 125-F:5, II IV, and V |
|
|
He-P 4041.01 |
RSA 125-F:1,
F:2, F:5 II & V |
He-P 4041.02 |
21
CFR 1020.30, 1020.31, 1020.32, 1020.33, 1020.40 |
He-P 4043.01 |
RSA 125-F:1, RSA
125-F:2, RSA 125-F:5, II & V |
He-P 4043.02 |
RSA 125-F:1, RSA
125-F:2, RSA 125-F:5, II & V |
He-P 4043.03 |
RSA 125-F:1, RSA
125-F:2, RSA 125-F:5, II & V |
He-P 4043.04 |
RSA 125-F:1, RSA
125-F:2, RSA 125-F:5, II & V |
He-P 4043.05 |
RSA 125-F:1, RSA
125-F:2, RSA 125-F:5, II & V |
He-P 4043.06 |
RSA 125-F:1, RSA
125-F:2, RSA 125-F:5, II & V |
He-P 4043.07 |
RSA 125-F:1, RSA
125-F:2, RSA 125-F:5, II & V |
|
|
He-P 4044.01 |
RSA 125-F:1, RSA
125-F2, RSA 125-F:5, II & V |
He-P 4044.02 |
RSA 125-F:1, RSA
125-F:2, RSA 125:5, II & V |
He-P 4044.03 |
RSA 125-F:1, RSA
125-F:2, RSA 125-F:5, II & V |
He-P 4044.04 |
RSA 125-F:1, RSA
125-F:2, RSA 125-F:5, II & V |
He-P 4044.05 |
RSA 125-F:1, RSA
125-F:2, RSA 125-F:5, II & V |
He-P 4044.06 |
RSA 125-F:1, RSA
125-F:2, RSA 125-F:5, II & V |
He-P 4044.07 |
RSA 125-F:1, RSA
125-F:2, RSA 125-F:5, II & V |
He-P 4044.08 |
RSA 125-F:1, RSA
125-F:2, RSA 125-F:5, II & V |
He-P 4044.09 |
RSA 125-F:1, RSA
125-F:2, RSA 125-F:5, II & V |
He-P 4044.10 |
RSA 125-F:1, RSA
125-F:2, RSA 125-F:5, II & V |
He-P 4044.11 |
RSA 125-F:1, RSA
125-F:2, RSA 125-F:5, II & V |
He-P 4044.12 |
RSA 125-F:1, RSA
125-F:2, RSA 125-F:5, II & V |
|
|
He-P 4045.01 |
RSA 125-F:1,
F:2, F:5 II & V |
He-P 4045.02 |
RSA 125-F:1,
F:2, F:5 II & V |
He-P 4045.03 |
RSA 125-F:1, RSA
125-F:2, RSA 125-F:5, II &V; 21 CFR 1020.30, 21 CFR 1020.31, 21 CFR
1020.32, 21 CFR 1020.40 |
He-P 4045.04 |
RSA 125-F:1,
F:2, F:5, II & V |
He-P 4045.05 |
RSA 125-F:1,
F:2, F:5, II & V; 21 CFR 1002.10, 1002.11,
1002.12, 1002.13, 1002.30, 1020.31, 1020.32, 1020.40 |
He-P 4045.06 |
RSA 125-F:1,
F:2, F:5, II & V |
He-P 4045.07 |
RSA 125-F:1,
F:2, F:5, II & V |
He-P 4045.08 |
RSA 125-F:1, F:
2, F:5 |
He-P 4045.09 |
RSA 125-F:1,
F:2, F:5 |
He-P 4045.10 |
RSA 125-F:1,
F:2, F:5 |
|
|
He-P 4046.01
|
RSA 125-F:1,
F:2, F:5, II & V; 21 CFR 1020.30, 1020.31,
1020.32, 1020.40 |
He-P 4046.02 |
RSA 125-F:1,
F:2, F:5, II & V; 21 CFR 1020.30, 21 CFR
1020.32 |
He-P 4046.03 |
RSA 125-F:1,
F:2, F:5, II & V; 21 CFR 1020.30, 21 CFR
1020.32, 21 CFR 1020.32(d)(3)(iv) |
He-P 4046.04 |
RSA 125-F:1,
F:2, F:5, II & V; 21 CFR 1020.30, 21 CFR
1020.32 |
He-P 4046.05 |
RSA 125-F:1,
F:2, F:5, II & V; 21 CFR 1020.30, 21 CFR
1020.32 |
He-P 4046.06 |
RSA 125-F:1,
F:2, F:5, II & V; 21 CFR 1020.30, 21 CFR
1020.32 |
He-P 4046.07 |
RSA 125-F:1,
F:2, F:5, II & V; 21 CFR 1020.30, 21 CFR
1020.31 |
He-P 4046.08 |
RSA 125-F:1,
F:2, F:5, II & V; 21 CFR 1002.10, 1002.11,
1002.12, 1002.13, 1002.30, 1002.40, 1020.30, 1020.31, 1020.32 |
He-P 4046.09 |
RSA 125-F:1,
F:2, F:5, II & V; 21 CFR 1002.10, 1002.11,
1002.12, 1002.13, 1002.30, 1002.40, 1020.30, 1020.31, 1020.32 |
He-P 4046.10 |
RSA 125-F:1,
F:2, F:5, II & V; 21 CFR 1002.10, 1002.11,
1002.12, 1002.13, 1002.30, 1002.40, 1020.30, 1020.31, 1020.32 |
He-P 4046.11 |
RSA 125-F:1,
F:2, F:5, II & V, 21 CFR 1002.10, 1002.11,
1002.12, 1002.13, 1002.30, 1002.40, 1020.30, 1020.31, 1020.32, 1020.33 |
He-P 4046.12 |
RSA 125-F:1,
F:2, F:5, II & V; 21 CFR 1020.33 |
He-P 4046.13 |
RSA 125-F:1,
F:2, F:5, II & V; 21 CFR 1020.33 |
He-P 4046.14
|
RSA 125-F:1, F:2,
F:5, II & V; 21 CFR 900 |
He-P 4046.15
|
RSA 125-F:1,
F:2, F:5 |
He-P 4046.16
|
RSA 125-F:1,
F:2, F:5 |
He-P 4046.17
|
RSA 125-F:1,
F:2, F:5 |
|
|
He-P 4047.01 |
RSA 125-F:1,
F:2, F:5, II & V |
He-P 4047.02 |
RSA 125-F:1,
F:2, F:5, II & V |
He-P 4047.03 |
RSA 125-F:1,
F:2, F:5, II & V |
He-P 4047.04 |
RSA 125-F:1,
F:2, F:5, II & V |
He-P 4047.05 |
RSA 125-F:1,
F:2, F:5, II & V |
He-P 4047.06 |
RSA 125-F:1,
F:2, F:5, II & V |
He-P 4047.07 |
RSA 125-F:1,
F:2, F:5, II & V |
He-P 4047.08 |
RSA 125-F:1, F:2,
F:5, II & V |
He-P 4047.09 |
RSA 125-F:1,
F:2, F:5, II & V |
He-P 4047.10 |
RSA 125-F:1,
F:2, F:5, II & V |
He-P 4047.11 |
RSA 125-F:1,
F:2, F:5, II & V |
He-P 4047.12 |
RSA 125-F:1,
F:2, F:5, II & V |
|
|
He-P 4062.01 –
He-P 4062.03 |
RSA 125-F:5,
IV&V; RSA 125-F:7, II-IV; and Appendix G to 10 CFR 20 |
|
|
He-P 4070.01 –
He-P 4070.09 |
RSA 125-F:5,
F:8, F: 22, IV |
He-P 4070.05(e),
Table 4070.1-A |
RSA 125-F:5,
F:8, F: 22, IV |
He-P 4070.06,
Table 4070.2 |
RSA 125-F:1,
F:2, F:5, II & V |
|
|
He-P
4071.01 - 4071.05 |
RSA
125-F:8-a, III |
|
|
He-P 4090.01 |
RSA 125-F:5, V;
Appendix B to 10 CFR 20 |
He-P
4090.02 |
10 CFR 20 Appendix B |
|
|
He-P 4091.01-
He-P 4091.03 |
RSA 125-F:5, V
and Appendix B to 10 CFR 30.71 |
|
|
He-P 4092.01 |
RSA 125-F:5, V
and Appendix C to 10 CFR 20 |
|
|
He-P 4093
|
Section 274 of the Atomic Energy Administration
(AEA) of 1954, as amended, and Title 10, Code of Federal Regulations (CFR),
Part 30, 10 CFR Part 30.70, Schedule A |
|
|
He-P 4095 (specific
provisions implementing specific statutes as specified below) |
RSA 125-F:1, RSA
125-F:2, & RSA 125-F:5 II and V; Section 274 of the Atomic Energy Act of
1954, as amended |
He-P 4095.01 |
Appendix A to 10
CFR 20.36 |
He-P 4095.02 |
Appendix A to 10
CFR 20.36 |
|
|
He-P 4096 |
Section 274 of
the AEA of 1954 as amended, and Title 10 CFR, Part 30, 10 CFR 30.71,
Schedule B |
|
|
He-P 4097.01 –
4097.02 |
10 CFR 20
Appendix E |